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Abstract
Porphyromonas gingivalis is a Gram-negative oral anaerobic pathogen and is one of
the key causative agents of the periodontitis. P. gingivalis utilises a range of virulence
factors to drive pathogenesis that are exported and attached to the cell surface via the
Type 9 Secretion System (T9SS). All cargo proteins possess a conserved C-terminal
signal domain (CTD) which is recognised by the T9SS via an unknown mechanism.
The T9SS transports cargo proteins to the outer membrane where the CTD is re-
move and the cargo is anchored to the cell surface. The aim of this thesis was to
provide structural characterisation of the CTD and to understand how it interacts
with components of the T9SS. To achieve this, solution state NMR was used to study
the structure and dynamics of the CTD from RgpB, showing it to be a seven stranded
β sandwich, in alignment with the crystallographic model. The model presented here,
supported by NMR relaxation data, suggests RgpB- CTD a monomer in solution,
unlike the crystal structure, in which a dimeric state is observed. It has previously
been shown that the outer-membrane β-barrel protein PorV is able to interact with
T9SS cargo proteins. It has been possible to recombinantly express and purify the
full length PorV protein and work is ongoing to demonstrate that it interacts with
RpgB-CTD via a pulldown assay. In this study a predicted structure of P. gingivalis
PorV was generated and simulated in a lipid bilayer using GROMACs. Representative
conformations were used to generate a structural ensemble for molecular docking with
the NMR model of RgpB-CTD. Binding was examined between the two proteins and
v
multiple binding poses were observed. From these models two possible mechanisms
of CTD recognition by PorV are suggested. Future work to experimentally study this
interaction will allow for the models to refined further.
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Periodontal disease is an inflammatory condition affecting the gingiva and the support-
ing structures of the periodontium [1]. In severe cases it can lead to the destruction
of the periodontal ligament, and alveolar bone leading to tooth loss [2]. Periodontal
disease is classified into two broad groups: gingivitis and periodontitis - both of which
can be either local or general [3]. Gingivitis is classified as inflammation of the gin-
gival tissue and accumulation of dental plaque but with no damage to the gingiva
and periodontium (Figure 1.1.1B). Gingivitis is a reversible state but it can progress
to periodontitis. Periodontitis is classified as irreversible inflammation of the peri-
odontal tissue with damage caused to the periodontal ligament, alveolar bone and
tooth (Figure 1.1.1C). This causes the formation of the periodontal pocket - a cavity
formed between the gum and the tooth that provides a suitable environment for fur-
ther colonisation by the oral biofilm [4]. Chronic periodontitis is widely prevalent with
around 10% of the global population being affected by severe periodontitis [5]. It is
particularly prevalent in the western world with an estimated 46% of the US adult pop-
ulation affected [6]. Many risk factors that contribute to the development of chronic
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periodontitis some of which can be modified and controlled, some which cannot [7].
Modifiable factors include smoking, obesity, diet, stress, oral hygiene and the compos-
ition of the oral microbiome. Non-modifiable factors include genetic polymorphisms
and underlying systemic conditions such as AIDS [8] and Downs Syndrome [9]. The
development of chronic periodontitis is in turn associated with increased susceptibility
to other diseases including cardiovascular disease [10], diabetes [11], arthritis [12] and
Alzheimer’s disease [13].
Figure 1.1.1: Progression of periodontal disease. (A) Healthy gingiva with
no inflammation and pocket depth of less than 3 mm. (B) Tooth with gingivitis,
characterised by a build up of plaque, swollen gums and a deepening of the period-
ontal pocket. (C) Tooth with periodontitis, characterised by severe inflammation,
destruction of the alveolar bone and recession of the gum leading to the formation of a
periodontal pocket with a depth greater than 5 mm. Advanced stages of periodontitis
can lead to loosening or loss of the tooth. (Adapted from [14]).
1.2 The Role of P. gingivalis in Periodontal Dis-
ease
The development of periodontal disease is not caused by a single pathogenic organism
but by a consortium of pathogenic microbes. As the biofilm develops the popula-
tion of Gram-negative anaerobes, including the potential pathogens Porphyromonas
gingivalis, Treponema denticola and Tannerella forsythia, increases [15]. These three
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bacterial species are known as the ’red complex’ and often co-associate during disease
progression [16]. The presence of these potentially pathogenic species does not neces-
sitate the development of a pathological state, but can swing the balance between a
healthy oral biofilm to a pro-inflammatory one [17]. These pro-inflammatory biofilms
are termed ’dysbiotic’, meaning that there is an imbalance in the relative microbial
composition and/or influence of the biofilm leading to inflammatory disease [18].
Of the microbes associated with the development of periodontal disease, P. gin-
givalis appears to play a particularly central role and was one of the earliest pathogens
found to associate with disease progression [19]. P. gingivalis is a Gram-negative,
non-motile, asaccharolytic, obligate anaerobe that can invade the oral epithelium and
periodontal tissue. P. gingivalis primarily inhabits the subgingival sulcus as part of a
complex biofilm. Because P. gingivalis is an obligate anaerobe it is a secondary col-
oniser that adheres to primary colonisers such as Corynebacterium and Streptococcus
[20]. Due to the low availability of sugars in the periodontal pocket, P. gingivalis relies
on the fermentation of dipeptides as a source of energy [21–23].
In recent years a hypothesis has developed that P. gingivalis drives disease pro-
gression by interfering with and impairing host immunity to favour the development of
a dysbiotic biofilm [17]. The ’keystone pathogen hypothesis’ is supported by evidence
from studies in mice that even very low colonisation levels, P. gingivalis can signific-
antly alter the composition of the periodontal biofilm and induce periodontitis [24].
Furthermore, colonisation of germ-free mice with P. gingivalis alone did not lead to
the development of periodontitis demonstrating the necessity of commensal microbes
in pathogenesis. This hypothesis is consistent with observations that there is a low
abundance of P. gingivalis in periodontitis patients [25–27], but a very high prevalence
and association with periodontitis pathogenesis [28, 29].
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1.3 P. gingivalis Virulence Factors
Due to the crucial role of P. gingivalis in periodontitis, there has been a considerable
research effort focused on understanding the virulence factors produced by P. gingivalis
that can impair host immunity, increase inflammation and alter the composition of the
oral microbiota [1]. P. gingivalis is known to produce a range of virulence factors that
enable invasion, inflammation, evasion of innate immunity and nutrient acquisition. A
brief description of the main virulence factors produced by P. gingivalis is given here.
Multiple strains of P. gingivalis are known to produce a capsule that surrounds
the cell and shields surface components from the host. Encapsulated strains of P. gin-
givalis are more virulent than non-encapsulated strains when studied using a mouse
infection model, with non-encapsulated strains forming non-invasive, localised abs-
cesses [30, 31]. Encapsulated strains are associated with a reduced pro-inflammatory
response, phagocytosis and cytokine and chemokine production [32, 33]. This enables
encapsulated strains to evade host immunity and increase bacterial survival.
P. gingivalis fimbriae have been shown to mediate adhesion to other bacterial
species, oral epithelial cells and tooth surfaces with fimbriae deficient mutants showing
a reduced ability to attach and invade oral epithelial cells [19, 34]. P. gingivalis
expresses two types of fimbriae, the first consisting of the FimA/fimbrillin subunit to
form the major fimbriae and the second consisting of the Mfa subunit to form the minor
fimbriae. While FimA appears to function primarily as an adhesin, the role of the Mfa
minor fimbriae is less clear [1]. It has been demonstrated that the minor fimbriae can
stimulate the production of IL-1α, IL-1β, IL-6 and TNF-α by macrophages [35]. This
increase in pro-inflammatory signals has been observed in rat infection models and is
suggested to promote resorption of the alveolar bone [36, 37].
Lipopolysaccharide (LPS) is an important component of the outer membrane of
Gram-negative bacterial. It is comprised of Lipid A, a core oligosaccharide and a distal
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O-antigen of repetitive glycan polymers. There are two major forms of LPS molecule
produced by P. gingivalis, the conventional O-antigen polysaccharide linked LPS (O-
LPS) and anionic-LPS (A-LPS) that possesses an anionic polysaccharide (APS) [38].
There is also variation in the acylation profile of Lipid A, with tri-, tetra- and penta-
acyl forms being observed [39]. The Lipid A component of LPS has been shown to
interfere with innate immunity by interacting with toll-like receptor (TLR)-2 and -4
[40]. It has been demonstrated that P. gingivalis LPS is a less potent activator of pro-
inflammatory signals than Escherichia coli LPS, which may also help P. gingivalis to
evade innate immunity [41]. P. gingivalis LPS is also capable of inhibiting osteoblast
differentiation of periodontal ligament stem cells which play an important role in the
regeneration of periodontal tissue [42].
P. gingivalis secretes a range of proteolytic, hydrolytic and lipolytic enzymes that
increase virulence and drive disease progression. Many of these enzymes are secreted
from the cell and they often remain attached to the surface. Of the different enzymes
classes produced by P. gingivalis, it is the proteolytic enzymes that appear to correlate
most closely with pathogenesis [43]. P. gingivalis mostly produces cysteine proteases
or serine proteases. The cysteine proteases, commonly called gingipains, are involved
in multiple detrimental interactions with the host and activate other surface-bound
components, such as the fimbriae [14].
P. gingivalis forms outer membrane vesicles (OMVs) that are highly enriched in
LPS and membrane-associated virulence factors, particularly gingipains [44]. The
vesicles are spherical structures, with a diameter of ~50-300 nm, composed of a single
lipid bilayer formed via the blebbing of the bacterial outer membrane [45]. OMVs
contribute to the destruction of host tissue by acting as an effective vehicle for the
delivery of proteases and other virulence factors [46]. For example, P. gingivalis OMVs
are capable of entering epithelial cells and interfering with host signalling pathways
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to prevent cell migration [47]. It is also believed that the release of OMVs contributes
to more effective colonisation and evasion of host immune defences via the activity of
surface-associated gingipains [45].
1.4 The Role of Gingipains in Periodontal Patho-
logy
Of the virulence factors produced by P. gingivalis, there has been a particular focus
on understanding a group of extracellular proteases, discovered in the early ’90s, that
closely associate with virulence and have the ability to degrade a broad spectrum
of host proteins [48–51]. The gingipains, as they are known, are cysteine proteases
that cleave at the C-terminus of arginine (gingipain R; or RgpA and RgpB) or lysine
(gingipain K; or Kgp) residues. Collectively, the gingipains account for ~85% of P.
gingivalis extracellular proteolytic activity at the site of infection [52]. The proteolytic
activity of the gingipains is involved in many pathogenetic processes including the
degradation of extracellular matrix proteins, complement factors, immunoglobulins,
cell surface receptors and deregulation of host signalling pathways.
One way in which the gingipains assist in the survival of P. gingivalis is by in-
creasing the availability of haemin required for growth. RgpA and RgpB can activate
prothrombin to thrombin by cleavage of coagulation factors IX and X into an active
state [53, 54]. Gingipains are also capable of degrading fibrinogen and fibrin, further
deregulating the coagulation cascade, leading to increased bleeding and inflammation
at the site of infection [55, 56]. Furthermore, the gingipains can cleave host haem-
binding proteins to release a usable source of haem and short peptides necessary for
P. gingivalis growth [? ]. This has been suggested to contribute to the extensive
proliferation in periodontal pockets where there is a high abundance of erythrocytes.
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Gingipains cause damage to the host extracellular matrix (ECM) via the proteo-
lytic activation of matrix metalloproteinases (MMPs) secreted by many host cells as
inactive pro-MMP precursors [57]. The activation of these enzymes causes them to
degrade collagen fibres, leading to the destruction of ECM and the periodontal liga-
ment. The destructive activity of activated MMPs contributes to the formation of a
deep periodontal pocket [58].
It has been observed that strains of P. gingivalis that produce gingipains can
significantly decrease the bactericidal activity of human serum. It was found that
low concentrations of gingipains could activate complement factors C3, C4 and C5,
perhaps to increase local inflammation and assisting in colonisation [59]. However, at
high concentrations the gingipains were found to degrade C3, C4 and C5 to prevent
activation of the complement cascade accounting for the bactericidal activity of human
serum. RgpA and B can further interfere with the complement pathway by activating
complement factor C5 to create subversive cross-talk between the C5a receptor and
TLR-2, preventing phagocytosis [60].
IL-8 is a pro-inflammatory chemokine that is produced by a variety of cell types
including lymphocytes, monocytes, neutrophils, endothelial cells and epithelial cells
[61]. IL-8 attracts and neutrophils towards sites of inflammation and is also a potent
activator of neutrophil activity [62]. Soluble gingipains that are released from the cell
cleave IL-8 into a shorter and more potent form, whereas surface-bound gingipains
degrade IL-8, eliminating its chemotactic function [63]. This dual process creates a
chemotactic gradient away from the site of infection helping P. gingivalis to evade the
host immune system. Gingipains can also attack host receptors directly. One target is
CD-14, the major receptor of LPS expressed by monocytes [64] and gingival fibroblasts
[65]. By degrading this receptor, renders the host less able to detect LPS reducing the
production of pro-inflammatory signals.
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Gingipain activity is also necessary for the processing and maturation of surface-
bound proteins expressed by P. gingivalis. P. gingivalis produces a range of haemag-
glutinin/adhesin (HA) domains that are encoded by rgpA, kgp and hagA. The gin-
gipain encoded adhesin domains are autolytically processed and form a non-covalent
gingipain-adhesin complex that is associated with the OM [66]. The HagA encoded
HA domains are also proteolytically processed by the gingipains [67]. The adhesin
domains are necessary for the haemagglutination and haemolysis of erythrocytes and
binding to haemoglobin to facilitate the acquisition of haem by P. gingivalis [68–70].
The maturation of both the major and minor fimbriae is also dependent on proteolytic
processing by RgpA and B [71, 72].
1.5 Gingipains Possess a Conserved C-terminal Do-
main
Ever since the discovery of the gingipains, it has been reasoned that there must a
mechanism by which these proteins are secreted to the cell surface [73]. The gingipains
possess an N-terminal Sec signalling peptide that mediates transport of the protein
into the periplasm where the protein folds [74]. An N-terminal pro-domain (NTP)
functions as a chaperone and maintains the protease in an inactive state to prevent
cleavage of cellular proteins [75]. In the mature surface-bound RgpB, the NTP is
removed, along with 72 amino acids at the C-terminus. RgpA and Kgp also possess a
C-terminal HA region that undergoes autolytic processing and remains non-covalently
linked to the catalytic domain (Figure 1.5.1) [66, 67]. The HA region of RgpA consists
of four domains referred to as RgpA1-4 [66]. The number of domains comprising the
Kgp HA region varies between sequenced strains of P. gingivalis [14]. The W50 strain,
used for experimental work in this thesis, contains five HA domains referred to as
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KgpA1-5 [67].
BN-PAGE analysis of surface associated complexes from P. gingivlalis has shown
that gingipain-adhesin complexes of Kgp and RgpA form either homodimeric or het-
erodimeric (Kgp:RgpA) complexes [76]. These complexes are found predominantly
bound to the cell-surface with very little protein released to the extracellular milieu
[74].
Figure 1.5.1: Schematic of gingipain structural domains. All three gingipains
possess a Sec signalling peptide, pro-peptide, catalytic domain and C-terminal domain.
RgpA and Kgp also possess haemagglutinin/adhesin domains which are extensively
processed by autolytic cleavage. Regions of sequence conservation are given the same
colouring. Sites of proteolytic processing are indicated with an arrow and residue
number. The HA domains are labelled according to the sites of autolytic processing
in the P. gingivalis W50 strain [67]. (Adapted from [14, 70]).
RgpB is also found primarily associated with the cell surface with a predicted
molecular mass of 56 kDa for the mature protein. Despite this Slakeski et al., [77]
observed migration of mature RgpB via SDS-PAGE as diffuse bands between 80-
90 kDa. This membrane-associated form of RgpB was found to bind MAb 1B5, a
monoclonal antibody raised against monomeric RgpA [78]. This antibody was also
found to be immunoreactive against P. gingivalis lipopolysaccharide but not against
soluble forms of the RgpA and RgpB or recombinantly expressed RgpA. It has since
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been demonstrated that this antibody binds to the phosphorylated branched mannan
in the APS repeating unit of A-LPS.
The crystal structure of soluble RgpB, solved in the same year, revealed that the
mature protein has a C-terminal truncation at Ser435 (according to mature enzyme
numbering; Ser664 according to full sequence numbering) [79]. It was therefore hy-
pothesised that the gingipains are attached to the cell surface via C-terminal LPS
attachment [67]. This led Veith et al., [67] to perform proteomic analysis of outer
membrane proteins present in P. gingivalis. They identified a group of proteins, in-
cluding all three gingipains, HagA, P27 (PG1795) and P59 (PG2100/TapC) that were
immunoreactive against MAb 1B5. It was also observed that all of these proteins
possess a conserved C-terminal domain (CTD) with sequence similarity to the CTD
of RgpB.
In 2006, Seers et al., [80] discovered that removal of the CTD from RgpB caused
accumulation of precursor isoforms in the periplasm and culture fluid, thus demon-
strating the importance of this domain in gingipain export. The authors also per-
formed sequence analysis of P. gingivalis open-reading frames to identify 34 putative
CTD proteins, 24 of which had previously been observed to associate with the cell
surface [80]. More recent analysis of 21 fully sequenced Bacteroidetes genomes has
predicted the presence of 663 proteins possessing the conserved CTD [81]. The cur-
rent list of known CTD protein encoded by P. gingivalis, some of which have yet to
be experimentally verified, has been extended to 36 proteins; these are listed in Table
1.5.1.
Many of these CTD proteins have no known function, but some of them are as-
sociated with P. gingivalis virulence. For example, haem-binding protein 35 (Hbp35)
is essential for P. gingivalis growth in haem depleted media and has been shown to
bind thioredoxin and haemin [88]. P. gingivalis peptidylarginine deiminases (PPAD)
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PG0026 PGN_0022 PorU T9SS cargo protein sortase [82]
PG0182 PGN_0291 Mfa5 Minor fimbriae accessory protein [83]
PG0183 - - Hypothetical CTD lipoprotein [81, 84]
PG0232 PGN_0335 CPG70 Zinc carboxypeptidase [67, 80, 82, 85]
PG0350 PGN_1611 - Internalin-like protein [80]*
PG0410 - - Hypothetical gingipain-like peptidase
C25
[86]*
PG0411 PGN_1556 - Putative haemmaglutinin [80, 84]*
PG0495 PGN_1476 - Hypothetical CTD protein [80]*
PG0506 PGN_1466 RgpB Arg-specific gingipain B [67]
PG0553 PGN_1416 PepK Lys-specific Serine protease [80, 87]
PG0611 PGN_0654 - Hypothetical CTD lipoprotein [80, 82]*
PG0614 PGN_0657 - Hypothetical CTD protein [80]*
PG0616 PGN_0659 Hpb35 Haem binding protein [80, 82, 88]
PG0626 - Omp40 Hypothetical CTD protein [67, 81]*
PG0654 PGN_0693 - Hypothetical CTD protein [80]*
PG0769 PGN_0795 - Fibronectin type III domain protein [81]†
PG0787 PGN_0810 - Hypothetical CTD protein [81]†
PG1030 PGN_1321 - Hypothetical CTD protein [80]*
PG1035 PGN_1317 - Hypothetical CTD protein [80, 89]
PG1326 PGN_1115 - Putative haemmaglutinin [80]*
PG1374 PGN_0852 PG97 Immunoreactive 47 kDa antigen [82]*
PG1424 PGN_0898 PPAD Peptidylarginine deiminase [80, 82, 88]
PG1427 PGN_0900 Periodontain Peptidase C10; PrtT-related [76, 90]
PG1548 PGN_0561 prtT Cysteine protease (domain peptidase
C10)
[76, 91]
PG1604 PGN_0509 PorZ β-propeller protein [92]
PG1795 PGN_1770 P27 Hypothetical CTD protein [67, 88]
PG1798 PGN_1767 PG99 Immunoreactive 46 kDa antigen [80, 93]
PG1837 PGN_1733 HagA Haemmaglutinin [82]
PG1844 PGN_1728 Kgp Lys-specific gingipain;
Haemmaglutinin
[67, 80]
PG1969 - - Hypothetical CTD protein [76, 81]*‡
PG2024 PGN_1970 RgpA/HagE Arg-specific gingipain;
Haemmaglutinin
[80]
PG2100 - TapC/PG102 Hypothetical CTD protein [80, 93]
PG2102 PGN_0152 TapA/PG91 Hypothetical CTD protein [80, 93]
PG2172 PGN_0123 - Hypothetical CTD protein [82]*
PG2198 PGN_2065 - Hypothetical CTD protein [82]*
PG2216 PGN_2080 - Hypothetical CTD protein [80]
* Identified using proteomic methodology. MS used to identify CTD containing protein in the outer mem-
brane.
† Identified using bioinformatic methodology only and not verified experimentally.
‡ No Sec signal peptide identified.
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is a CTD protein capable of citrullinating (converting protein arginine to citrulline)
host and endogenous proteins. This activity has been associated with protection from
acid cleansing in the mouth [94], modulation of biofilm growth [95] and rheumatoid
arthritis pathogenesis [96]. One of the more recently discovered CTD proteins is the
minor fimbriae accessory component Mfa5 [83]. This protein is necessary for fim-
briae polymerisation and mediates the incorporation of Mfa3 and Mfa4 into the minor
fimbriae.
Alignment of the CTD sequences in P. gingivalis W83 revealed the presence of
five conserved sequence motifs, labelled A-E [80]. Of these, motifs D and E, which
comprise the 22 C-terminal residues, show the highest level of conservation. Further-
more, it was demonstrated that fusion of the 22 amino acid fragment is sufficient for
the export of GFP from P. gingivalis [97]. This is consistent with motifs D and E
having an important functional role in the export of surface-associated proteins from
P. gingivalis. However, the overall sequence identity of the motifs is relatively low,
which led to the suggestion that the domain is structurally, rather than sequentially,
conserved [98].
1.6 Discovery of a System Related to Gingipain
Export
Wild-type P. gingivalis grown on blood agar plates appear as black-pigmented colon-
ies due to the accumulation of haem at the cell surface [99]. This pigmentation is
dependent on Kgp activity and P. gingivalis mutants that are deficient in the sur-
face expression of this protein grow as beige non-pigmenting colonies [100]. This
relationship between pigmentation and Kgp activity makes it possible to use colony
pigmentation as a screening tool for genes related to the export and maturation of
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gingipains.
Initial studies used transposon mutagenesis for the production of non-pigmenting
colonies. In these early studies, genes corresponded to the gingipains themselves, sur-
face polysaccharide expression and the virulence modulating gene VimA, were iden-
tified [101–104]. Then, In 2005, this method was employed to detect the new gene,
porT, that encodes a protein related to the export of gingipains [105]. In this mutant
strain, gingipains were seen to accumulate in the periplasm rather than being exported
to the cell surface. Furthermore, sequence analysis of the porT gene showed that it is
only present in certain species of the Bacteroidetes phylum.
Following on from the discovery of porT, two more genes, sov and PG0027, were
discovered which display very similar mutant phenotypes to that of the porT mutant
[106, 107]. The name of the PG0027 gene has since been changed to lptO [108] and
is now more commonly referred to as porV [88]. In 2010, Sato et al., [109] analysed
the genomes of two Bacteroidetes species (Cytophaga hutchinsonii and P. gingivalis)
that possess the porT gene compared to the genome of Bacteroides thetaiotaomicron,
a porT -negative species of the Bacteroidetes phylum. This analysis yielded a list of
55 genes that were unique to C. hutchinsonii and P. gingivalis. Deletion mutants
were created for 46 of these genes in P. gingivalis, eleven (including sov and porT ) of
which showed a decrease in the surface and extracellular gingipain activity. Five of the
identified genes (porK, porL, porM, porN, porP) are located within a single operon
in the P. gingivalis genome [110]. The other components identified in this study,
and subsequently discovered genes, are located throughout the P. gingivalis genome.
There are now 22 known genes that are associated with the export of gingipains and
other CTD proteins from P. gingivalis (Table 1.6.1). Bioinformatic prediction has
been used to predict an additional 11 proteins associated with CTD protein export
but, no experimental data is available for these [111]. Therefore, they have not been
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included in the table of system components.
This system was assumed to be novel because the identified proteins showed no
significant sequence similarity to proteins of other known bacterial secretion systems.
This novel system was named the Por secretion system (PorSS) [109] with the name
later changed to the type IX secretion system (T9SS) to be consistent with standard
nomenclature.
1.7 The T9SS Forms a Large Complex that Spans
Both Membranes
When the PorK, L, M, N proteins were originally identified PorL and PorM were
found primarily in the inner membrane as part of a 1.1 mDa complex, whereas PorK
and PorN were found primarily localised to the outer membrane forming a 1.2 mDa
complex [109]. In 2016, cryo-electron microscopy (cryo-EM) was used to visualise
recombinantly expressed PorK and PorN [115]. A 50 nm diameter ring structure
was observed comprising between 32-36 subunits of each protein which could form
independent from any other system component. In recent analysis, using cryo-electron
tomography (cryo-ET), it was confirmed that this structure also forms in situ (pre-
print:[89]). The lipoprotein PorK is responsible for forming the upper portion of the
ring and attaching the complex to the inner leaflet of the outer membrane, whereas
PorN forms the lower portion of the ring complex. The ring complex was found to
interact with the outer membrane β-barrel protein PorG and PorT [89, 115, 117]. The
function of the ring complex, and associated PorG and PorT proteins is still unknown.
The interaction network of the PorKLMNP operon proteins was studied using
bacterial two-hybrid and co-immunoprecipitation [117]. Their analysis revealed that
PorL and PorM form a complex at the inner membrane which spans the periplasm to


































































































































































































































































































































































































































































































































































































































































































































































































































































1.7 The T9SS Forms a Large Complex that Spans Both Membranes 16
interact with the KN ring via the periplasmic portion of PorM. The outer membrane
β-barrel protein PorP was also shown to form part of this complex by binding to
PorK and PorM. In 2018, the periplasmic portion of PorM was crystallised and the
structure resolved using X-ray crystallography [118]. The periplasmic portion of PorM
is formed of four similar domains in an extended arrangement with a ~45° angle
between domains D2 and D3 and a total length of ~180 Å, capable of spanning most
of the periplasmic space [118]. These results are consistent with the observation that
PorM bridges the inner and outer membrane complex of the T9SS. It has recently
been demonstrated, in Flavobacterium johnsoniae, that the transmembrane helices of
each GldM (PorM) monomer interact with five GldL monomers (pre-print: [122]).
Each GldL monomer possesses two transmembrane helices that form a ring structure
around the transmembrane helices of GldM, with the N- and C- termini of GldL
localising to the cytoplasm. Given that GldM and GldL possess conserved glutamate
residues within the hydrophobic transmembrane helices it was speculated that these
two proteins may be responsible for energy transduction in the T9SS [123]. To test this,
single residue mutants (E49Q and E49D) were created for the conserved glutamate
residues in GldL. These mutants showed a significant reduction in gliding motility
and chitinase activity, two phenotypes that are dependent on a functional T9SS in F.
johnsoniae (pre-print:[89]).
Another recent study has used co-immunoprecipitation to understand the inter-
actions that exist between components of the T9SS (pre-print:[89]). The periplas-
mic lipoprotein PorE was found to form a complex with PorP and the CTD protein
PG1035, predicted to bind to the outer face of PorP. PorE was originally discovered
using comparative genome analysis and was predicted to comprise four domains: a
tetratricopeptide repeat (TPR) domain, a β-propeller domain, a carboxypeptidase reg-
ulatory domain-like fold (CRD) and an OmpA_C-like putative peptidoglycan binding
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domain [111]. A crystal structure of the C-terminal OmpA_C-like domain has been
solved [121]. This structure possesses a protein cleft similar to that of other pep-
tidoglycan binding proteins and it was possible to model a peptidoglycan fragment
within the cleft. This data suggests that PorE may be responsible for anchoring the
T9SS to the bacterial cell wall. However, the function of the other three domains is
unknown. PorF is predicted to be a β-barrel protein that has been shown to localises
to the outer membrane in P. gingivalis [119]. However, no function has been assigned
to this protein, nor has it been identified in any of the studies analysis protein-protein
interactions of T9SS components.
1.8 Sov Mediates Export of Cargo Proteins Across
the Outer Membrane
In 2007 the outer membrane protein Sov was identified and found to be essential for
T9SS functionality [106]. Given the length of the translated peptide sequence (~2500
aa) it was speculated that Sov may form an outer membrane channel of the size
necessary to transport folded proteins across the membrane. In 2018, Lauber et al.,
[113] used cryoEM to observe the F. johnsoniae homolog of Sov, SprA.
The resulting structure was of a 36 strand β-barrel protein that is capped at the
extracellular face but with a lateral opening to the surface of the outer membrane.
Two other proteins were found in complex with SprA. The first is a novel lipoprotein
peptidyl-prolyl cis-trans isomerase (PPI) that did not appear to have any effect on
T9SS function. The second protein identified was PorV, bound to the lateral opening
of SprA, with three extracellular loops dipping into the central pore. Purification of
SprA following the removal of the porV gene led to SprA being purified with another
novel protein, simply called the Plug protein. This name was given because it was
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found to occlude the central pore of SprA by binding at the periplasmic face. The
model of these two complexes suggests that there is a gating between a plug bound
and PorV bound state to allow regulation of the system and prevent aberrant export
of periplasmic proteins and components.
Blue native (BN)-PAGE of Sov in P. gingivalis has revealed that it also inter-
acts with the periplasmic lipoprotein PorW, which in turn interacts with PGN_1783
(PG1850) (preprint: [89]). PorW is predicted to possess several TPR domains, which
are commonly involved in protein-protein interactions. It may therefore have a role
in attaching to other T9SS components or cargo proteins present in the periplasm.
The authors also demonstrate that Sov complexes with PorN, suggesting that the Sov
complex directly interacts with the KN ring.
1.9 The T9SS is Linked to LPS Transport
During the initial studies of the porV gene, it was found to have a similar phenotype
to the porT deletion mutant [107]. Further analysis of these two mutants revealed
that A-LPS accumulates within the periplasm along with unprocessed CTD proteins
[108]. The lipid profile of the PorT mutant was found to be similar to that of the wild-
type. However, the PorV mutant was unable to deacylate penta-acylated Lipid A to
tetra-acylated Lipid A. In the PorV mutant high levels of non-phosphorylated Lipid
A and novel forms of Lipid A, not seen in the wild type, were also observed. It has
also been demonstrated that disruption of A-LPS synthesis causes CTD proteins to
accumulate in the periplasm [124]. It was suggested that the secretion of A-LPS and
CTD proteins is co-ordinated and that disruption of either process causes blockage of
the entire system.
The porU gene, identified by comparative genome analysis, is located directly
upstream of porV and was previously found to be essential for gingipains secretion
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[109]. Bioinformatic analysis of the protein sequence revealed that it has a putative
CTD and similarity to the catalytic domain of the gingipains with His657 and Cys690as
catalytic residues [82]. Due to the presence of a CTD in PorU, the protein was assessed
for outer membrane localisation and LPS modification. Despite localising to the outer
membrane the PorU protein was not modified via A-LPS attachment, nor was the
CTD cleaved from the mature protein.
Analysis of the secretion profiles in a porU deletion mutant and catalytic mutant
(C690A) showed that there is only partial secretion of gingipains in these strains and
some accumulation of CTD proteins in the periplasm [82]. Despite detecting CTD
proteins at the cell surface, no LPS modification or CTD removal of cargo proteins
occurred. Analysis of RgpB maturation showed that processing was stalled at the
stage of CTD removal in the two mutant strains, suggesting that PorU is responsible
for the proteolytic cleavage of the cargo protein CTD.
A wbaP mutant strain of P. gingivalis, which does not produce A-LPS, showed an
accumulation of T9SS cargo proteins in the culture fluid with cleaved CTDs but no
LPS modification [91]. Mass spectrometry analysis of these released proteins revealed
that they are modified at the C-terminus via the attachment of single amino acids or
short peptides, suggesting that C-terminus is the site of cargo protein modification.
This was confirmed by analysis in the wild-type, where CTD proteins were found to
be attached to a 648 Da linker molecule via a peptide bond. Based on this evidence
it was suggested that PorU is responsible for the conjugated removal of the CTD and
C-terminal modification of T9SS cargo proteins via a sortase-like mechanism [91].
In 2014, purification of tagged PorV from P. gingivalis showed that it co-purifies
with PorU, suggesting that is responsible for anchoring PorU to the cell surface [125].
Further analysis of this complex by BN-PAGE revealed the presence of a 440 kDa com-
plex comprising PorU, PorV, PorZ and PorQ and smaller sub-complexes of PorU:Porv
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and PorZ:PorQ [112]. PorZ is similar to PorU, in that it possesses a CTD that is not
removed following transfer to the outer membrane [92]. It is likely that the CTD of
PorU and PorZ mediates anchoring to PorV and PorQ, respectively. Deletion of PorU
causes the accumulation of immature cargo proteins bound to PorV and A-LPS bound
to PorZ [112]. From this data it was suggested that PorV acts as a shuttle protein
delivering CTD proteins to the ’attachment complex’, composed of PorU, PorV, PorZ
and PorQ, for CTD removal and LPS attachment.
The outer membrane Omp17 was found to be necessary for CTD cleavage and
surface attachment of cargo proteins [116]. Deletion of the omp17 gene caused CTD
proteins to be released into the culture fluid and is necessary for surface expression of
PorU. However, the exact role of Omp17 in this process is unclear.
1.10 Regulation of the T9SS
PorX and PorY encode a two-component regulatory system involved in the regulation
of the T9SS [109]. The PorX response regulator is the only known component of
the T9SS to fully localise to the cytoplasm. The sensor kinase PorY is localised to
the inner membrane via two transmembrane helices [120]. Recombinantly expressed
PorY is able to auto-phosphorylate and transfer a phosphoryl group to PorX. PorX is
then able to activate the extra-cytoplasmic function sigma factor SigP which can bind
to the promoter region of T9SS genes [114]. PorX has also been shown to interact
with the cytoplasmic domain of PorL and may transfer regulatory information to the
PorL/M motor complex. However, the specific environmental factors that affect this
system are not known.
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1.11 Current Model of T9SS Secretion
Evidence for the structural arrangement and functional role of T9SS components is
increasing at a fast rate. When work for this project was begun there was no structural
data available for any system component and very limited understanding of individual
protein function. However, it is now possible to create a much clearer picture of how
cargo CTD proteins are exported and processed by the T9SS.
There are essentially two major steps during the secretion process, summarised in
Figure 1.11.1. The first step involves recognition of cargo proteins, that have passed
into the periplasm via the Sec system, and exporting them to the outer membrane via
Sov. There is also evidence that the CTD proteins interact with multiple periplasmic
domains of PorM and are then passed to PorN (preprint: [126]). It is not clear if there
are interactions between CTD proteins and system components prior to recognition
by PorM, or in between PorN binding and transfer to the Sov complex. The second
stage of the secretion process involves shuttling of cargo proteins, via PorV, to the
attachment complex where the CTD is removed and the A-LPS modification occurs.
At this stage the cleaved CTD is released from the cell.
Understanding of how these complexes interact is also developing. The KN ring
appears to facilitate the assembly of multiple protein complexes involved in secretion
including the PorL/M motor complex and the Sov complex. However, it is not clear
whether the complexes that associate with the KN ring are localised to the inside or
outside of the ring, or if they are free to pass in and out. There is no data to suggest the
attachment complex directly interacts with the KN ring and evidence from BN-PAGE
analysis suggests that the attachment complex is independent from other proteins of
the T9SS. PorF and Omp17 remain the only proteins that have experimental data
supporting their role in the secretion process that are not known to interact with any
of these complexes.
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Figure 1.11.1: Schematic model of the P. gingivalis T9SS. T9SS cargo pro-
teins possess a N-terminal signal peptide, for transfer through the Sec system into the
periplasm, and a CTD, for transfer through the T9SS. Periplasmic cargo proteins are
recognised by the T9SS and pass to Sov, the outer membrane translocon. The cargo
protein is then transferred to PorV which then shuttles the cargo protein to the at-
tachment complex, comprised of PorQ, U, V and Z. Finally, the PorU sortase cleaves o
the cargo CTD and adds an A-LPS molecule to the C-terminus of the cargo anchoring
it to the membrane. The PorL/M complex is believed to power export of cargo protein
across the outer membrane using proton motive force. The two-component system,
comprised of PorX and PorY, is involved in regulation of the system via interaction
with the sigma factor SigP and porL. The PorK/N ring complex forms an anchor for
many other proteins of the T9SS to bind. PorE interacts with the PorP:PG1035 com-
plex in the OM and anchors the system to the peptidoglycan layer. PorT and Omp17
are not known to interact with any other component of the T9SS. Structural mod-
els are shown for proteins that have an experimentally determined atomic structural
model available. Legend: IM - Inner membrane, PG - Peptidoglycan, OM - Outer
membrane.
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1.12 Project Aim
1.12.1 Generation of a Structural Model for the T9SS CTD
The first aim of this project was to develop a structural model for the CTD of T9SS
cargo proteins. When work on this project was started there was no available struc-
tural model for the CTD of any T9SS cargo. Given that there is low levels of sequence
identity between the CTD of cargo proteins it is possible that the information confer-
ring recognition by the T9SS is contained within the secondary and tertiary structure
rather than the primary amino acid sequence. It was therefore reasoned that solving
a structural model of the CTD would significantly advance our understanding of how
cargo proteins are recognised by the T9SS.
1.12.2 Identification of T9SS Components that Interact with
Cargo Protein CTD
When this project was conceived there was no available information regarding the
interaction of T9SS proteins and CTD proteins. Indeed, most of the identified com-
ponents still had no functional characterisation beyond the effect of gene deletion of
the secretion profile and surface protease activity in P. gingivalis [127]. Therefore, the
second of aim of this project was to identify components of the T9SS that are capable
of interacting with the CTD of cargo proteins. This aim was selected as it would help
to elucidate the functional role of T9SS proteins and provide a pool of interaction
partners which could be investigated further.
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1.12.3 Characterisation of T9SS Interaction with the Cargo
Protein CTD
The final aim of this project was to characterise the most promising identified interac-
tion(s) in further detail, with the ultimate aim of generating a structural model for this
complex. To date, no structural models are available for a CTD protein in complex
with any T9SS component. The characterisation of this interaction and generation
a structural complex would further our understanding of how CTD proteins interact
with the T9SS and how the system mediates protein transport. This may have also
led to the identification of important structural motifs in the CTD that explain how
this domain is recognised by the T9SS.
Chapter 2
Theory of NMR Spectroscopy
The method of nuclear magnetic resonance (NMR) was first developed in 1946 through
the experiments of Bloch and Purcell [128, 129] and is now widely used by physicists,
chemists and biologists. In this project, NMR has been the primary method used for
studying protein structure and dynamics. Furthermore, unlike other techniques de-
scribed in this thesis, NMR spectroscopy is the least intuitive technique to understand
and interpret. Therefore, this chapter will cover the basics of NMR theory and how it
can be applied to the study of biomolecules such as proteins. Much of the theoretical
descriptions that follow are derived from the book ’Understanding NMR spectroscopy’
by James Keeler [130], unless referenced otherwise.
2.1 Principles of Nuclear Magnetism
2.1.1 Nuclear Spin and Spin States
The subatomic nuclei of atoms possess a property known as nuclear spin, an intrinsic
type of angular momentum. This spin property is characterised by the spin quantum
number, I, which can take either whole or half-integer values. As a general rule, most
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atomic particles that have an odd mass number will have half-integer I values and are
called spin-half nuclei. For particles where I = 0, the spins of each nucleon interact to
cancel out. Therefore, such nuclei are termed to be NMR invisible. However, it is pos-
sible to use nuclear isotopes such that the particles necessary for the characterisations
of proteins, primarily 13C and 15N, take a half-integer I value.
Spin-half nuclei, act as small bar magnets, with a nuclear magnetic moment de-
noted by the symbol, µ. The magnetic moment, defined in Equation 2.1.1, is pro-
portional to the spin of the nuclei, I, and an intrinsic property of the nuclei called
the gyromagnetic ratio (γ). γ is constant for a specific type of nucleus and is defined
as the ratio of the magnetic moment to the angular momentum of the particle. The
gyromagnetic ratios for nuclei commonly detected in protein NMR experiments are
shown in Table 2.1.1.
µ = γI (2.1.1)
Table 2.1.1: Spin properties of isotopes commonly used in biomolecular
NMR.
Isotope Spin Gyromagnetic









1 H 1/2 26.752 600.000 -1 to 12
2 H 1 4.107 92.104 -1 to 12
13 C 1/2 6.728 150.870 0 to 200
15 N 1/2 -27.13 60.821 0 to 900
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2.1.2 Bulk Magnetisation
When analysing samples by NMR spectroscopy we consider not the individual mag-
netic moments, but the net or bulk, magnetisation of the sample. Bulk magnetisation
is denoted by the symbol M and defined as the sum of each magnetic moment. In
the absence of a magnetic field, spin orientation is random and the magnetic moments
essentially cancel each other out (Figure 2.1.1A). In the presence of a static magnetic
field (B0 ) there are two possible energy levels the spins can adopt; a high energy
and a low energy state. These energy levels are described by the magnetic quantum
number (m), which for the case of spin-half nuclei can be either m = −12 or m = +
1
2 .
The low-energy state (m = −12) is termed as the α-state and the high energy state
(m = +12) is termed the β-state.
Figure 2.1.1: The distribution of spin orientation in an external magnetic.
(A) In the absence of an external magnetic field, the orientation of the magnetic
moments is random, represented by the cloud of possible distributions. (B) When the
sample is placed in an external magnetic field (B0 ) the spins are still orientated in
all directions but now have a slight propensity to align with the external field. This
magnetisation vector (M) is shown by the large vertical arrow aligned along the z-axis
of the B0 field.
It is often misrepresented that the α and β states relate to parallel and antiparallel
alignment of the spins relative to B0 , respectively. In reality, spins still orientate in
an almost entirely random manner in the presence of the B0 field due to the thermal
energy of the sample [131]. There is, however, a slight propensity for the spins to point
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along the direction of the B0 field (defined as the z-axis). This alignment, although
slight, gives rise to bulk magnetisation of the sample along the z-axis, represented by
the blue arrow in Figure 2.1.1B. This magnetisation vector is central to the technique
of NMR spectroscopy and all following discussions will be in regard to this vector.
2.1.3 Larmor Precession
In a static magnetic field, in which the magnetisation vector is aligned with B0 , the
vector product of M and B0 will be zero. Therefore, the magnetisation vector will
be static. However, if there is a non-parallel alignment of M relative to B0 , then M
will precess around B0 at the angular frequency, commonly referred to as the Larmor
frequency, of ω0 (rad s-1) given in Equation 2.1.2.
ω0 = −γB0 (2.1.2)
This equation shows the frequency of precession is dependent on field strength
and the gyromagnetic ratio (γ) of the nucleus. The Larmor frequency for commonly
detected nuclei in a 14.093 Tesla field are shown in Table 2.1.1. We can see from this
that the frequency of a 1H spin is much higher than that of 13C and 15N spins. Due
to the higher frequency at which 1H spins precess they give a sharper signal with a
better signal-to-noise ratio. As such, NMR spectra are often detected using proton
magnetisation.
2.1.4 Chemical Shift and Shielding
In NMR the Larmor frequency is dependent on field strength (Equation 2.1.2). This
makes it confusing to express characteristic resonances in Hz because nuclei will pre-
cess at different frequencies depending on spectrometric power. Therefore, precession
frequency is written in ppm relative to a chemical standard, as derived in Equation
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2.1.3. Where, ν is the resonance frequency for the nuclei of interest and ν0 is the
resonance frequency of the reference compound. When represented in this way, the
frequency is referred to as the chemical shift of the magnetic moment.
δ(ppm) = 106 · ν − ν0
ν0
(2.1.3)
Chemical shift values vary for nuclei of the same type due to an effect called
shielding. Shielding is caused by the electrons surrounding the nucleus, which are
induced by the external magnetic field (B0 ) to produce local induced fields (BLocal).
Therefore, the actual magnetic field experienced by the nucleus is the sum of these
two fields [132]. This shielding effect causes differences to be observed in chemical
shift that is dependent on the chemical and the structural environment of the nuclei.
Several chemical shift references are available and commonly used. In protein
NMR spectroscopy the residual H2O signal is commonly used for referencing to avoid
any possible interference of the reference with the sample [133]. This was the refer-
encing method used in this study. However, the reference chemical 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS) was used as an external standard, to calibrate the
spectrometer for the temperature-dependent water signal.
2.1.5 Relaxation
In NMR spectroscopy the Larmor precession is induced by the use of radio frequency
(RF) pulses perpendicular to Bo. However, when this applied field is removed, trans-
verse magnetisation is lost as the spins return to equilibrium, a process referred to as
relaxation. It is caused by the interaction of individual magnetic moments with local
magnetic fields in the sample (BLocal). The type of local field that has the most impact
arises from other non-zero spin nuclei, in particular 1H nuclei. As such, the rate of
relaxation varies between nuclei, due to their proximity to other nuclei in the system.
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Figure 2.1.2: Transverse and longitudinal relaxation of magnetisation. (A)
Transverse relaxation occurs due to interactions with local magnetic fields which alter
the frequency of each spin precession. The red arrows represent individual magnetic
moments that de-phase over time. This leads to loss of coherence and thus the magnet-
isation vector is diminished, represented by the large black arrow. (B) Longitudinal
relaxation occurs due to re-equilibration of the individual magnetic moments. The
green arrows represent the longitudinal and transverse components of magnetisation
as M moves back to the z-axis.
There are two types of relaxation, both of which are driven by local magnetic
fields as described above. The first is that of transverse relaxation, also referred to
as spin-spin relaxation, in which there is a loss of sample coherence in the transverse
plane. The BLocal field interacts with the magnetic moments to change the frequency
of precession, as shown in Equation 2.1.4. As each nuclei experiences a different
BLocal field, the Larmor precession will de-phase over time and spin coherence will
be lost. When this occurs the magnetic moments cancel each other out and net
transverse magnetisation is diminished, as shown in Figure 2.1.2A. The time constant
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for transverse relaxation is referred to as transverse relaxation time (T 2).
ω0 = −γ (Bo + BLocal) (2.1.4)
The second type of relaxation is known as longitudinal, or spin-lattice, relaxation
and involves the re-equilibration of the magnetisation vector. Re-equilibration refers
to the movement of M from the transverse plane back to being aligned with the B0
static field. This process causes a decrease in transverse magnetisation and a relative
increase in longitudinal magnetisation until M is realigned with B0 , as shown in Figure
2.1.2B. The time constant for this is referred to as longitudinal relaxation time (T 1 ).
2.1.6 Spin Coupling
2.1.6.1 Scalar coupling
Scalar coupling, or J coupling as it is often referred to, is the indirect interaction
between nuclear magnetic moments mediates via the shared electron cloud. The in-
teraction between σ bonding orbital electron spins creates an effective nuclear coupling
that can transverse through the length of several bonds [134, 135]. For two coupled
spins, A and B, the effect experienced by spin A will change depending on the quantum
state of spin B. This difference causes the peak to split into a multiplet, as shown in
Figure 2.1.3.
This effect is independent of magnetic field strength and is therefore represented
as a frequency in Hz. The symbol that denotes J-coupling is NJA, B where A and
B are the spins involved in the coupling and N is the number of bonds between the
two spins. Geminal coupling refers to an interaction between two bonds and vicinal
coupling refers to an interaction through three bonds. Coupling over greater distances
is possible but is uncommon.
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Figure 2.1.3: J-Coupling in a two spin system. (A) Two uncoupled spins, A
and B, will give two single peaks in a 1D NMR spectrum. (B) If spins A and B are
J coupled they will give doublet peaks in an NMR spectrum. The doublet peaks are
separated by the coupling constant J AB.
J coupling is central to bio-molecular NMR as it is through J-coupling that mag-
netisation is transferred in many of the more advanced experiments. Furthermore, it
can be used to derive structural information about the sample. For example, vicinal
J coupling in proteins can provide information on φ and ϕ backbone dihedral angles
[136] and side-chain χ1 angles [132].
2.1.6.2 Dipolar Coupling and the Nuclear Overhauser Effect
The second type of spin interaction between two magnetic moments is dipolar coup-
ling. Unlike J-coupling it occurs through space, rather than covalent bonding. Dipolar
coupling cannot be directly detected by NMR spectroscopy due to the isotropic tum-
bling of molecules in solution [137]. This tumbling causes the dipolar couplings to
average to zero, cancelling the effect. However, we can detect dipolar couplings in-
directly via cross-relaxation, also known as the nuclear Overhauser effect (NOE). The
NOE was first described in 1953 [138] and refers to the change in peak intensity of
a given spin when its dipolar coupled partner is irradiated to saturation (see Section
2.2.4). Saturation of the source spin causes cross-relaxation of the coupled spin and
leads to a change in signal intensity. The magnitude of this change is directly related
2.2 Making use of the Larmor Precession 33
to the inter-spin distance. The NOE is restricted to short-range interactions of ~5 Å
because of the distance dependence of 1/r6 for the dipole-dipole coupling where, r is
the intermolecular distance [132]. Since the strength of the effect is dependent on the
distance between the interacting spins it can be utilised to determine a structural map
of the atoms within a molecule.
2.2 Making use of the Larmor Precession
2.2.1 Radio Frequency Pulses
Larmor precession of the magnetisation vector is the observable signal in NMR spectro-
scopy. As the vector precesses an oscillating current is generated in a receiver coil that
is aligned in the transverse-plane relative to the sample. The receiver coil detects only
the transverse-component of magnetisation and none of the longitudinal-component.
Relaxation causes the signal to decay over time, giving rise to the name free induction
decay (FID).
The Larmor precession can be induced by the use of radio frequency (RF) pulses
which push the magnetisation vector away from the z-axis. However, it is not a trivial
matter to overcome the strength of the Bo field; we cannot simply apply a stronger field
in the direction of the x-axis. Instead, a much weaker RF field is applied that exploits
the phenomenon of resonance to overcome the strength of the B0 field. An RF field
that is on resonance with the Larmor frequency can be used to tilt the magnetisation
vector away from Bo.
The magnetisation vector now experiences the vector sum of the static field, B0 ,
and the applied field, B1 . The duration of the RF pulse, for time tp, governs the angle
to which the magnetisation vector is rotated. This is called the flip angle, denoted
by the symbol β and given in Equation 2.2.1, where ω1 is the precession frequency
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around the B1 field. It is common to use pulses giving flip angles of π/2, which is a
90° excitation pulse, and π, which is a 180° inversion pulse.
β = ω1tp (2.2.1)
When we have a system with multiple spins, each with a different precession fre-
quency, our RF pulse will not resonate with all of them. However, if the RF pulse
is strong enough we can flip spins that have precession frequencies several kHz away
from the frequency of the RF pulse. This so-called hard pulse is achieved by selecting
a large bandwidth and it is used to flip all spins of the system.
2.2.2 1-Dimensional NMR
By use of a hard pulse, we can now record the most basic 1-dimensional experiment,
consisting of three steps. 1, the spins are allowed to come to equilibrium, 2, the RF
transmitter flips the spins by 90° with a hard excitation pulse, and 3, the RF trans-
mitter is switched off and the resultant FID is recorded. These stages are represented
in the commonly used pulse pattern diagram (Figure 2.2.1), in which the excitation
pulse is shown as a black rectangle and the acquisition is represented by a decaying sine
wave. This process can then be repeated many times to remove residual background
signals and improve the signal to noise.
Although 1D NMR has limited use in the resolving of protein structures it can
provide useful information as to the stability, solubility, degree of folding and purity
of a protein sample. Such information provides a useful guide before pursuing the
expensive preparation techniques involved in expression and purification of isotopically
labelled protein samples.
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Figure 2.2.1: 1D pulse pattern. In step 1 the pre-delay allows spins to come to
equilibrium and recover from any previous experiments. In step 2 a hard pulse is used
to tilt the magnetisation by 90o . In step 3 the free induction decay signal is detected
and recorded.
2.2.3 Spin-Echo
The spin-echo was first developed in 1950 by Erwin Hahn [139] and is now a key
building block of multi-dimensional experiments. The spin-echo pulse sequence has the
interesting property of re-phasing, or ’refocusing’, the spin magnetisation as shown in
the phase diagram of Figure 2.2.2. After magnetisation is transferred to the transverse
plane with an excitation pulse, the different precession frequencies of each spin causes
dephasing. After a set time τ , a 180° pulse is applied which flips the magnetisation
in the transverse plane, i.e. it is moved from xy to -x-y. After a second time of τ ,
the spins will be rephased because of the 180° inversion pulse. This can be seen in
the phase diagram of Figure 2.2.2 for two spins with different precession frequencies.
Crucially, this effect works regardless of precession frequency and for different times
of τ .
One reason we use this sequence in NMR is to remove any artefacts or ’acoustic
ringing’ from our initial pulse, particularly from low-frequency nuclei such as 15N. The
delay caused by the spin-echo prior to data acquisition provides time for this unwanted
signal to decay. The second use of the spin-echo is to rephase signals that we want to
detect whilst ignoring those that we don’t. The most simple example of this is water
suppression, in which the strong water signal is reduced to give clearer spectra with
2.2 Making use of the Larmor Precession 36
Figure 2.2.2: Spin-Echo Pulse Pattern. The precession of two spins is shown
with the red and blue lines. Using the 180° inversion pulse the phase is re-aligned for
the two spins after the 2τ time period.
a better signal to noise. To achieve this the spin-echo inversion pulse is selectively
applied to the whole sample excluding water signal frequency. This leaves the water
signal dephased and it cancels out during data acquisition. This technique can be
applied to selectively include and exclude any frequency ranges in the sample.
2.2.4 Saturation and Decoupling
Although J-coupling provides useful structural information, the multiplet peaks can
complicate data analysis, particularly for complex systems. Additionally, the split
multiplet peaks have less intensity giving a lower signal-to-noise ratio. To overcome
these issues the spins can be ’decoupled’ to give a single intense peak in the spectrum.
Decoupling can be achieved by irradiating the sample such that the population of
spins in the α and β energy states are equal. This process is referred to as saturation.
Saturation causes loss of the NMR signal because the two equal populations cancel
each other out (Mx = My = Mz = 0). Broadband decoupling uses a series of
weak pulses that target a wide range of spins; usually targets specific nuclei type such
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as 15N or 13C. Increasing the RF pulse length at a lower power enables a narrower
range of spins to be targeted, such as α- or carbonyl-carbons. These broadband pulse
sequences are often applied during the detection period to heteronuclei (e.g. 15N or
13C) to decouple them from the nuclei being detected (e.g. 1H).
A variation of the spin-echo can also be applied to decouple spins during the course
of the experiment. In a heteronuclear experiment, involving 1H and 15N spins, applying
a spin-echo to both spins will refocus the phase of both spins. However, if the 180°
pulse is targeted only to the 1H nuclei, then only these nuclei will be refocused and not
the 15N nuclei. This causes the effect of the coupling to be refocused which effectively
decouples the 15N spins from the 1H spins.
By combining the spin-echo decoupling and broadband decoupling techniques,
spins in a heteronuclear system can be decoupled to reduce the peak multiplet into a
single peak with greater intensity.
2.2.5 Two-Dimensional NMR
2-Dimensional NMR was first developed during the late-1970’s and is now routinely
used in the fields of chemistry and biochemistry [140, 141]. It is particularly useful
for studying complex systems as it increases the resolution of each peak. That is, a
collection of peaks that may be severely overlapped in a 1-dimension can be separated
by addition of a second dimension.
In 2D NMR there are four basic stages to the experiment: preparation, evolution,
mixing and detection. These steps are illustrated in Figure (2.2.3A). During the
preparation period, spins are first brought to equilibrium and then excited by one or
more pulses. With the spins now precessing, magnetisation is allowed to evolve for the
variable time period, t1 . During the mixing period, magnetisation is then transferred
from one spin to another via scalar or dipolar coupling. In some cases, the type of
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magnetisation present during the evolution period is not a detectable signal. The
mixing period can therefore be used to convert magnetisation back into a detectable
signal. Finally, the detection period, labelled t2 , is when the FID is acquired.
Figure 2.2.3: Schematic of stages in 2D pulse pattern. (A) Schematic of the
four basic stages in 2D NMR. (B) Schematic of how t1 evolution time is varied to
measure different frequencies in the F1 dimension.
It is important to note that a signal is not collected during the t1 period. However,
the frequency and amplitude of magnetisation detected during t2 is modulated by spin
evolution that occurs during t1 . This information is transferred to the second spin
during the mixing period via spin coupling. To properly see the effect of t1 on t2 a
number of spectra are recorded with variable values of t1 . Initially, the value of t1 is
set to zero and the data recorded. t1 is then set to time ∆1 and the data recorded again.
This is repeated for evolution times 2∆1, 3∆1, 4∆1 and so on (Figure 2.2.3B). These
incremental steps may be repeated 100-1000 times for a given experiment, allowing us
to record as many FIDs. These will have to be Fourier transformed twice to convert
data from being time-dependent (t1 and t2 ) to being frequency dependent (F1 and
F2 ). F1 and F2 are then plotted as a topographical map with contour lines displaying
peak intensity. This map can then be used to derive the interactions between spins of
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a system, either from scalar or dipolar coupling.
2.2.6 Three-Dimensional NMR
For small peptides, 2D NMR may provide adequately clear spectra for full system
characterisation. However, for full proteins, even relatively small ones of around 5 kDa,
there will be a severe degree of overlap in the peaks. This is is particularly prevalent
in more complex experiments where multiple J-coupled or NOE peaks are detected.
Peak overlap can hinder data analysis and resonance assignment. To circumvent this
issue we can resolve the data in a third dimension to separate the overlapped peaks.
The general scheme of a 3D experiment is very similar to that of the 2D experiment
except that t2 is now also an evolution period followed by a second mixing period. This
precedes the detection period now labelled as t3. Fourier transformation of these three
time-dependent functions into the frequencies F 1, F 2 and F 3 allows the generation of
a 3D spectrum.
It is difficult to predict with any certainty the chemical shifts of nuclei in a protein
due to the myriad of factors that influence chemical shift values [132]. Therefore,
the network of spin connections is studied to infer which amino acid the spin system
relates to. The most commonly used method to achieve this is that of 3D triple-
resonance NMR. The technique was first developed during the 1990s and has gained
prominent use in the assignment of protein structures [142]. It utilises J-coupling
between individual amino acids to show the network of bonds that exist along the
protein sequence. Experiments that are used to assign the backbone sequence of the
proteins are used in pairs with one experiment showing peaks for the i-1 residues and
the corresponding experiment showing peaks for i and i-1 [142–144].
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2.2.6.1 Triple Resonance 3D NMR
The HNCO experiment shows the correlation between 1H and 15N spins of residue i
with the 13CO spins of residue i-1. Firstly, magnetisation is passed from 1H to 15N,
via the 1JN, H coupling, and then to the 13CO nuclei via the 1JN, CO coupling (Figure
2.2.4). The experimental pair to the HNCO experiment is the HN(CA)CO experiment.
Unlike the HNCO experiment, which only shows correlations to i-1 13CO spins, the
HN(CA)CO shows correlations to i and i-1 13CO spins. The sequence of magnetisation
transfer starts with transfer from 1H to 15N. Magnetisation is then transferred to 13Cα
spins, via the 1,2JN, CA coupling, and then to the 13CO spins via the 1JCA, CO coupling
(Figure 2.2.4). For both experiments, chemical shift is evolved first on the 13CO nuclei
(t1) and then the 15N nuclei (t2). Finally, magnetisation is passed back to the 1H nuclei
for signal detection (t3).
Figure 2.2.4: Schematic of HNCO/HN(CA)CO magnetisation transfer.
Blue circles indicate nuclei for which magnetisation is evolved leading to a detect-
able signal and green circles indicate nuclei for which no evolution is performed. Red
arrows indicate the transfer path of magnetisation.
In the HNCACB, and the analogous CBCANH experiment, correlations are shown
between the 1H and 15N spins of residue i and the α and β 13C spins of residues i and i-1.
The HNCACB is often used over the CBCANH as it offers higher sensitivity for larger
proteins with shorter T 2 relaxation times [145]. However, the CBCANH experiment
is described here due to the reduced complexity of magnetisation transfer. Magnet-
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isation is initially transferred from 1Hα/β to 13Cα/β spins via the 1JC, H coupling.
Magnetisation is evolved on the α and β carbons (t1) and the then passed from 13Cβ
to 13Cα. Depending on whether magnetisation is on residue i or i-1, it is passed to the
15N spin via the 1JC, N or the 2JC, N coupling, respectively. 15N chemical shift is then
evolved during the t2 period before magnetisation transfer to the 1H spin for signal
detection (t3) (Figure 2.2.5).
In the CBCA(CO)NH, or HN(CO)CACB, correlations are shown between the 1H
and 15N spins of residue i and the α and β 13C spins of the i-1 residue only. Magnet-
isation transfer is similar but includes transfer from the 13Cα spin to the carbonyl-13C
spin via the 1JC, C coupling (Figure 2.2.5). This limits magnetisation transfer to the i-1
residue only. Chemical shift evolution is the same as it is in the CBCANH experiment.
Figure 2.2.5: Schematic of CBCANH/CBCA(CO)NH magnetisation trans-
fer. Blue circles indicate nuclei for which magnetisation is evolved leading to a de-
tectable signal and green circles indicate nuclei for which no evolution is performed.
Red arrows indicate the transfer path of magnetisation.
The HNCA experiment correlates the 1H and 15N spins of residue i with the 13Cα
spins of residues i and i-1. It is therefore similar to the HNCACB experiment and
should not be necessary for backbone assignment. However, if the HNCACB/HN(CO)CACB
experiments prove difficult to assign accurately, then the HNCA/HN(CO)CA exper-
iments can be helpful due to the reduced complexity and higher sensitivity of these
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spectra. Magnetisation is transferred from 1H to 15N spins via the 1JN,H coupling. The
1JN,CA coupling is then used to pass magnetisation to the 13Cα spin and evolved for
the t1 time period. This is followed by magnetisation transfer back to 15N spin and
evolution for the t2 time period. Finally, magnetisation is transferred to the 1H spin
for acquisition (t3) (Figure 2.2.6).
The HN(CO)CA experiment correlates the 1H and 15N spins of residue i with
the 13Cα spins of residue i-1. The selection of inter-residue magnetisation transfer is
achieved in the same way as in the CBCA(CO)NH. Magnetisation is transferred from
13Cα to 15N via the 13CO spins which only occurs for i-1 α-carbons (Figure 2.2.6).
The evolution periods are the same as in the HNCA experiment.
Figure 2.2.6: Schematic of HNCA/HN(CO)CA magnetisation transfer.
Blue circles indicate nuclei for which magnetisation is evolved leading to a detect-
able signal and green circles indicate nuclei for which no evolution is performed. Red
arrows indicate the transfer path of magnetisation.
2.2.7 COSY and TOCSY Experiments
COSY and TOSCY experiments can be recorded in two or three dimensions. For
small peptides the separation in two dimensions may be sufficient to allow full peak
assignment. However, proteins above around 3 kDa the three-dimensional experiments
are used to reduce peak clustering.
The correlation spectroscopy (COSY) experiment was the first 2D experiment to be
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developed [140]. The 2D version of the experiment is homonuclear with 1H frequencies
in both x and y dimensions. The 3D experiment, which is used for most proteins, is
a double-resonance experiment with the 13C frequencies in the z axis.
The spectra show two types of peaks. Those that appear along the diagonal (F1 =
F 2) represent the peaks of the 1D proton spectrum. Cross-peaks, which have different
F1 and F 2 frequencies, arise from magnetisation transfer between J-coupled spins. It
is the occurrence of these cross-peaks that allows correlation between the two diagonals
that contribute to the cross-peaks. A schematic of a COSY spectrum for a simple three
spin system is shown in Figure 2.2.7.
Figure 2.2.7: Schematic of a three-spin system COSY and TOCSY spec-
trum. Diagonal peaks (green) show the F1 and F 2 frequencies for a given spin in the
absence of coupling. The cross-peaks (blue) arise due to the J-coupling between two
spins. For example, the F1 frequency from spin A and the F 2 frequency from spin
B. The COSY spectrum shows only directly bond partners. However, The TOCSY
experiment shows J-coupling over the length of several covalent bonds.
In the HCCH-COSY experiment correlations are made between neighbouring side-
chain 1H and attached 13C resonances [142, 146, 147]. If we are to take a Hγ resonance
as an example, then magnetisation is first generated on the 1Hγ resonance and evolved
for the t1 time period. Magnetisation is then transferred to the 13C γ-carbon resonance
via the resonance 1JC, H coupling and evolved for the t2 time period. The 1JC, C
coupling is then used to pass magnetisation to the neighbouring 13C resonances (Cβ).
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Magnetisation is then passed to the 1Hβ resonance for carbon-decoupled acquisition
(t3).
The magnetisation transfer is very similar for the total correlation spectroscopy
(HCCH-TOCSY) experiment. However, there is further mixing to allow magnetisation
to pass to all the side-chain 13C resonances, utilising the 1JC, C coupling. This leads
to chemical shift evolution on Cα, Cβ and Cγcarbons during the t2 time period.
Similarly, during the t3 time period, a signal is acquired from the Hα,Hβ and Hγproton
resonances.
Figure 2.2.8: Schematic of COSY/TOCSY magnetisation transfer. Blue
circles indicate nuclei for which magnetisation is evolved leading to a detectable signal
and green circles indicate nuclei for which no evolution is performed. Red arrows
indicate the transfer path of magnetisation.
2.2.8 NOESY Experiments
The experiments described above allow the assignment of chemical shifts for most
backbone and side-chain resonances. However, they cannot provide information about
the tertiary structure of the protein. To generate a 3D structural model of a protein
the highest possible number of distance restraints should be generated. The most
powerful and commonly used method to achieve this is by using a NOESY (Nuclear
Overhauser Effect SpectroscopY) experiment.
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In the NOESY-HSQC experiment magnetisation is transferred between 1H res-
onances using the NOE and evolved for the t1 time period. Magnetisation is then
transferred to the heteronuclei, either 15N or 13C, via the 1JX,H coupling and evolved
for the t2 time period (Figure 2.2.9). Finally, magnetisation is transferred back to the
1H resonance via the same J-coupling and the signal recorded (t2 ). This results in a
3D spectrum that has 1H-X diagonal peaks, arising from J-coupling and 1H-1H cross-
peaks arising from the NOE. The intensity of the peak corresponds to the distance
between the coupled spins which means the experiment can be used to determine the
tertiary structure of the protein.
The process can become complicated if spin X has two dipolar coupled spins, A
and B, with a similar chemical shift, leading to overlapping peaks in the resulting spec-
trum. In addition, incomplete resonance assignment can lead to missing or incorrect
assignment. For these reasons, peaks in the NOESY spectrum are not given definitive
assignments but are ambiguously assigned to a number of possible resonances.
Figure 2.2.9: Schematic of NOESY magnetisation transfer. The X nuclei J-
coupled to the H nuclei can be either carbon or nitrogen giving rise to the 13C-NOESY
or 15N-NOESY, respectively.
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2.3 NMR Spectroscopy to Derive Structure and
Function
2.3.1 Generation of protein structural models
By assigning the resonances of a protein, using the experiments described in this
chapter, it is possible to generate a structural model for the protein. There are two
main constituents required to do this. Firstly, ambiguous assignment of 15N and 13C
NOESY are used to determine the inter-atomic distance between nuclei of the system.
The greatest possible number of these are used to improve the accuracy of the model.
However, overlapping or broadening of peaks means that some are discarded during
distance calculation and only the restraints that are consistent with a compact folded
structure are included [132].
In addition to NOEs, shift-based dihedral angle restraints can be used to im-
prove the accuracy of the structural model [148]. Indeed, several methods for struc-
ture determination use dihedral angle predicted fragments to construct initial models
[149, 150]. The DANGLE (Dihedral ANgles from Global Likelihood Estimates) al-
gorithm uses Bayesian inference to estimate the likelihood of conformations throughout
Ramachandran space [149]. The algorithm uses the expected population distributions
for different amino acid types to generate dihedral restraints for each residue in the
protein
The dihedral restraints and NOE peaks are used to generate structural models via
an automated process, implemented by programs such as ARIA or CYANA [151, 152].
The software takes the spectral information and uses it to produce initial structural
models of the protein. Assignments that conflict with the structural models are dis-
carded and new models created. Several iterations of this process are performed to
further refine the models.
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The researcher will have to filter through restraints that violate the structural
models. The erroneous restraints may arise due to incomplete and/or incorrect peak
assignment or due to peak overlap that means unambiguous assignment is not pos-
sible [153]. Such errors can be reviewed and either removed from the calculation or
corrected, if possible.
It is important to be aware that structures produced do not represent the ’true’
structure, but a model that aligns with experimental observations [132]. Therefore,
there are two main classes of structural statistics that are used to gauge the quality of
the model. Knowledge-based metrics measure model conformance to expected values
via comparison to databases of experimentally determined structures. The metrics
include the distribution of dihedral angles, bond length, the geometry of hydrogen
bonds and atomic packing [154]. Model versus data metrics measure the alignment
of structural models to the experimental data. It is an assessment of the data used
to derive the model and includes measures such as assignment completeness and the
violation of restraints. Root mean square deviation (RMSD) for backbone or all heavy
atoms is also used as a measure of structure precision [154].
2.3.2 Probing Protein Structural Dynamics by NMR
Of the techniques available for studying proteins at the atomic level, only NMR spec-
troscopy provides temporal information down to the ps timescale. As described in
Section 2.1.5 molecular motion is the primary source of local magnetic fields that drive
spin relaxation. As such, the rate of relaxation can be measured to infer information
about the dynamic state of the protein molecule.
There are many possible mechanisms that contribute to the rate of relaxation.
However, when studying relaxation for proteins the primary mechanism observed is
that of dipole-dipole (DD) relaxation. The local magnetic field fluctuations that arise
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Where, γXγH is the gyromagnetic ratio of the coupled spins, h is Plank’s constant,
τc is correlation time and rHX is the distance between the two nuclei. Given that the
mechanism is dependent on the gyromagnetic ratio of the interacting nuclei, protons
are the most effective at causing DD relaxation. This equation also tells us that nuclei
located in a protein core, experiencing many dipolar couplings, will relax faster than
nuclei located in flexible disordered regions where very few dipolar couplings exist.
Correlation time can also vary within a single molecule with large globular regions
taking much longer to make one complete rotation relative to flexible coil regions.
T 1 relaxation is measured using inversion recovery. This involves the use of a
hard pulse followed by a variable delay period (τ) to allow for spin-lattice relaxation.
Proton saturation is applied to suppress relaxation via other mechanisms. The meas-
urement of T 2 relaxation is achieved using the Carr-Purcell-Meiboom-Gill sequence
(CPMG) pulse pattern. This pattern is based on the spin-echo pulse pattern with
variable τ times used to allow for spin-spin relaxation. Both of these techniques can
be incorporated into HSQC experiments to measure the relaxation of each NH nuclei
in a given protein sample.
The NOE effect, described in Section 2.1.6.2, is dependant on the correlation time
of the coupled nuclei. It is theoretically possible therefore, to determine the correlation
time from homonuclear NOESY experiments. However, this is very difficult in practice
because the true distance between the dipolar coupled nuclei is often not known and
multiple similar couplings may be occurring simultaneously [155].
To address this difficulty heteronuclear NOE experiments can be used which meas-
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ure one proton and a covalently linked heteronucleus, often the backbone 1H-15N.
Given that the bond distance is well defined this makes analysis easier and more ac-
curate. Bond vectors that undergo molecular motion that is faster than the average
correlation time of the entire protein (pico- to nanosecond time scale) have a reduced
NOE intensity relative to the average NOE observed for most bond vectors in the
protein. Fewer NOEs are often observed at the protein N- and C-terminus and in
regions of increased flexibility.
Values for the heteronuclear-NOEs are calculated from the ratio of peak intensities
according to Equation 2.3.2.
NOE = (Isaturated/Iequilibrium) − 1 (2.3.2)
Where, I saturated refers to the peak intensity in the spectrum where proton satur-
ation is applied during the preparation stage, and I equilibrium refers to peak intensity
where the proton spins are left at equilibrium prior to the 15N excitation pulse. By
saturating the proton signal cross-relaxation occurs via the NOE causing a loss of
magnetisation. This effect can therefore be used as a proxy to study correlation time
and local differences in molecular motion.
Chapter 3
Materials and Methods
3.1 Strains and Plasmids
Bacterial strains and plasmids used in this study are listed in Appendix A.
3.2 Oligonucleotides
IDT OligoAnalyzer Tool was used to check oligonucleotide melting temperatures, GC
content and dimerisation probability. Oligonucleotides were selected to have a GC
content as close to 50% as possible. Sequences were also selected to have the lowest
possible probability to form either self- or hereto-dimers. Where possible the last
five bases at the 3’ end of the oligonucleotide was designed to have two or three G
or C bases to promoter more specific 3’ annealing. The majority of oligonucleotides
were designed to be 18-22 bp in length. For Gibson assembly oligonucleotides were
deigned to possess at least 20 bp of overlap with adjacent fragments. Therefore, these
oligonucleotides were significantly longer. All oligonucleotides were synthesised and
delivered by IDT.
All oligonucleotides used in this study are listed in Appendix A.
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3.3 preparation of Growth Media
Granulated Luria Agar was used to make agar plates for growth of E. coli cells. 37 g
of granulated powder was added to 1 L of ddH2O and autoclaved for 15 minutes. The
solution was cooled to 50 °C and the appropriate antibiotics added. 20 mL aliquots
were made into 90 mm petri dishes in a laminar flow cabinet to maintain sterility.
Plates were stored at 4 °C prior to use.
E. coli cells were grown in Miller’s Luria broth (LB) or 2XYT broth for the pro-
duction of unlabelled proteins. 25 g granulated LB powder or 31 g granulated 2XYT
powder was added to 1 L of ddH2O and the pH adjusted to 7.2. Media solutions were
autoclaved for 15 minutes and stored at room temperature for no more than one week.
Antibiotics were added to the media just prior to use.
Table 3.3.1: Recipe for M9 minimal media.




Glucose (13C6 glucose for carbon labelling) 2.0 g
NH4Cl (15NH4Cl for nitrogen labelling) 1.0 g
1 M MgSO4 2.0 mL
1 M CaCl2 10 µL
100 mM FeSO4 100 µL
Trace Element Solution (100X; ThermoFisher Scientific) 10 mL
Micronutrient solution (1000X)* 1 mL
* (3 μM Ammonium molybdate; 400 μM H3BO4; 30 μM CoCl2; 10 μM CuSO4; 80 μM
MnCl2; 10 μM ZnSO4).
M9 minimal media (Table 3.3.1) was used to grow E. coli cells producing 13C
and/or 15N labelled proteins. Na2HPO4, KH2PO4 and NaCl were dissolved in 0.8 L
ddH2O and adjusted to pH 7.4. The solution was then made up to 1 L and auto-
claved for 15 minutes. Prior to use all remaining reagents in Table 3.3.1 were added
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to the solution along with the appropriate antibiotics. D-glucose-13C6 and 15NH4Cl
(Cambridge Isotopes) were used, where appropriate for isotopic labelling of the re-
combinantly expressed protein.
Blood agar plates were used for plate growth of P. gingivalis. 40 g blood agar base
(Oxoid) was added to 950 mL ddH2O and autoclaved for 15 minutes. The solution
was cooled to 50 °C followed by the addition 50 mL sterile defibrinated horse blood
(TCS Biosciences) and appropriate antibiotics.
Liquid culturing of P. gingivalis was performed using brain heart infusion (BHI)
broth (Oxoid). 37 g BHI powder was dissolved in 1 L ddH2O and autoclaved for 15
minutes. Prior to use the media was supplemented with 5 µg/ mL haemin (BHI-H)
and appropriate antibiotics. BHI-H was equilibrated to anaerobic conditions for at
least 24 hours prior to use.
The antibiotic stocks used in bacterial culturing were all prepared at 1000× con-
centration and filter sterilised using a 0.22 µm filter syringe. Sterilised antibiotic stocks
were stored at -20 °C to prevent degradation. The stock concentration and solvent for
all antibiotics used in this study are listed in Table 3.3.2. Where possible, ethanol was
used as a solvent to prevent stocks from freezing. All chemicals used in the preparation
of bacterial cultures and antibiotics were provided by Melford Laboratories Ltd.
Table 3.3.2: Antibiotic stock specifications.
Antibiotic Abbreviation Stock Concentration Solvent
Ampicillin Amp 100 mg mL-1 50% Ethanol
Chloramphenicol Cam 30 mg mL-1 50% Ethanol
Erythromycin Erm 50 mg mL-1 95% Ethanol
Kanamycin Kan 50 mg mL-1 ddH2O
Tetracycline Tet 12.5 mg mL-1 50% Ethanol
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3.4 Bioinformatic Analysis
Protein sequences were submitted to the ExPasy ProtParam server [156, 157] was used
to calculate the protein isoelectric point (pI), protein molecular weight, extinction co-
efficient and grand average of hydropathy [158] (GRAVY) score for the protein of
interest. Additional sequences, such as tags and protease cleavage sites, were included
in parameter predictions where appropriate.
Protein signal sequences were identified using the online SignalP 5.0 server [159].
Search queries were limited to the Gram-negative bacteria database. The prediction
of transmembrane beta-strands was achieved using the PRED-TMBB web-server [160,
161].
NCBI BlastP was used to identify similar protein sequences for multiple sequence
alignments [162]. The default settings were using with an except threshold of 0.05
and the maximum number of target sequences adjusted to 500. The online MUSCLE
server was used for multiple-sequence alignments of less than 50 sequences, with default
settings [163]. For large multiple-sequence alignments (more than 50 sequences) the
online Clustal Omega server was used, with default settings[164]. FASTA output
format was selected for visualisation of sequence alignments. The FASTA output
files from the multiple sequence files were uploaded to the WebLogo server [165],
using default settings, to generate consensus sequence images. The multiple sequence
alignment results were uploaded to the online ConSurf server [166, 167], along with
the appropriate structural model, to produce structural models coloured by sequence
conservation. The default settings for the ConSurf server were used.
The online PHYRE2 server was used for the prediction of protein tertiary structure
based on protein sequence [168]. Signal peptide sequences, for transport through the
Sec system, were excluded from model calculation. Intensive modelling mode was
selected for model calculation.
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3.5 Molecular Cloning
3.5.1 Polymerase Chain Reaction
DNA fragments for use in molecular cloning were amplified via polymerase chain reac-
tion (PCR). Q5 High-Fidelity DNA Polymerase (NEB) was used in all PCR reactions
following the 25 µl reaction protocol according to manufacturers instructions (Table
3.5.1). The design of oligonucleotides used as primers is described in Section 3.2. Re-
actions were performed in a TC-312 thermo-cycler (Techne) using the settings shown
in Table 3.5.2.
Table 3.5.1: PCR reaction components.
Component Volume
5×Q5 reaction buffer 5 µl
10 mM dNTPs 0.5 µl
10 µM forward primer 1.25 µl
10 µM reverse primer 1.25 µl
Template DNA variable*
Q5 high-fidelity DNA polymerase 0.25 µl
Nuclease-free water to 25 µl
* 50-100 ng of genomic DNA template and 10-50 ng of plasmid DNA was used per
reaction.
3.5.2 Restriction Enzyme Digestion
All restriction enzymes used in this study were provided by NEB and used according to
manufacturers instructions. All digestions performed using CutSmart buffer (NEB).
Reactions were incubated at 37 °C for 1 hour, immediately followed by agarose gel
electrophoresis.
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Table 3.5.2: PCR Thermocycler Settings.




72 30 (per 1000bp)
72 180 1
4 Hold -
* Annealing temperatures used were 5°C lower than the lowest Tm of the primer pairs
used.
3.5.3 Agarose Gel Electrophoresis
DNA samples were separated via agarose gel electrophoresis using 1-1.5% agarose gels
prepared with TAE buffer (40 mM Tris pH 7.6, 20 mM acetic acid, 1 mM EDTA) and
SYBR safe stain (ThermoFisher Scientific). Gels were run using a PowerPac™ Basic
Power Supply (BioRad) at 90 V for 30 minutes. 2-log DNA ladder (NEB) was used
as a marker to determine band size.
3.5.4 DNA Purification
3.5.4.1 Genomic DNA Purification
P. gingivalis W50 genomic DNA was extracted for use as a template in PCR. A 10
mL culture grown overnight at 37 °C was used for each purification. The DNeasy
UltraClean Microbial kit (Qiagen) was used according manufacturer instructions. Ge-
nomic DNA samples were stored at -20 °C.
3.5.4.2 Plasmid DNA Purification
The Monarch® Plasmid Miniprep Kit (NEB) was used for the extraction of plasmid
DNA from E. coli. A total volume of 3 mL bacterial culture, taken from a 10 mL
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overnight culture, was used for each miniprep. Purifications were performed according
to manufacturers instructions. Samples were eluted in 30 µl Nuclease-free water.
Plasmid DNA samples were stored at -20 °C.
3.5.4.3 PCR Product Purification
PCR amplified products were purified using the Monarch® PCR & DNA Cleanup Kit
(NEB) according to manufacturers instructions. Samples were eluted using 10-15 µl
Nuclease-free water. This purification was used to remove reagents, unwanted buffers
and impurities from the sample prior to restriction endonuclease digestion or ligation.
3.5.4.4 Agarose Gel Band Extraction and Purification
DNA bands of the appropriate size were excised from agarose gels using a sterile
scalpel. The sample was then purified using a GeneJET Gel Extraction Kit (Ther-
moFisher Scientific) or a QIAquick Gel Extraction Kit (Qiagen) according to manu-
facturer instructions.
3.5.5 Plasmid Assembly
3.5.5.1 Ligation Independent Cloning of His-RgpB-CTD
The pET-46 Ek/LIC Vector Kit (Novagen) was used to perform ligation independent
cloning (LIC) for the His-RgpB-CTD construct. The LIC compatible purified PCR
product of the RgpB-CTD gene fragment was treated by T4 DNA Polymerase (Ther-
moFisher Scientific) and annealed into the pET-46 vector according to manufacturers
instructions. NovaBlue GigaSingles™ Competent Cells (Novagen), provided in the kit,
were used for heat-shock transformation of the assembled plasmid. Insert sequences
were confirmed by Sanger sequencing (Eurofins).
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3.5.5.2 Gibson Assembly of pTIO-AI Constructs
pTIO-AI constructs were assembled using the NEBuilder® kit (NEB). pTIO-I vector
was cut using BamHI and NcoI and the digested plasmid purified from agarose gel
extraction. PCR fragments were amplified using primers with >20 bp overhangs and
purified prior to use in assembly. 0.05 pMol of each fragment was used for each
reaction at an 1:1 molar ratio. DNA fragment molarity was calculated using the
online NEBioCalculator™ tool. Fragments were ligated using the NEBuilder master
mix, according to manufacturers instructions, allowing 1 hour for ligation reactions to
proceed. Insert sequences were confirmed by Sanger sequencing (Eurofins).
3.5.5.3 Molecular Cloning of PorV Construct
The pET28(b)-OSS plasmid was provided by Sunjun Wang (KCL) for cloning of the
PorV construct. The vector, and corresponding PCR fragment, were cut using HindIII
and NotI. The pASK-IBA2C vector, and corresponding PorV PCR product, were cut
using SacI and XhoI. The digested products were separated by agarose gel electro-
phoresis and the bands purified (Section 3.5.4.4).
Plasmid ligations were performed using T4 DNA ligase (NEB) according to manu-
facturer instructions. Molar ratios of 1:3, 1:5 and 1:10 of vector to insert were screened.
Room temperature incubation for 10 minutes was used, followed by heat inactivation
at 65 °C for 10 minutes. Ligation samples were used immediately for bacterial trans-
formation and remaining sample stored at -20 °C.
3.5.6 Bacterial Transformation
3.5.6.1 Heat-Shock
20 µL chemically competent cells were incubated on ice with plasmid for 20 minutes.
Cells were then heat shocked for 30 seconds using a 42 °C water bath then incubated
3.6 Protein Techniques 58
on ice for 2 minutes. Outgrowth of transformed cells was achieved using 400 µl LB
with 1 hour of 37 °C incubation. 50-200 µl was then taken and plated on LB agar
plates with appropriate antibiotics for selection.
3.5.6.2 Electroporation
Electrocompetent P. gingivalis cells were prepared using a 6 hour 30 mL culture har-
vested by centrifugation at 10,000 × g for 10 minutes. The cell pellet was resuspended
in 1 mL ice-cold sterile electroporation buffer (EPB; 10% glycerol-1mM MgCl2). Cells
were pelleted again and washed two more times with 1 mL EPB and again suspended
in 1 mL EPB. Electrocompetent P. gingivalis cells were then used immediately for
electroporation.
100 ng of plasmid DNA was mixed with the 200 µl aliquots of the cell suspension.
The mixture was then electroporated (2500V, 25 µF capacitance and 200Ω resistance)
in a 2 mm electroporation cuvette. 1 mL of room temperature BHI-H was immediately
added and cells allowed to recover for 16 hours at 37 °C under anaerobic conditions.
Cells were then plated onto blood agar plates with appropriate antibiotics.
3.6 Protein Techniques
3.6.1 Expression and Purification of Recombinant CTD
3.6.1.1 Protein Expression
pET46-His-RgpB-CTD was transformed in to BL21 (DE3) cells using heat-shock
transformation. The transformed cells were grown on Luria agar plates overnight.
3-5 colonies were taken from the plate and used to inoculate 10 mL LB cultures in 30
mL universal containers which were grown at 37 °C for 4 hours with 240 rpm shak-
ing. A single 10 mL culture was then used to inoculate 0.5 L of LB or M9 minimal
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media, for the preparation of isotopically labelled protein, in a 2.5 L full-baffle flask.
These cultures were grown, under the same conditions, to an optical density at 600 nm
(OD600), of between 0.6 - 0.8. Absorbance was measured for bacterial cultures using
UV spectroscopy after blanking the spectrometer with LB media. After achieving the
correct density, culturing temperature was decreased to 18 °C and protein expression
induced by the addition of 100 µM Isopropyl β-D-1-thiogalactopyranoside (IPTG).
Cultures were then incubated for a further 16 hours to allow for protein expression.
Ampicillin was used for positive selection at all stages of growth and expression.
3.6.1.2 Ni-NTA Chromatography
Following protein expression cells were harvested by centrifugation at 5000 × g for 15
minutes at 4 °C. The cell pellet was resuspended in the ice-chilled lysis buffer (20 mM
Tris-HCl, pH 8.0, 300 mM NaCl, 5 mM MgCl2, 6 µg/ mL lysozyme, 1 µg/ mL DNase
I (NEB) and 1 mM PMSF) at approximately 5 g mL-1 of wet cell weight. Samples
were then sonicated, using a Sonics® Vibra Cell VC130 sonicator, for 3 minutes at
70% power with 3 second pulses. Sonicated samples were centrifuged at 25, 000 × g
for 30 minutes at 4 °C to remove cellular debris.
The cell lysate was loaded onto 5 mL HF HisTrap column (GE Healthcare) pre-
equilibrated with Ni-NTA wash buffer (20mM Tris-HCl, pH 8.0, 300 mM NaCl, 10
mM imidazole). The column was washed using an AKTA Pure (GE Healthcare) until
A280 absorbance reached a steady baseline. The sample was then eluted in 2 mL
fractions using a linear gradient from 100% Ni-NTA wash buffer to 100% Ni-NTA
elution buffer (20mM Tris-HCl, pH 8.0, 300 mM NaCl, 300 mM imidazole). Elution
was continued until a steady baseline was reached.
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3.6.1.3 Enterokinase Cleavage
The Ni-NTA purified sample was first transferred to enterokinase cleavage buffer (20
mM Tris-HCl, pH 8.0, 50 mM NaCl, 2 mM CaCl2) using SnakeSkin™ Dialysis Tubing,
3.5K MWCO (ThermoFisher Scientific). Samples were dialysed using an excess of
500× for external dialysis buffer and left for 16 hours at 4 °C with gentle mixing.
Protein concentration was then adjusted to 2 mg mL-1 and 16 units of enterokinase
light chain (NEB) added for every 10 mL of sample. The reaction was allowed to
proceed for 16 hours at 25 °C with gentle mixing.
The cleaved sample was then immediately processed by reverse Ni-NTA chroma-
tography to remove the enterokinase and cleaved His-tag peptide. Reverse Ni-NTA
was performed using the same method as above (Section 3.6.1.2). However, lysate
flow-through and five column volumes of washing flow-through was taken as the en-
terokinase cleaved protein sample. Five column volumes of elution buffer was used for
a single elution step to collect remaining bound protein.
3.6.1.4 Size Exclusion Chromatography
Following HisTrap or reverse Ni-NTA purification samples were further purified us-
ing size exclusion chromatography. This was performed using an AKTA PURE (GE
Healthcare) with a Superdex 16/600 S75 column (GE Healthcare). The column was
first equilibrated one column volume of buffer containing 20 mM NaPO4, pH 6.0 and
100 mM NaCl. Prior to loading the protein sample was concentrated to ~1 mL and
injected onto the column using a 2 mL injection loop. The sample was then separated
using a flow rate of 1 mL min-1with 2 mL fraction size collection. 20 µl samples were
taken from fractions corresponding to major elution peaks for sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) analysis. Fractions corresponding to
the correct elution peak were pooled and concentrated using a Vivaspin® 20 (5 kDa
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MWCO) centrifugal concentrator (Sartorius) at 4000 × g and 4 °C until the desired
protein concentration was achieved.
3.6.2 Expression and Purification of Recombinant PorV
3.6.2.1 Protein Expression Trials
Prior to large-scale expression of recombinant PorV, small scale protein expression
trials were performed. The relevant plasmids (pASK-IBA2C-PorV, pET28-Oss-His-
PorV and pET28-Oss-PorV-His) and were transformed into BL21 (DE3), Lemo21 and
C41 cells by heat-shock transformation. However, given that Lemo21 is optimised
for T7 promoter plasmids, the pASK-IBA2C-PorV, which contains a Tet promoter,
was not transformed into Lemo21. The transformants were grown overnight on Luria
agar plates at 37 °C with appropriate antibiotic selection. Single colonies were then
transferred to 10 mL LB in 30 mL universal containers containing the appropriate
antibiotic. In addition, Lemo21 cultures were supplemented with 0, 100, 250, 500, 750,
1000 and 2000 µM L-Rhamnose. Cultures were grown at 37 °C with 240 rpm shaking
to an OD600 of ~0.4. Cells carrying pET28-Oss-His-PorV and pET28-Oss-PorV-His
were then induced with 0 or 0.4 mM IPTG. Cells carrying pASK-IBA2C-PorV with
induced with 0, 1 or 2 µg mL-1 anhydrotetracycline (IBA Lifesciences). Cells were
grown post-induction at 18 °C for 16 hours with 240 rpm shaking.
0.5 mL samples from each culture were taken and centrifuged at 13, 000 × g for 1
minute. The cell pellet was resuspended in 50 µl of 1×BugBuster® Protein Extraction
Reagent (ThermoFischer Scientific), prepared from a 10× stock solution diluted in
phosphate buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and
KH2PO4, pH 7.4). Cells were incubated at room temperature for 15 minutes with
gentle mixing and then centrifuged again at 16, 000 × g for 20 min at 4°C to remove
insoluble material. The supernatant was then mixed with 50 µl of 2×sodium dodecyl
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sulfate (SDS)-loading buffer. Additional 0.5 mL samples were taken from each culture
and resuspended in 100 µl 1×SDS-loading buffer. Samples were then analysed by
SDS-PAGE and Western blot.
pET28-Oss-His-PorV was selected for additional screening of different IPTG con-
centrations, OD600 for induction and media composition. The method for screening
was adapted from the above, using cells grown to an OD600 of 0.4, 0.8 and 1.2 in LB
media, and 0.8, 1.2 and 1.6 in 2XYT media. Cells were then induced with 0.4 mM
IPTG and treated the same as above. 2XYT with induction at OD600of 0.8 was selec-
ted as the best condition for growth and the screen repeated using a range of IPTG
concentrations (0, 50, 100 200, 400 and 600 µM). Expression conditions providing the
highest protein yield was selected for large-scale protein expression.
3.6.2.2 Large-scale Protein Expression
3-5 colonies from pET28-Oss-PorV-His in BL21 (DE3) were taken from transformation
plates (see above) for inoculation of 10 mL LB cultures in 30 mL universal containers.
These were grown at 37 °C for 4 hours with 240 rpm shaking. A single 10 mL culture
was then used to inoculate 0.5 L of 2XYT. These cultures were grown, under the same
conditions, to an optical density at 600 nm (OD600), of between 0.8 and expression
induced by addition of 100 µM IPTG. The temperature was then decreased to 18
°C and the cultures incubated for a further 16 hours to allow for protein expression.
Kanamycin was used for positive selection at all stages of growth and expression.
3.6.2.3 Solubilisation Trials
For PorV solubilisation efficiency was tested using the solubilisation trial protocol
adapted from Morrison et al. [169]. Purified membranes containing the target protein
was suspended in buffer containing 20 mM Tris, pH 8 and 200 mM NaCl. The buffer
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was supplemented with 2% octyl-β-D-glucoside (OG; Sigma Aldrich), 2% n-dodecyl-
β-D-maltopyranoside (DDM; Sigma Aldrich), 1% Lauryldimethylamine oxide (LDAO;
Sigma Aldrich), 1% Tetraethylene glycol monooctyl ether (C8E4; Sigma Aldrich) and
2.5% styrene maleic anhydride (SMA2000; gifted from Dr. Alan Goddard). The
suspension was left to slowly mix at room temperature on a rolling-mixer for one hour.
Samples were centrifuged at 100, 000 × g, 4 °C for 30 minutes and the supernatant
retained as the solubilised protein fraction. The pellet was resuspended in buffer
containing 20 mM Tris, pH 8, 200 mM NaCl and 2% SDS.
Soluble vs insoluble fractions for each solubilising agent were analysed by western
blot in triplicate. Band intensities were calculated using ImageLab (Biorad) and av-
erage band intensities for soluble vs insoluble material used to calculate solubilisation
percentage.
3.6.2.4 Membrane extraction
For extraction of bacterial membranes containing folded PorV protein large-scale cul-
tures were collected after 16 hours of protein expression by centrifugation at 5000 × g
for 15 minutes at 4 °C. The pellet was resuspended in the ice-cold lysis buffer (20
mM Tris-HCl, pH 8.0, 300 mM NaCl, 5 mM MgCl2, 6 µg/ mL lysozyme, 1 µg/ mL
DNase I and 1×cOmplete™ EDTA-free protease inhibitor cocktail (Sigma Aldrich))
at approximately 5 g mL-1 of wet cell weight. Samples were then sonicated for 3
minutes at 70% power with 3 second pulses. Sonicated samples were centrifuged at
20, 000 × g for 30 minutes at 4 °C to remove cellular debris. The supernatant was
collected and centrifuged at 100, 000×g, 4 °C for 1 hour to pellet bacterial membranes.
The pellet was resuspended in buffer containing 20 mM Tris, pH 8, 200 mM NaCl and
1% LDAO. The suspension was left to mix for 45 minutes at room temperature on
a rolling mixer. The suspension was centrifuged again at 100, 000 × g for 1 hour at
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4 °C to remove insoluble material. The supernatant was retained as the solubilised
membrane fraction.
3.6.2.5 Ni-NTA Chromatography
Ni-NTA Chromatography for His-PorV constructs were purified using a poly-prep
gravity flow column containing 1 mL Ni-NTA agarose resin (ThermoFisher Scientific).
The column was equilibrated with 10 column volumes of Ni-NTA wash buffer and
the solubilised membrane sample loaded. The column was washed using 20 column
volumes of Ni-NTA wash buffer. A series 2 mL elution factions were collected using
Ni-NTA elution buffer. All Ni-NTA buffers were supplemented with 0.1% LDAO to
maintain protein solubility.
3.6.2.6 Size Exclusion Chromatography
Size exclusion of Ni-NTA purified PorV was performed using the same technique as
described in Section 3.6.1.4 with the following modifications. A Superdex 16/600
S200 column (GE Healthcare) was used following equilibration with buffer containing
20 mM Tris, pH 8, 200 mM NaCl and 0.1% LDAO. Prior to loading the protein sample
was concentrated to ~0.5 mL and injected onto the column using a 1 mL injection loop.
Pooled fractions were concentrated using a Vivaspin® 20 (30 kDa MWCO) centrifugal
concentrator (Sartorius) at 4000 × g and 4 °C until the desired protein concentration
was achieved.
3.6.3 Oligomerisation Analysis
3.6.3.1 Glutaraldehyde Cross-linking of RgpB-CTD
Cross-linking of His-RgpB-CTD was performed according to de Diego et al., [170] using
protein concentrations of 0.1, 0.5 and 1.0 mg/mL with glutaraldehyde at 0.01% in PBS.
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Reactions were performed at at 37 °C for 5 minutes followed by reaction quenching
by addition of Tris to a final concentration of 100 mM. Cross-linking quenching was
performed at room temperature for 15 minutes. Sample was mixed SDS-PAGE loading
buffer and heated to 70 °C for 30 minutes to prevent cross-link breakage.
3.6.3.2 DSP Cross-linking of PorV
A 50 mM stock of dithiobis succinimidyl propionate (DSP) was prepared using 100%
dimethyl sulfoxide (DMSO). Cross-linking reactions for His-PorV were performed us-
ing a series of 20 µl reactions containing 0.5 mg mL-1, ~12 µM, His-PorV in PBS
supplemented with 0.1% LDAO. DSP was added to the suspension to a final concen-
tration of 120 µM. Samples were incubated at room temperature for a time series of
0-60 minutes, with 10 minute intervals. 1 M Tris, pH 7.4 was added to a final con-
centration of 100 mM and incubated for a further 15 minutes at room temperature to
quench the reaction.
3.6.4 Protein Quantification & Qualification
3.6.4.1 Determination of protein concentration
Protein sample concentration was quantified with UV spectroscopy using a Nano-
Drop™ 2000/2000c Spectrophotometer (ThermoFisher Scientific). Wavelength meas-
urements at 280 nm were made and protein concentration calculated using the Beer-
Lambert law (Equation 3.6.1).
A = ε × c × l (3.6.1)
where A is the light absorbance, ε is the extinction coefficient (M-1 cm-1), c is the
protein molar concentration and l is the pathlength (cm). The protein extinction
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coefficients were estimated by ProtParam from the ExPASy webpage [156].
3.6.4.2 SDS-PAGE
Protein samples were mixed with SDS Loading buffer (50 mM Tris-HCl pH 6.8, 30%
glycerol, 10% SDS, 2 mM DTT and 0.05% bromophenol blue) and heated to 95 °C
for 5 minutes. Samples were then loaded into a 4-20% polyacrylamide gel (NuSep)
in a Mini-PROTEAN® Tetra Vertical Electrophoresis Cell (Biorad) and run at 200 V
for 40 minutes in Tris-glycine buffer (25 mM Tris, 250 mM glycine and 0.1% SDS).
Protein colour standard (NEB) was used as a marker to determine protein band sizes.
3.6.4.3 Western Blot
Following SDS-PAGE electrophoresis the gels was removed from the cassette and trans-
ferred to an iBlot®2 PVDF transfer stack (Invitrogen). The stack was prepared accord-
ing to manufacturers instructions and ran using the preset P0 method for 7 minutes.
The PVDF membrane was then transferred to 10 mL blocking buffer (3% BSA in
TBST buffer (137 mM NaCl, 2.7 mM KCl and 19 mM Tris-HCl, pH 7.4)) and left to
block at room temperature for 1 hour. The membrane was then left to incubate with
the primary antibody diluted in blocking buffer overnight at 4 °C (Anti-CTD and Rb7
diluted to 1:1000; Anti-mouse diluted to 1:2000).
The membrane was then washed three times with TBST for 10 minutes. The
membrane was then incubated with the secondary antibody at room temperature for
2 hours (anti-rabbit diluted to 1:2000). The membrane was then washed a further
three times with TBST before development with either 3,3’-diaminobenzidine (DAB)
or enhanced chemiluminescence (ECL).
The DAB solution was prepared by adding 25 mg of DAB to 50 mL of PBS and
33 µL of hydrogen peroxide was added immediately prior to use. 10 mL was added
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to the membrane and the reaction allowed to develop for 5 minutes or until protein
bands were visible. The reaction was stopped by the remove of DAB solution and
resuspension of 10 mL H2O. ECL was prepared using the ClarityTM western ECL
substrate kit (Biorad). 7 mL substrate mix was prepared by mixing the two substrate
solutions at a 1:1 ratio. The solution was added to the blot and incubated for 5
minutes before imaging with a ChemiDocTM MP imaging system (Biorad).
3.7 NMR Spectroscopy
3.7.1 NMR Data Acquisition
NMR samples were prepared in 20 mM NaPO4 buffer with 50 mM NaCl, 10% 2H2O,
0.05% (w/v), NaAzide and 0.1 mM PMSF. NMR experiments for RgpB-CTD reson-
ance assignment were collected using a Bruker 700 MHz NMR spectrometer at 310
K, except for 15N-HSQC-NOESY and 13C-HSQC-NOESY spectra, which were collec-
ted at 800 MHz and 900 MHz, respectively. All spectrometers were equipped with a
triple-resonance TXI cryoprobe.
2D HSQC experiments for 15N longitudinal (T1) and transverse (T2) Relaxation
Measurements were acquired as pseudo-3D experiments on a Bruker 700 MHz NMR
spectrometer at 310K. Delay times of 10, 50, 100, 200, 500, 800, 1200 and 1600 ms
were used to measure T1 relaxation. CPMG delay times used for T2 relaxation were
8, 16, 24, 32, 48, 64, 96, 144 ms. {1H}-15N NOE experiments were also measured on
a Bruker 700 MHz NMR spectrometer at 310K with a 3 s saturation time.
All NMR experiments recorded for His-RgpB-CTD are listed in Table 3.7.1.
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Table 3.7.1: NMR experiments recorded for RgpB-CTD.
Experiment type Dimensions purpose Reference
N-HSQC 1H; 15N Backbone Assignment [171–173]
HN(CO)CACB 1H; 13C; 15N Backbone Assignment [174]
HNCACB 1H; 13C; 15N Backbone Assignment [145, 175]
HN(CA)CO 1H; 13C; 15N Backbone Assignment [176]
HNCO 1H; 13C; 15N Backbone Assignment [143, 175]
C(CCO)NH 1H; 13C; 15N Side-chain Assignment [174, 177]
HC(CCO)NH 1H; 13C; 15N Side-chain Assignment [174]
(H)CHH-TOCSY 1H; 1H; 13C Side-chain Assignment [178]
H(C)CH-TOCSY 1H; 13C; 13C Side-chain Assignment [178]
CBHD-COSY 1H; 13C Side-chain Assignment [179]
CBHE-COSY 1H; 13C Side-chain Assignment [179]
C-NOESY 1H; 1H; 13C Distance Restraints [180–182]
N-NOESY 1H; 1H; 15N Distance Restraints [180–182]
H-Bond HNCO 1H; 13C; 15N Distance Restraints [183]
T1 Relaxation 1H; 15N Dynamics [184]
T2 Relaxation 1H; 15N Dynamics [184]
Unsat. HetNOE 1H; 15N Dynamics [184]
Sat. HetNOE 1H; 15N Dynamics [184]
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3.7.2 NMR Data Processing
Raw NMR data in Bruker format was converted to NmrPipe format using NmrPipe
[185]. NmrPipe functions were used to process the time-dependent data via a series
of solvent filtering, zero filling, window functioning, Fourier transformation, phase
correction, extraction and transposition to frequency dependent data. NMR spectra
were visualised and phasing values calculated throughout this process using NmrDraw.
3.7.3 NMR Data Analysis
TopSpin 4.0.6 (academic licence) was used to process and visualise 1D NMR spectra.
CCPN Analysis 2.4 was used for visualisation, analysis and assignment of processed
2D and 3D NMR spectra [186]. The DANGLE tool in Analysis 2.4 was used to generate
dihedral restraints based off backbone chemical shift assignments [149]. Hydrogen
bond restraints were produced using the built-in tool in Analysis 2.4. All spectral
images shown in this thesis were produced using the Analysis 2.4 print function.
T1 and T2 relaxation times were calculated using the ’follow intensity changes’
tool in Analysis2.4. The fitting function A exp(−Bx) was used to calculate relaxation
rates for all assigned peaks. One divided by the relaxation rate was then used to
calculate the T1 and T2 relaxation time constants for each peak.
3.7.4 NMR Structural Calculation and Validation
H-bond, NOE and dihedral restraints were used by ARIA 2.3 [152], run through the
NMRBox server [187], to create structural model ensembles. Eight iterations, with
20 conformers per iteration, were performed. Water refinement was the performed for
the 10 lowest energy state models from the eighth iteration ensemble. A total of 2207
unambiguous NOE distance restraints, 524 ambiguous NOE distance restraints, 22
hydrogen bond restraints and 92 dihedral restraints were used for the ARIA structural
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modelling.
Structure quality was calculated using ARIA reports and Procheck-NMR [188].
The online server RAMPAGE was used to produce Ramachandran plots for the water
refined structural ensemble[189]. Structure visualisation was performed using PyMOL
[190]. All structural images were produced in PyMOL using ray-tracing drawing.
3.8 Protein-Protein Interaction Studies
3.8.1 P. gingivalis Growth Conditions
Both plate and liquid cultures of P. gingivalis were grown in a Don Whitley anaerobic
workstation to maintain anaerobic conditions and a constant temperature of 37 °C.
Blood agar plates were grown for 5 days or until colonies could be visibly identified.
For recently electroporated P. gingivalis cells, it would often take 10-14 days before
colonies would emerge. BHI-H cultures were grown for 24 hours under these conditions
with no shaking agitation.
3.8.2 Fractionation of Bacterial Cultures
P. gingivalis cells were collected by centrifugation at 10, 000 × g for 10 minutes at 4
°C and the pellet resuspended in PBS, supplemented with 5 mM Nα-Tosyl-L-lysine
chloromethyl ketone hydrochloride (TLCK) and 10 mg mL-1 Leupeptin. The super-
natant was retained as the culture fluid fraction. Cells were lysed by sonication for
5 minutes at 70% power with 3 second pulsing. The lysate was centrifuged again at
10, 000 × g for 10 minutes to collect cellular debris.
Extraction of periplasmic proteins from P. gingivalis was performed using osmotic
shock [108]. 20 mL of P. gingivalis culture, grown for 16 hours to an OD600~ 1.5, was
centrifuged at 10, 000 × g for 30 minutes at 4 °C. A sample of the culture fluid was
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collected for analysis by SDS-PAGE. The pellet was washed once with 5 mL PBS to
remove excess culture media and cells pelleted again. The pellet was then suspended
in 500 mM sucrose, 20 mM Tris-HCl, pH 7.4, 5mM TLCK and 1× cOmplete™ EDTA-
free protease inhibitor cocktail (PIC; Sigma Aldrich). The solution was incubated for
10 minutes on ice followed by centrifugation at 8000×g for 30 minutes at 4 °C. The cell
pellet was immediately resuspended in 5 mL ice cold buffer containing 5 mM MgCl2,
1 mM TLCK and 1× PIC and incubated for 10 minutes on ice. The suspension was
centrifuged at 10, 000 × g for 30 minutes at 4 °C and the supernatant taken as the
periplasmic fraction. Cell pellet was taken as the inner-membrane and cytoplasmic
fraction.
3.8.3 Ni-NTA Pull Down
Pull-down experiments were performed using recombinantly expressed His-tagged RgpB-
CTD, purified by Ni-nitrilotriacetic acid (NTA) chromatography and Size-exclusion
chromatography.
For reactions in which no cross-linking was performed, 50 µm His-RgpB-CTD was
first captured using 40 µl pre-equilibrated Ni-NTA agarose resin. This was washed
three times with using 200 µl Ni-NTA wash buffer supplemented with triton-X100,
to remove unbound protein. Cells from a 10 mL P. gingivalis collected and lysed
by sonication, as described in Section 3.8.2. The buffer used for sample lysis was
supplemented with 1% triton X-100 to solubilise membrane proteins. Lysates were
incubated with the Ni-NTA:His-RgpB-CTD suspension for 1 hour at 4 °C with gentle
mixing.
For samples where chemical cross-linking was incorporated into the protocol, His-
RgpB-CTD was added directly to P. gingivalis lysate and formaldehyde added to a
final concentration of 1%. The suspension was incubated for 30 minutes at 37 °C
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followed by the addition of 1M glycine to a final concentration of 125 mM to quench
the cross-linking reaction. Quenching was allowed to proceed for 15 minutes at room-
temperature and then urea added to a final concentration of 8M and SDS to a final
concentration of 1% to denature all proteins. The sample was loaded onto 40 µl
pre-equilibrated Ni-NTA agarose resin.
The sample was washed for 15 minutes at 4 °C three times, using 5 column volumes
of Ni-NTA wash buffer. wash buffer supplemented with 8M ureas and 1% SDS was
used for pull-down experiments containing the additional cross-linking step. Samples
were eluted directly into 80 µl SDS-PAGE loading buffer and heated to 70 °C for 20
minutes.
3.8.4 pTIO-AI Protein Extraction
Extraction of protein from P. gingivalis strains carrying pTIO-AI-ss-CTD-His, pTIO-
AI-ss-His-CTD or pTIO-AI-CTD-His was performed using whole cell lysates, periplas-
mic fractions and clarified culture fluid. The method of fractionation is described in
Section 3.8.2. Samples from each fraction were purified using Ni-NTA agarose resin
(ThermoFisher Scientific) with a batch flow protocol. 50 µl of resin was loaded into a
1.5 mL microcentrifuge tube and equilibrated using 10 resin bed volumes of Ni-NTA
wash buffer. 1 mL of fractionation sample was loaded onto the resin and incubated
at 4 °C for 1 hour with gentle mixing. The resin was then washed three times with
250 µl Ni-NTA wash buffer. At each washing step the sample was incubated at 4 °C
with gentle mixing for 15 minutes. Elution was achieved by adding 50 µl 2×SDS-
PAGE loading buffer directly to the resin followed by heating to 95 °C for 5 minutes.
Samples of the Ni-NTA chromatography flow-through, wash and elution were also
taken for SDS-PAGE analysis.
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3.8.5 Co-Immunoprecipitation
Co-immunoprecipitation reactions were performed using the BioVision Immunoprecip-
itation Kit according to manufacturer’s instructions. 20 mL P. gingivalis cultures were
centrifuged at 10, 000×g for 10 minutes at 4 °C to harvest bacterial cells. Pellets were
washed three times using 5 mL PBS and finally resuspended in 1 mL PBS. Where ap-
propriate, 50 mM DSP was added at a final concentration of 2 mM, or formaldehyde
added to a final concentration of 1%. Cross-linking reactions were incubated at 37 °C
for 30 minutes followed by 15 minute quenching via the addition of 100 mM Tris, pH
7.4.
For reactions in which no chemical cross-linking was performed the non-denaturing
lysis buffer, supplemented with 5 mM TLCK, was used for protein extraction. For
reactions involving chemical cross-linking the denaturing RIPA lysis buffer was used.
50 µl of 1 mg mL-1Anti-RgpB-CTD Rabbit immunoglobulin (Generon) was added to
each sample and left to incubate overnight at 4 °C with gentle mixing.
30 µl of pre-equilibrated Protein A/G beads were used per sample for antibody
capture and suspensions incubated at 4 °C for 1 hour. Beads were washed three times
using 1 mL of kit wash buffer and all samples were eluted using a denaturing method
via the addition of 40 μl 2×SDS-PAGE loading buffer.
3.9 Molecular Dynamics and Protein Docking
3.9.1 Production of Protein Models
The cryo-EM model for F. johnsonsiae PorV:SprA complex (PDB: 6H3I [122]) was
initially ran through the online MODELLER server [191] to fill missing atoms in the
structural model. The Phenix package, Cryo_fit1, was used to further refine the
structural model via flexible fitting of the structural model to the electron microscopy
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map by molecular dynamics [192]. The default values were used for all fitting options.
The resulting structural model of PorV was selected and used for molecular dynamics
simulations.
Given that there is no experimental structural model of P. gingivalis PorV, a pre-
dicted structural model was derived using the following method. Firstly, the amino
acid sequence for P. gingivalis W50 PorV (excluding the N-terminal Sec signalling
peptide) was uploaded to the online server GREMLIN [193] for the generation of co-
evolutionary distance restraints. The GREMLIN multiple sequence alignment was
generated using the HHBlits method and an E value cutoff of 1e-10 selected. The res-
ulting distance restraints were used alongside the primary protein sequence to perform
comparative modelling using the Robetta protein structure prediction server [194]. A
total of 100 structural models was generated and the F. johnsonsiae PorV structural
model used as a template for modelling.
3.9.2 Molecular Dynamics Simulations
The F. johnsoniae experimental PorV model and the P. gingivalis predicted PorV
model were first run through the online PPM server [195] to determine the rotation
and position within the membrane. The output from this server was then uploaded the
CHARMM-GUI membrane builder server [196] to generate the necessary input files to
build the protein:membrane complex for molecular dynamics simulations. A hetero-
geneous lipid bilayer with 100 lipids per leaflet was created using 80% 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) and 20% 1-Palmitoyl-2-oleoyl-sn-glycero-
3-phosphoethanolamine (POPE). The initial system size was 90 × 90 × 130Å for both
models and the system was determined using the replacement method with 150 mM
NaCl.
Simulations were performed using GROMACS with the CHARMM36m force field.
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The system was minimised and equilibrated at a temperature of 310K and a pressure
of 1 bar using protocol files produced using CHARMM-GUI [197]. Once equilibrated
a 200 ns production simulation was carried out at 310K and a pressure of 1 bar. The
temperature was controlled using the Nose-Hoover thermostat and the pressure was
controlled using the Parrinello-Rahman barostat.
The trajectory output was centred and fitted around the protein using the ’gmx
trjconv’ command. The python package MD-Analysis [198] was used for analysis of
trajectory RMSD and RMSF. Clustering of frame states was performed using the
python package TTClust used for the clustering a trajectory frame states [199]. The
clustering analysis was performed using Cα atom RMSD values and an empirically
determined cutoff value was used to generate representative clusters. Representative
models from each cluster were combined into a structural ensemble for protein docking
experiments. Secondary structure analysis was performed using the VMD Timeline
module [200].
3.9.3 Protein Interaction Docking
For protein interaction docking of P. gingivalis PorV and RgpB-CTD the cluster en-
semble from TTClust was used. For RgpB-CTD the ten water refined NMR structural
models were aligned using POSA server [201] and the RMSD values for each model was
summed. The model with the lowest sum-RMSD value was taken as representative
model for the structural ensemble. Representative P. gingivalis PorV and RgpB-CTD
structural models were uploaded to the CPORT server [202] for the prediction of
protein-protein interface residues. For PorV, predicted residues that are membrane
embedded or at the inner leaflet were excluded.
The PorV structural ensemble and the RgpB-CTD structure were submitted to the
HADDOCK2.4 server [203] for flexible docking analysis. The list of refined CPORT
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residues was used to assign active residues. Passive residues were defined as those
within 6.5Åof active residues. The structures sampled in iteration 0, 1 and water-
refinement was set to 10,000, 400 and 400, respectively. A total of five trials was used
for rigid body minimisation with 180° rotational sampling enabled.
3.10 Statistical Analysis
The statistical analysis for detergent extraction screening was adapted from Morrsion
et al., [169] and was carried out in Python 3.6 using the Statsmodels v0.12.1 module
[204] and Scipy library [205]. The data was fitted using the ordinary least squares
method, with solubilisation agent as the independent variable. A 1-way ANOVA
was then performed on the fitted data and the difference between individual groups
was analysed by a Tukey post hoc test. A value of P < 0.05 was considered to be
statistically significant. A Levene test was used to calculate the equality of variance
between groups and a Shapiro-Wilk test was used to calculate normality for each
group.
Chapter 4
Structural Characterisation of the
RgpB C-terminal Domain
4.1 Chapter Aims
The aim of this chapter was to understand the structural nature of the CTD of cargo
proteins secreted by the T9SS. To date, there have been 35 proteins identified in
P. gingivalis which possess a CTD recognised by the T9SS [81]. When this project
was started there were no structural models available for a T9SS cargo CTD. In this
chapter, the structure of one CTD from a T9SS cargo protein was characterised in
detail using NMR Spectroscopy. This model was produced to further our understand-
ing of how this domain can facilitate cargo protein export and the identification of
structural features that may allow this.
NMR spectroscopy was selected as it provides a model for the protein in solu-
tion state, which more closely resembles physiological conditions compared to X-ray
crystallography. In addition, NMR spectroscopy allows experimental studies to be per-
formed for protein dynamics and for detection of protein-protein interactions. Given
that this project ultimately seeks to understand how the CTD interacts with compon-
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ents of the T9SS this makes the technique particularly well suited to the aims set out
here.
4.2 Rational Design of Recombinant RgpB C-Terminal
Domain
4.2.1 Selection of Model CTD
There are a number of published studies that investigate the consensus CTD sequence
recognised by the T9SS [80, 81, 97, 206, 207]. Veith et al., [81] used 30 experimentally
identified CTD proteins from P. gingivalis and Tannerella forsythia for analysis by the
GLAM2 [208] and MEME [209] sequence alignment servers to identify conserved motifs
in the CTD of T9SS cargo proteins. The author’s analysis revealed a conserved motif of
42 amino acids containing three conserved motifs (B, D and E) identified by Seers et al.,
[80]. Motifs B and D could readily be identified using multiple sequence alignment for
all known CTD proteins from the P. gingivalis W50 strain using the online MUSCLE
server [163] (Figure 4.2.1A). However, conservation in motif E, originally reported to
be seven residues in length, was more difficult to identify.
It has previously been demonstrated that the last 22-residues of the Hbp35 CTD,
containing motifs D and E, was sufficient to achieve secretion, supporting the theory
that these motifs are important in recognition by the secretion system [97]. However,
it has since been suggested that structural conservation is more important than se-
quence conservation in allowing cargo protein recognition [98]. Therefore, determining
a structural model for the domain would prove useful to functional studies and mod-
elling of interaction complexes. In this study, the CTDs from the three gingipains,
RgpA, RgpB and Kgp were selected because these are the most widely studied T9SS
cargo proteins with crystal structures available for the catalytic domains of RgpB [210]
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Figure 4.2.1: Multiple sequence alignment of P. gingivalis W50 gingipain
C-terminal domains using MUSCLE. The three conserved sequence motifs (B,
D and E) identified by [81] are highlighted.
(PDB: 4IEF) and Kgp [52] (PDB: 4RBM). In addition, it has been shown that the
gingipains are the most abundant T9SS cargo proteins in the outer membrane and
outer membrane vesicles of P. gingivalis [44, 84].
Alignment of the three gingipain CTDs shows that Kgp-CTD and RgpA-CTD have
95.8% sequence identity. The RgpB-CTD has 50.0% and 52.7% identity to RgpA-CTD
and Kgp-CTD, respectively. All three gingipains contain the three conserved motifs B,
D and E. Given the sequence identity between these three proteins, RgpB was selected
for further analysis and recombinant expression as it is perhaps the most extensively
studied gingipain.
An NCBI BlastP [162] search using the P. gingivalis W50 RgpB-CTD sequence,
with an expect threshold of 0.05, was used to identify 322 aligned sequences. The
Clustal Omega server [164] was then used to generate a multiple sequence alignment
for the BlastP results and a consensus RgpB-CTD sequence was generated using the
online WebLogo server [165] (Figure 4.2.2).
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Figure 4.2.2: Consensus CTD sequence for P. gingivalis W50 RgpB. The
Alignment was generated using NCBI BlastP [162] and Clustal Omega [164]. The
consensus sequence image was generated using the WebLogo server [165].
4.2.2 Construct Design
The P. gingivalis strain W50 (ATCC 53978) was selected as a model organism for
this study. W50 was selected as it is a virulent and prevalent strain, making it a
clinically relevant strain to study [211]. In addition, a variety of deletion mutants
have been created using this strain which are available in our laboratory. Access to
this wider array of mutant strains has provided more options for phenotypic screening
throughout the research project.
The crystallographic structure of mature RgpB, purified from P. gingivalis, has
S664 as the C-terminal residue, suggesting this is the site of CTD cleavage [79] (PDB:
1CVR). However, mass spectrometry analysis suggests the CTD cleavage site is at
T663 [82]. To ensure the cleavage site is included in recombinant constructs the se-
quence G662- K736 was taken from the P. gingivalis W50 rgpB gene (PG0506; NCBI
Reference Sequence: WP_010956050.1) and cloned into the recombinant expression
vector pET46 EK/LIC using ligation independent cloning (Figure 4.2.3). This vector
adds a 6×His-tag to the N-terminus of the protein, followed by an enterokinase cleav-
age site to allow tag removal. The vector possesses a T7 promoter with lac operator
control, allowing IPTG induced expression, and an AmpR cassette for positive selec-
tion. These features make this vector an ideal choice for recombinant expression in E.
coli.
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Figure 4.2.3: Vector map of pET46-RgpB-CTD. (A) Circular plasmid map for
pET46 EK/LIC vector. (B) Open reading frame of RpgB-CTD (G662-K736) insert
with N-terminal His-tag and enterokinase cleavage site under the control of the IPTG
induced T7 promoter.
4.3 RgpB-CTD Expression and Purification
4.3.1 Protein Expression
The E. coli strain BL21 (DE3) was selected for expression due to its compatibility
with the T7 expression system, high yields and ease of use [212]. Cells were grown
to an OD600 of 0.8 in LB media at 37 °C with 240 rpm shaking. Cells were induced
with 100 µM IPTG and left for 16 hours at 18 °C with 240 rpm shaking. Preparations
using these conditions consistently yielded around 20 mg L-1 of culture. Therefore, no
further optimisation of these expression conditions was performed.
4.3.2 Ni-NTA Chromatography
Cells were collected by centrifugation, resuspended in lysis buffer the sample and lysed
by sonication (Section 3.6.1.2). Following sonication, the cytosolic fraction was ob-
tained by centrifugation, and loaded onto a 5 mL HisTrap column. After washing, the
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protein was eluted using a linear gradient of low to high imidazole, which competitively
binds the NTA resin, releasing the His-tagged protein. Fractions containing His-RgpB-
CTD were confirmed through SDS-PAGE analysis, and these fractions pooled. For
long-term storage, some preparations were lyophilised following His-Trap purification.
Prior to this, a PD-10 buffer-exchange column was used to remove the imidazole from
the sample. Figure 4.3.1 shows this protocol was successful in the purification of
His-RgpB-CTD with minimal contamination and degradation.
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Figure 4.3.1: HisTrap purification of His-RgpB-CTD. (A) SDS-PAGE of His-
Trap elution profile. (B) UV A280 absorbance chromatogram (blue) with elution
gradient from buffer A (20 mM imidazole) to buffer B (300 mM imidazole) (green).
Fractions C7-E2 were deemed pure enough for pooling and further study. Legend: Pel-
let - Insoluble cell lysate pellet, Supp. - Soluble cell lysate fraction, FT - Flow-through
during sample loading, A1-E2 - 2 mL fractions collected by AKTAPure.
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4.3.3 Size Exclusion Chromatography
Pooled sample from Ni-NTA purification was further purified by size exclusion chro-
matography to remove any additional contaminants and to transfer the protein to a
suitable buffer for downstream assays. Due to the molecular size of the His-RgpB-
CTD construct (9.8 kDa), a HiLoad 16/600 Superdex 75 pg column was used as it
provides good resolution for proteins between 10-75 kDa. Figure 4.3.2A shows that
His-RgpB-CTD elutes as a single major peak. Separation of collected fractions com-
prising this peak shows it is a single clean band of the correct size with only minimal
degradation (Figure 4.3.2B).
Figure 4.3.2: Result of size exclusion chromatography for His-RgpB-CTD.
(A) UV A280 absorbance chromatogram with the His-RgpB-CTD peak highlighted
in grey. (B) SDS-PAGE of the His-RpgB-CTD 3 mL fractions from 72 mL to 90 mL
highlighted in grey on the above chromatogram.
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4.4 Initial NMR Characterisation of RgpB-CTD
Following purification, 1D 1H NMR was used for the initial characterisation of His-
RgpB-CTD to determine its suitability for NMR structural studies. A spectrum for
1D His-RgpB-CTD, recorded at 310 K, is shown in Figure 4.4.1. The spectrum dis-
plays a good dispersion of chemical shifts in the region of 10-6 ppm, characteristic
of amides forming ordered secondary structure elements in the protein. In addition,
peaks present between 2-0 ppm indicates the methyl and aromatic resonances are
forming a structured protein core.
Figure 4.4.1: 1H NMR spectrum of RgpB-CTD. The Spectrum shows good dis-
persion of amide chemicals shifts between 10-6 ppm and methyl region peaks between
2-0 ppm, indicative of a well-folded protein. The spectrum was recorded using a Bruker
700 MHz NMR spectrometer at 310 K.
To further determine if the His-RgpB-CTD construct would remain stable for the
duration of the runtime of longer NMR experiments, required for full assignment
and NOE restraints acquisition, an 15N labelled sample was prepared for 2D 1H-15N
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heteronuclear single quantum coherence (HSQC) spectroscopy [171–173, 213]. This
experiment was measured at 310 K (37 °C) because this temperature is physiologically
relevant for P. gingivalis pathology and higher temperatures cause the protein to
tumble faster in solution giving narrower line-widths. The 15N-HSQC spectrum was
recorded for His-RgpB-CTD after 0, 2.5 and 5 days incubation at 37 °C. As shown
in Figure 4.4.2 there is no observable change in the spectrum over the five-day time-
course. In addition, peaks are well dispersed with narrow line widths indicative of a
well-folded protein. There were only a few overlapping peaks, primarily in the centre
of the spectrum, which were later found to mostly correspond to the highly disordered
N-terminal His-tag.
Figure 4.4.2: 2D 1H-15N-HSQC analysis of His-RgpB-CTD temperature
stability. Spectra were recorded for the protein after 0, 2.5 and 5 days incubation
at 37 °C (310K). Good dispersion and narrow line widths could be observed for the
majority of peaks suggesting this is a well-folded protein. No new peaks were observed
following 5 days incubation at 37 °C, showing that the protein does not significantly
degrade during this time. The spectra were recorded using a Bruker 700 MHz NMR
spectrometer at 310 K.
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4.5 RgpB-CTD Chemical Shift Assignment
4.5.1 Backbone Resonance Assignment
The assignment of backbone resonance chemical shifts is a critical step in studying
proteins by NMR as it allows for the sequential identification of residues in a protein.
It is also necessary for the analysis of more advanced spectra that show side-chain
resonances or for the generation of distance restraints. To begin the assignment process
79 peaks were selected, excluding side-chain peaks, from the 15N-HSQC spectrum
shown in Figure 4.4.2. A total number of 87 peaks were expected, however, due to
overlapping peaks for the N-terminal His-tag and enterokinase site in the centre of the
spectrum not all peaks could be resolved.
Triple resonance experiments (HN(CO)CACB, HNCACB, HNCO and HN(CA)CO
[214]) were recorded to allow sequential backbone assignment for 13C 15N labelled His-
RgpB-CTD. The 15N and 1H chemical shift assignment of the 15N-HSQC peaks were
used to guide peak identification in the triple resonance spectra. HNCACB and HNCO
experiments show intra- and inter-residue chemical shifts, whereas the HN(CA)CO and
HN(CO)CACB experiments only provide inter-residue chemical shifts. By matching
the corresponding peaks between the HN(CA)CO to the HNCO and the HN(CO)CACB
to the HNCACB it is possible to assign Cα, Cβ and C’ chemical shifts for each 15N 1H
spin system.
The selected peaks from the 15N HSQC spectrum were assigned to individual spin
systems with an arbitrary numbering system. The semi-automated ’protein sequence
assignment’ tool from Analysis 2.4 [186] was then used to align spectral peaks in
the triple resonance spectra. The program uses the assigned spin systems to identify
peak positions in the triple resonance spectra. These peaks in the NH(CO)CACB
and HN(CA)CO are then used to query the HNCACB and HNCO, respectively. By
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aligning the inter-residue peaks of the HN(CO)CACB with intra-residue peaks of the
HNCACB strip of a different spin system to determine a connection between the
two spin systems. The HN(CA)CO-HNCO assignment is performed in tandem to
help elucidate more ambiguous connections. An example of the sequential assignment
process, using the NH(CO)CACB and HNCACB spectra, from residues V702-A705 is
shown in Figure 4.5.1A. The corresponding assignment of V702-A705 C’ resonances,
using the HNCO and HN(CA)CO spectra, is shown in Figure 4.5.1B.
Using sequential assignment it was possible to achieve 100% assignment of back-
bone resonances (1HN, 15N, Cα, Cβ and C’), excluding the His-tag, enterokinase cleav-
age site and proline resonances. Full assignment of prolines is not possible due to the
cyclic secondary amide structure of proline residues.
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Figure 4.5.1: Sequential assignment example for residues V702 to A705
in His-RgpB-CTD. (A) Cα and Cβassignment using NH(CO)CACB(purple) and
HNCACB (green, positive/pink, negative). (B) C’ assignment using HNCO (red) and
HN(CA)CO (green) spectra. Sequential matches are denoted with a black arrow. The
spectra were recorded using a Bruker 700 MHz NMR spectrometer at 310 K.
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All resonances comprising a given spin system have distinct chemical shift values
that are dependent on amino acid type. It is therefore possible, following chemical shift
assignment, to determine amino acid types for spin systems with backbone resonance
assignments. Using reference chemical shift tables in Analysis 2.4, the arbitrarily
numbered spin systems were assigned to specific amino acid types. These assignments
were used alongside the sequential links derived from the triple-resonance spectra, to
calculate residue positions within the His-RgpB-CTD protein. A fully assigned 15N
HSQC spectrum is shown in Figure 4.5.2.
Figure 4.5.2: Assigned 2D 1H-15N-HSQC spectrum of His-RgpB-CTD. As-
signed 1H-15N peaks are annotated with residue number and amino acid type. The
spectrum was recorded using a Bruker 700 MHz NMR spectrometer at 310 K.
4.5.2 Side-chain Resonance Assignment
Side-chain assignments were initially mapped using spectra from the C(CCO)NH and
HC(CCO)NH experiments. These spectra show resonances for aliphatic side-chain
carbons and hydrogens, respectively, of the preceding residue. The 15N and 1H chem-
ical shift assignments from the 15N-HSQC are again used to guide assignment. As
shown in Figure 4.5.3 a 15N plane is navigated to and the 1H assignment used to guide
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assignment of Cα/β/γ/δ/ϵ and Hα/β/γ/δ/ϵ resonances. Cα and Cβ chemical shifts derived
from the NH(CO)CACB and HNCACB spectra were also used to assist assignment.
Figure 4.5.3: Example strips for side-chain 13C and 1H assignment using
HC(CCO)NH C(CCO)NH spectra. The N and H planes from Y718 are shown.
Peaks represent Cα/β/γ/δ/ϵ and Hα/β/γ/δ/ϵ resonances from the preceding V717 residue.
(A) C(CCO)NH with Cα , Cβ and Cγ peaks of V717 highlighted. (B) HC(CCO)NH
with Hα , Hβ and Hγof V717 highlighted. The spectra were recorded using a Bruker
700 MHz NMR spectrometer at 310 K.
Assignment of the C(CCO)NH and HC(CCO)NH is not strictly necessary for
the full assignment of side-chain resonances as this can be solely achieved using the
(H)CHH-TOCSY (13C resonances) and the H(C)CH-TOCSY (1H resonances) spec-
tra. However, the C(CCO)NH and HC(CCO)NH assignments help to initiate the
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(H)CHH/H(C)CH-TOCSY assignment process by providing a greater starting number
of side-chain resonance assignments. This is useful when trying to resolve ambiguities
and assignment of peaks that are weak or overlapping. The H(C)CH-TOCSY spectra
provide strips for each 13C and 1H resonance in the protein side-chain with all side-
chain hydrogen resonances visible. The (H)CCH-TOCSY provides similar information
but instead shows all side-chain carbon resonances. An example strip for the Cδ - Hδ
resonances of R701 is shown in Figure 4.5.4.
Figure 4.5.4: Assignment of example strips from (H)CHH-TOCSY and
H(C)CH-TOCSY spectra. (A) A single 1H-13C strip in the (H)CHH-TOCSY
showing the assignment of side-chain 13C resonances for residue R701. (B) 1H-13C
strip in the H(C)CH-TOCSY showing side-chain 1H resonance assignment for R701.
The spectra were recorded using a Bruker 700 MHz NMR spectrometer at 310 K.
CBHD and CBHE experiments were also recorded for His-RgpB-CTD to allow
4.5 RgpB-CTD Chemical Shift Assignment 93
assignment of aromatic Hδ and Hϵ resonances of tyrosine and phenylalanine residues.
Given that these aromatic rings often form the core of folded protein assignment of
these resonances is beneficial to structural calculation. This is because resonances
in the core of the protein show a high number of distance restraints which helps
to guide the calculation of structural models. The CBHD and CBHE spectra were
assigned using the known Cβ shifts and reference chemical shift charts. The fully
assigned spectra can be seen in Figure 4.5.5. It was possible to assign all tyrosine and
phenylalanine Hδ and Hϵ resonances using these spectra.
Figure 4.5.5: Assignment of His-RgpB-CTD HD and HE resonances using
CBHD and CBHE spectra. The CBHD spectrum, used for assignment of HD
resonances, is shown in blue. The CDHE spectrum is shown in red and was used for
assignment of HE resonances. The spectra were recorded using a Bruker 700 MHz
NMR spectrometer at 310 K.
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Reference chemical shift tables in Analysis 2.4 were used to assign atom type to
peaks in the assigned C(CCO)NH, HC(CCO)NH, H(C)CH-TOCSY and (H)CCH-
TOCSY spectra. Using this method it was possible to assign 253 side-chain 1H reson-
ances (96.2%) and 165 side-chain 13C resonances (85.1%). The reason for incomplete
assignment, particularly of 13C resonances is because it is not possible to measure the
resonances of certain side-chain atoms using the spectra mentioned here. For example,
the Cγ resonance of aspartate is not bonded to any 1H resonances and therefore cannot
be detected in any of the above experiments.
4.6 RgpB-CTD Structural Restraints
4.6.1 Dihedral Angle Restraints
The estimation of phi and psi dihedral angles allow the prediction of protein secondary
structure. These restraints are also used during automated structure calculation,
alongside distance restraints, to guide the algorithm. The DANGLE (dihedral angles
from global likelihood estimates) tool [149] within Analysis 2.4 was used for estimation
of dihedral angle restraints. The program utilises amino acid sequence, chemical shift
assignments and a database of chemical shifts for known protein structures to predict
phi and psi angles. A maximum of two discontinuous prediction islands was selected
to filter out poorly predicted restraints.
A total of 92 restraints were generated, composed of 46 phi and 46 psi restraints.
Dihedral restraints for the remaining 41 residues were not committed as they exceeded
the maximum number of prediction islands. All rejected restraints were in regions of
the protein that were predicted to be disordered.
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4.6.2 NOE Restraints
For a structural model to be calculated from a protein assigned by NMR, distance
restraints are required to guide the structure modelling algorithms. To generate dis-
tance restraints for His-RgpB-CTD, 15N-HSQC-NOESY and 13C-HSQC-NOESY ex-
periments were recorded. The spectra derived from these experiments provide NOE
through-space connections from the 15N-1H and 13C-1H spin systems, respectively. In
these spectra, a proton resonance plus either a carbon or nitrogen resonance is present
as the diagonal peak with all NOE connections of that atom appearing as cross-peaks.
Cross-peaks in the F1 dimension are picked for each strip and assigned to the given
spin system. However, the F3 dimension, that is the through-space coupling, is left
ambiguously assigned. This allows the algorithmic program used in structural mod-
elling, Aria 2.3 [152], more freedom to test different assignments to find the correct
solution. Example strips for both 15N and 13C NOESY spectra, propagating from a
single diagonal peak, are shown in Figure 4.6.1.
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Figure 4.6.1: Example strips from 13 C-NOESY (A) and 15 N-NOESY (B)
spectra for His-RpgB-CTD. Diagonal peaks are identified from previous assign-
ments. Cross-peaks in the F1 dimension are picked for each strip, highlighted in red,
and assigned to the given spin system. However, the F3 dimension, that is the through-
space coupling, is left ambiguously assigned. The15N-NOESY and 13C-NOESY spectra
were collected using a Bruker 800 MHz and 900 MHz NMR spectrometer, respectively,
at 310K.
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4.6.3 Hydrogen Bond Restraints
Hydrogen bond restraints were determined to further assist the structural calculation
process. Because these bonds have a defined length they can be used to restrain two
residues within 1.730 to 2.700 Å at the very start of the model refinement process.
The ‘long-range’ HNCO is a three-dimensional experiment that shows the 15N amide
donor, 1HN and the 13C’ resonances [183]. That is, all partners in the hydrogen bond
are visible and the restraint can be directly assigned using one peak. An example
plane of the ‘long-range’ HNCO spectrum is shown in Figure 4.6.2. The through-bond
HNCO spectrum is also displayed as it was used to assign the F3 (15N) and F1 (1HN)
resonances.
Figure 4.6.2: Long-range HNCO-COSY for identification of hydrogen bond
restraints in His-RgpB-CTD. The HNCO spectrum, shown in blue, was used as
a reference for F3 and F1 assignment. F2 assignment, for the C’ hydrogen bond
partner, was achieved using the red peaks in the long-range HNCO-COSY spectrum.
The spectra were recorded using a Bruker 700 MHz NMR spectrometer at 310 K.
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4.7 RgpB-CTD Structural Model
4.7.1 ARIA Structure Ensemble Modelling
Using the calculated restraint for His-RgpB-CTD it is possible to derive a structural
model for the protein. Developing an accurate model of the protein tertiary structure
depends on the accurate assignment of NOE cross-peaks as these confer information
on the through-space distance between two proton nuclei in the system. Such an as-
signment can be performed manually but would be a very laborious task and could
lead to the misassignment of connections. To perform this task in a faster and more
accurate manner, structural calculations were performed using the ARIA 2.3 (Am-
biguous Restraints for Iterative Assignment) software [152]. Providing ARIA with
ambiguously assigned NOE peaks and a table chemical shifts for resonances in the
protein, the program uses an iterative structural calculation scheme in which the full
range of ambiguous distance restraints are tested. The calculation of the structures
is driven using CNS (Crystallography & NMR System) [215] and ARIA analyses the
conformers to filter out distance restraints that violate the structural arrangement.
The structural calculation is also guided by the dihedral and the hydrogen bond re-
straints to further increase the accuracy of models generated. The total number of
restraints that were committed to the final structural model ensemble are shown in
Table 4.7.1.
4.7.2 The Solution Structure of RgpB-CTD
For the His-RgpB-CTD ensemble, 20 structures were calculated for each cycle with a
total of eight iterations. The 10 lowest energy models from iteration eight were taken
for further refinement by molecular dynamics in water. The His-RgpB-CTD ensemble,
comprising the 10 lowest energy refined structures (Figure 4.7.1), shows a well-defined
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Table 4.7.1: NMR assignment and structure statistics for RgpB-CTD.
NMR Distance Restraints
Total Unambiguous Restraints 2207
Intra ((|i − j|) = 0 Å) 621
Sequential ((|i − j|) = 1 Å) 372
Short ((|i − j|) < 3 Å) 120
Medium ((|i − j|) < 4 Å) 60
Long ((|i − j|) > 4 Å) 510
Ambiguous Restraints 524
Total Dihedral Angle Constraints 92
Phi/Psi 46/46
Hydrogen Bond Restraints 22
Structural statistics
Violations
Distance restraints (Å) 0.00778 ± 0.00181
Dihedral angle restraints (°) 0.221 ± 0.0435
Deviation from idealised geometry
Bond length (Å) 0.00316 ± 0.0000817
Bond angles (°) 0.412 ± 0.00928
Improper bond angles (°) 1.060 ± 0.0710
Average pairwise RMSD (Å)
Backbone 0.311 ± 0.0239





*All dihedrals in the disallowed region are in the disordered N-terminus and inter-
strand loops.
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backbone region for residues K672 - K736, with the N-terminal residues G662 - D671
poorly defined. Per reside root mean square deviation (RMSD) values for the ensemble
were calculated using CcpnNmr Analysis 2.4 [186]. Analysis calculates RMSD values
by orientating models within the ensemble so that they are superposed. Structural
variation and co-ordinate spread is measured for all residues in the protein sequence.
Figure 4.7.2 shows the per residue RMSDs for all atoms and backbone atoms only.
For the globular domain of the protein (K672 - K736), the average backbone RMSD is
0.44 Å. A similar value was observed using average pairwise RMSD for heavy atoms
and backbone atoms (Table 4.7.1). These scores demonstrate that there is a strong
convergence of conformers in the final ensemble.
Figure 4.7.1: Structural ensemble of the 10 lowest energy water-refined
models for His-RpgB-CTD. (A) The wireframe model shows the structural en-
semble rotated by 180° in the y axis. (B) Cartoon model of the energy minimised
average structure for RgpB-CTD rotated by 180° in the y axis, with β strands 1-7
highlighted. The N-terminus is shown in blue and the C-terminus is shown in red.
His-tag residues not shown.
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Figure 4.7.2: Per residue RMSD values for final 10 water refined His-RgpB-
CTD structural models. Legend: Orange bars - backbone; Blue bars - all atom.
All RMSD values were calculated using CcpnNmr Analysis 2.4.
4.7.3 Structure Model Validation
Table 4.7.1 lists the experimental restraint statistics used for structural model calcu-
lation. The listing of distance restraints represents all restraints that were used in
the final ARIA run after optimisation and removal of violating restraints. The total
number NOE restraints displayed represents merged NOEs merged from the 15N and
13C HSQC-NOESY spectra. For the unambiguous restraints, NOE distance is also
listed.
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Figure 4.7.3: Ramachandran Plot for water refined structural ensemble of
RgpB-CTD. Residues with dihedral angles in disallowed regions are highlighted in
red. All disallowed dihedrals are for residues in the disordered N-terminal and loop
regions.
The geometric quality of the His-RgpB-CTD structure was can be measured using
the distribution of the backbone dihedral angles. Dihedral angle distribution was as-
sessed using Procheck-NMR which analyses and compares the stereochemical geometry
of ensemble structures [188]. The summary of Ramachandran statistics, assessed using
the online RAMPAGE server [189], are shown in Table 4.7.1. 98.9% of residues have
dihedrals within the favoured or allowed regions, indicative of a structure with good
geometric quality (Figure 4.7.3). The remaining dihedrals in the disallowed region
are from residues in the disordered N-terminus and loop regions. The 14 N-terminal
residues, comprising the His-tag and enterokinase cleavage site, were not included in
this analysis.
Restraint violations and deviations from idealised geometry refer to the 10 lowest
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energy water-refined conformers. In addition to the average distance restraint violation
score, no distance restraint violations above 0.5Å were observed. Average violations
> 0.3Å and > 0.1Å were 0.2±0.4 and 2.2±1.6, respectively. All 92 DANGLE derived
dihedral restraints and hydrogen bond restraints were committed to the final structure
with no violations.
4.7.4 Structural Features of RgpB-CTD
As seen in Figure 4.7.1C the globular C-terminal domain (K672 - K736) adopts an
Ig-like fold comprised of seven antiparallel β-strands. The domain forms a compact
β-sandwich fold with the S1, S2 and S5 strands tightly packed against the S3, S4,
S6 and S7 β-strands. The S1 and S2 strands run along the N-terminal face of the
sandwich, interspersed by a β-hairpin. A loop passes to the opposite, C-terminal face
of the sandwich forming the S3 strand. S3 passes to S4 via a twisted beta-hairpin
followed by a loop back to the N-terminal face. The S5 strand runs antiparallel to
the S2 strand, succeeded by another loop to the C-terminal face where S6 and S7
complete the β-sandwich arrangement. The maximal dimensions of the β-sandwich
are 23.8 × 27.9 × 37.5Å, not including residues G662 - D671.
The MUSCLE multiple sequence alignment for all W50 CTD proteins and the
BlastP/Clustal Omega alignment for the W50 RgpB-CTD (Section 4.2.1) were up-
loaded to the online ConSurf server [166, 167] along with a representative RgpB-CTD
structural model. The server was used to generate structural models coloured by
sequence conservation (Figure 4.7.4B-C) and reveals that the most highly conserved
residues are all located primarily at the C-terminal face of the domain. This region of
conservation corresponds closely to the three conserved motifs previously identified by
Veith et al., [81] (Figure 4.7.4A). The S3-S4 loop in motif B is folded back with D696
forming hydrogen bonds to R700 and the highly conserved G699. Motifs D and E com-
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prise the S6 and S7 β-strands, respectively, which run anti-parallel to each other. This
close spatial alignment of the three motifs adds further credibility to the hypothesis
that these conserved regions play an important role in recognition by the T9SS.
Figure 4.7.4: Spatial arrangement of conserved residues in RgpB-CTD. (A)
Cartoon of the RgpB-CTD with the three conserved motifs identified by Veith et al.,
[81] highlighted in blue, orange and green. (B) ConSurf colouring for RgpB-CTD
using the BlastP/Clustal Omega alignment for RgpB-CTD. (C) ConSurf colouring for
RgpB-CTD using the MUSCLE alignment of all W50 CTDs. A water refined ensemble
average energy-minimised model of RgpB-CTD was used for all of the images.
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4.8 RgpB-CTD Dynamics
4.8.1 Enterokinase Cleavage of His-tag
During the process of assigning the NMR spectra for RgpB-CTD, an X-Ray crystallo-
graphic structure was published for the same domain with the PDB code, 5HFS [170].
In this structure, the CTD is shown to form a dimer via domain swapping of the
S7 strands. In addition, the authors demonstrated dimerisation by cross-linking with
0.1% glutaraldehyde. The construct used for these experiments contained residues
K672 - K736 expressed with an N-terminal GST tag. This tag was removed prior to
crystallisation and cross-linking studies.
The formation of a dimer is not something that was observed during sample pre-
paration and NMR data collection as part of this study. This conclusion is based on
the elution volume during size exclusion chromatography and peak line-widths during
NMR data acquisition. To test the formation of an RgpB-CTD dimer the cross-linking
experiments performed by de Diego et al., [170] were repeated. To ensure there was
no interference from the N-terminal His-tag it was removed by enterokinase cleavage.
Pooled sample from Ni-NTA purification was used directly for enterokinase cleav-
age. The sample was transferred to enterokinase cleavage buffer, via PD-10 buffer
exchange, followed by cleavage overnight at 25 °C. The processed sample was then
purified by reverse Ni-NTA chromatography, using a gravity flow column, to remove
enterokinase and uncleaved sample. Flow-through and wash from reverse Ni-NTA
chromatography was pooled and concentrated. This was loaded onto the HiLoad
16/600 Superdex 75 pg column to exchange buffer and remove any remaining contam-
inants. Figure 4.8.1A shows that RgpB-CTD elutes as a single major peak. Fractions
of this peak show it is a single clean band of the correct size with only minimal de-
gradation (Figure 4.8.1B).
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Figure 4.8.1: Result of size exclusion chromatography for RgpB-CTD fol-
lowing enterokinase cleavage. (A) UV A280 absorbance chromatogram with the
RgpB-CTD peak highlighted in grey. (B) SDS-PAGE of the RpgB-CTD 3 mL fractions
from 72 mL to 90 mL highlighted in grey on the above chromatogram.
4.8.2 RgpB-CTD Glutaraldehyde Cross-linking
To test the formation of an RgpB-CTD dimer the glutaraldehyde cross-linking exper-
iment was repeated using 0.1% glutaraldehyde and increasing concentration of RgpB-
CTD (0.01, 0.5 and 1 mg mL-1). The same method as described by de Diego et al.,
[170] was used for the reaction. However, instead of observing two bands, represent-
ing a monomer and dimer, multiple oligomerisation states could be observed (Figure
4.8.2).
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Figure 4.8.2: RgpB-CTD oligomerisation analysis by Glutaraldehyde cross-
linking. Multiple oligomerisation states can be observed for RgpB-CTD following the
addition of glutaraldehyde.
4.8.3 T1 and T2 Relaxation
Due to the inconclusive nature of the cross-linking experiment, NMR relaxation ex-
periments were collected for RgpB-CTD to determine the molecular dynamics of the
protein domain. The aim of these experiments was to ascertain if there is increased
flexibility in the S7 strand, indicative of a potential domain swapping event. NMR
relaxation times can also be used to calculate the correlation time of a protein which
can be used to estimate protein molecular weight.
T1 and T2 relaxation data were analysed using the 15N-HSQC spectrum as a
4.8 RgpB-CTD Dynamics 108
reference for peak assignments. In order to reduce the overlapping of peaks in the
middle of the spectrum, relaxation data was collected for RgpB-CTD with the His-tag
removed. Comparison of peak locations to the 15N-HSQC spectrum for His-RgpB-
RCTD shows that cleavage of the His-tag does not significantly alter the peak locations
4.8.3.
Figure 4.8.3: Comparison of 15N HSQC spectra for RgpB-CTD with and
without the N-terminal His-tag. The spectrum for His-RgpB-CTD is shown in
grey and the spectrum for RgpB-CTD is shown in orange. Other than the loss of
peaks, due to removal of the 13 N-terminal protein residues, only minor changes in
peak location can be observed and these are limited to the C-terminus.
Relaxation rates were calculated for T1 and T2 spectra using the exponential func-
tion A exp(−Bx). Peaks with poor curve fitting, due to peak overlap, were removed
and not analysed. The average T1 and T2 relaxation times for the structured region
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of the protein (K672 - K736) were calculated to be 545.38±80.46 ms and 218.11±63.58
ms, respectively. The T1 and T2 times are plotted against residue number in Figure
4.8.4. Analysis shows a uniform pattern for most residues in the β-sandwich domain.
An increased relaxation time was observed for the flexible N-terminus as expected.
The T1 T2 ratio in the s7 β-strand, which is meant to be domain swapping to form
dimers, shows the same level of structural dynamics as the other β-strands in the
CTD.
The average correlation time for the domain was calculated, using Equation 4.8.1
derived from eq 8. in Kay et al. [216], to be τc ∼ 3.3 ns [216]. The online Protein
Correlation Time Calculator tool [217] was used to predict the expected correlation
time for the RgpB-CTD monomer at 310K. The predicted value was found to be









where υN is the resonance frequency of 15N nuclei in Hz in 700mHz Bo field.
4.8.4 Heteronuclear NOE
1H-15N heteronuclear NOE (hetNOE) experiments were recorded alongside relaxation
experiments to provide supportive information on the N-H bond motions of residues
in the RgpB-CTD protein. Two hetNOE spectra were recorded, the first with proton
saturation and the second without. Residues with faster motion, indicative of increased
flexibility in the protein backbone, show a decreased NOE intensity relative to other
residues in the protein [218]. Values of steady-state NOEs were calculated from the
ratio of peak intensities (saturated over unsaturated).
The spectrum derived from these experiments is comparable to an 15N-HSQC spec-
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Figure 4.8.4: HetNOE, T1 and T2 relaxation times for each residue in
RgpB-CTD. Increased flexibility can be seen for residue in the disordered N-terminus
do not within the β-sandwich fold of the CTD.
trum, allowing easy propagation of peak assignments from the HSQC to HetNOE
spectra. The HetNOE experiments were recorded for RgpB-CTD with the His-tag
removed. To ensure this had no impact on the location of other peaks in the spectra,
the Heteronuclear NOE spectra were compared to the 15N-HSQC containing the His-
tag. As shown in Figure 4.8.5 no major changes to peak location could be observed
beyond the loss of peaks due to the removal of His-tag residues. Peaks were selected
using the 15N-HSQC peaks as a reference with assignment propagation being possible
for all residues. Residues with overlapping peaks were discarded from analysis due to
inaccuracies in measuring intensity difference.
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Figure 4.8.5: Heteronuclear NOE spectra for RpgB-CTD compared to the
15N-HSQC for His-RgpB-CTD. The saturated HetNOE spectrum is shown in
green, positive peaks, and pink, negative peaks. The unsaturated HetNOE spectrum
is shown in blue, positive peaks, and orange, negative peaks. The 15N-HSQC for
His-RgpB-CTD, used as a reference for peak assignment, is shown in grey.
The HetNOE ratios are shown in Figure 4.8.4 and demonstrate that increased
motion, relative to the folded protein domain, is seen for the flexible N-terminus
(G662 - K672). The average Het-NOE score for the full protein was calculated to be
0.656±0.300. The average score for the folded β-sandwich domain only has an average
score of 0.740 ± 0.0369. No deviation from this average was observed in the S7 strand
involved in dimer formation observed in the crystallographic model.
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4.9 Discussion
When work for this chapter was initiated no structural models were available for the
CTD of any protein secreted by the T9SS. In this chapter, the CTD from RgpB was
successfully cloned and expressed recombinantly in E. coli. The protein was purified
and NMR experiments used to assign chemical shifts values for nuclei in the protein.
Structural modelling using distance restraints and chemical shift values derived from
the NMR experiments revealed that it possesses and an Ig-like fold comprised of seven
anti-parallel β-strands. This structural motif is widely observed in a diverse set of
protein families isolated from eukaryotes, prokaryotes and archaea [219]. The domain
is involved in a variety of functions often mediated by protein-protein interactions -
consistent with the proposed function of the T9SS cargo CTD [220].
The same fold was observed for the crystallographic model of RgpB-CTD, which
also contained the preceding IgSF domain of RgpB [170]. Alignment of the average
energy minimised NMR model to the IgSF-CTD crystal model using the online server
TM-Align [221] reveals that the models have an RMSD of 0.74 Å and a TM score of 0.82
(Figure 4.9.2). Although the models are well aligned the packing of the IgSF domain
against the CTD does not allow for the linker region to connect the two domain. This
suggests that the packing of the two domains may be due to crystallisation conditions
and the CTD may orient differently relative to the IG-SF domain in solution state.
When RgpB-CTD was crystallised without the IG-SF domain the resulting struc-
tural model was dimeric via domain swapping of the C-terminal S7 strand (Figure
4.9.1)[170]. Given the essential function of the S7 strand in recognition by the T9SS
[97], the formation of CTD dimers via domain swapping of this strand would have
significant implications for cargo protein recognition. However, oligomerisation of
the RgpB-CTD construct used for the NMR experiments described above was not
observed, nor was there any indication of chemical exchange between a dimeric and
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monomeric state. Furthermore, correlation time calculated from T1 and T2 relaxation
data for the Rgp-CTD are consistent with a monomeric state of the domain. It has
also been demonstrated for a range of proteins that individual domains may form non-
functional domain-swapped dimers when crystallised, whereas the full-length protein
does not [222]. It is therefore possible, that the domain swap observed for the crystal
model of RgpB-CTD is an artificial state induced by non-physiological crystal packing
conditions.
Another possible explanation of the dimerisation is that the RgpB-CTD construct
expressed for crystallisation possessed a GST purification tag. The GST tag is itself
a dimeric protein and has previously been shown to induce the formation of dimers
in fusion proteins [223, 224]. Bringing two CTD molecules together via the addition
of the GST tag may lead to an increased propensity for domain swapping and the
formation of dimers.
Figure 4.9.1: Dimerisation of RgpB-CTD via domain swapping of S7
strand. The crystal structure of RgpB-CTD (PDB: 5HFS) shows the protein in
a dimeric state formed by domain swapping of the S7-strand. However, no dimerisa-
tion is observed in the IgSF-CTD crystal model (PDB: 5AG8) or the NMR structural
models presented here.
Glutaraldehyde cross-linking was used by de Diego et al., [170] to show the form-
ation of CTD dimers. The CTD construct used here, which contains addition N-
terminal residues G662 - D671, revealed the formation of multiple oligomerisation states
and visible laddering of the protein in an SDS-PAGE gel (Figure 4.8.2). Glutaralde-
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hyde forms cross-links predominantly between the ϵ-amine group of lysine side-chains
which can trap proteins in complexes or oligomeric states. Due to the high number of
surface-exposed lysines in RgpB-CTD, the multiple oligomeric states observed when
using glutaraldehyde may be due to non-specific cross-linking of lysines rather than
from multiple domain swap events.
Figure 4.9.2: Comparison of RgpB-CTD NMR and crystal structures.
Alignment of the NMR model (orange) to the crystal model (grey) for RgpB.
Structure based alignment of the NMR structural model to the recently resolved
crystal models for two other T9SS cargo protein CTDs (PorZ [92] and Hbp35 [225])
reveals that the Ig-like fold is well conserved (Figure 4.9.3). This is despite having a
relatively low sequence identity: 24.3% between RgpB and PorZ and 27.5% between
RgpB and Hbp35. This adds support to the hypothesis that structural conservation
within the CTD, and not only the conservation of sequence motifs, is important for
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the function of the domain. Comparison of the three available structural models was
performed using the TMAlign web server [221]. This server calculates a TM-score for
the alignment which is more sensitive to global fold similarity than RMSD scoring, with
an expected score of < 0.17 for two randomly aligned proteins with a score of 0.5-1.0
for proteins that possess the same fold according to SCOP and CATH classifications
[221]. This analysis revealed a TM-score of 0.76 for RgpB-CTD compared to PorZ-
CTD and and a TM-score of 0.69 for RgpB-CTD aligned with Hbp35-CTD. This
shows that the Ig-like fold is conserved between the known CTD structures of T9SS
cargo proteins, despite the low level of sequence identity.
Figure 4.9.3: Comparison to RgpB, PorZ and Hbp35 CTDs. (A) Comparison
of averaged NMR model of RgpB-CTD (orange) against the crystal model of Hbp35-
CTD (grey). (B) Comparison of averaged NMR model of RgpB-CTD (orange) against
the crystal model of PorZ-CTD. Alignments were performed using the TMAlign web
server [221].
Superposition of the RgpB, Hbp35 and PorZ models, along with ConSurf analysis
for RgpB, reveals that the C-terminal face of the domain is the most highly conserved
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region. This corresponds closely to the three conserved motifs B, D and E previously
identified by Seers et al., [80]. Several of the most highly conserved residues, located in
motifs D and E, correspond perfectly to strands S6 and S7, previously demonstrated to
be sufficient for export of GFP [97]. The high degree of structural similarity within the
S6 and S7 strands, and the presence of the highly conserved residues at the C-terminal
face, gives support to the idea that the C-terminal face of the domain is important for
the recognition of cargo proteins by the T9SS.
Truncation of the two, four and ten C-terminal residues of RgpB cause the protein
to accumulate in the periplasm and prevent protein secretion [226]. It has therefore
been suggested that these residues are essential for cargo protein recognition. However,
given the β-sandwich fold observed here it is possible that the truncation of these
residues prevents the correct folding of this domain.
There is one example in the literature of a point mutation in the RgpB-CTD
the fully prevents the surface attachment RgpB [207]. The D696A mutant showed
a strong band corresponding to unprocessed RgpB in the clarified culture fluid and
no periplasmic accumulation. It was therefore suggested, that this residue, located
in conserved motif B, is important for processing and surface attachment but not
for secretion. Analysis of D696s in the NMR model of RgpB-CTD shows it forms
a hydrogen bond to the highly conserved G699 residue and to R700. The D696 side-
chain may help to stabilise the structural motif in this loop facilitating cargo protein
processing. However, the same motif can be observed in the structural model of
PorZ which does not undergo surface attachment. It is interesting to note that the
corresponding residue in Hbp35-CTD is asparagine but the structural motif is still
maintained. It remains unclear how this motif may direct cargo protein attachment.
Given that the D696A mutant localises to the clarified culture fluid, this motif may




This chapter describes how a representative CTD was selected for P. gingivalis T9SS
cargo proteins and the process by which it was cloned, expressed and purified. NMR
spectroscopy was used to generate chemical shift values and distance restraints for
the majority of atoms in this domain. These were used to derive a structural model
of the domain revealing that it has an Ig-like fold comprised of seven β-strands. An
X-ray crystallographic model of this domain has since been published for this domain
suggesting it is dimeric. To test this NMR relaxation experiments were performed to
determine flexibility in the C-terminal β-strand and to estimate the molecular mass
of the protein construct. The data presented here suggested that the CTD is in a
monomeric state in solution and dimerisation may be a result of the crystallisation
process. Comparison of the RgpB-CTD to other more recently published structures
of the PorZ and Hbp35 CTDs reveal that this fold is well conserved between cargo
proteins despite a low level of sequence identity. This further supports the hypothesis
that structural motifs are important for cargo protein recognition by the T9SS.
Chapter 5
Screening for Interactions Between
RgpB-CTD and the T9SS
5.1 Chapter Aims
The aim of this chapter was to identify components of the T9SS from P. gingivalis
capable of interacting with RgpB-CTD. Due to the relative novelty and lack of detailed
characterisation for the T9SS, a non-specific approach for interaction screening was
employed. This was to ensure known system components with unknown function
or novel system components could be identified. The primary purpose of doing this
was to develop a pool of potential interaction partners that could be tested in more
detail, potentially including structural studies of an interaction complex. However,
the aim was not to perform an exhaustive screen for the identification of all potential
interactions. Instead, the aim was to immediately take forward the most promising
candidate protein(s) for interaction verification and further characterisation.
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5.2 His-RgpB-CTD:P. gingivalis Lysate Pull-Down
Pull-down assays are commonly used in vitro techniques for the identification of un-
known protein-protein interactions. The technique is based on affinity chromato-
graphy, in which the bait protein is captured by an immobilised affinity ligand. The
immobilised bait protein is then incubated with cell lysate containing the potential
interaction partners. Following a series of washing steps, to remove non-interacting
proteins, the sample is eluted to release the bait protein and any captured prey pro-
teins.
In this study, the bait protein used was the His-tagged RgpB-CTD construct de-
scribed in Chapter 4. The P. gingivalis strain W50 (ATCC 53978) was selected as
a source of prey proteins for the same reasons as described in Section 4.2.2. Again,
in brief, this strain is one of clinical significance and has the widest available array
of deletion mutant constructs for additional analysis. Ni-NTA agarose was used for
immobilisation of His-RgpB-CTD via His-tag affinity binding. 10 mL cultures of P.
gingivalis, grown for 24-hours in BHI-H broth, was collected and lysed by sonication.
This lysate was added to the resin bed and incubated for 1 hour at 4 °C. The sample
was then washed with Ni-NTA wash buffer containing detergent to maintain solubility
of membrane proteins (20 mM Tris, pH 8; 200 mM NaCl; 10 mM imidazole; 0.1%
Triton-X100). The sample was washed for 3 × 15 minutes at 4 °C, using 5 column
volumes of wash buffer. Samples were eluted directly into SDS-PAGE loading buffer
and heated to 70 °C for 20 minutes. This method of elution was used to ensure that
all protein sample captured by the resin, or the CTD bait protein, were released to
allow for identification in subsequent SDS-PAGE analysis.
Figure 5.2.1 shows the gel image following SDS-PAGE separation of eluted pull-
down samples. His-RgpB-CTD, with no W50 lysate washed over, and W50 lysate
washed over resin, with no captured bait protein, were used as negative controls. Many
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non-specific bands could be identified in the W50 only sample, suggesting that proteins
from the cell lysate are able to interact with the Ni-NTA resin. Some non-specific
bands could also be seen in the His-RgpB-CTD only lane as well. The test sample,
containing His-RgpB-CTD and W50 lysate showed no additional bands relative to the
His-RgpB-CTD only negative control.
Figure 5.2.1: SDS-PAGE analysis of His-RgpB-CTD pull-down against P.
gingivalis lysate. No additional bands can be identified in the test sample (W50 +
His-RgpB-CTD) compared to the two control samples. Number markers on the left-
hand side represent the size of marker proteins in kDa. Legend: W50 - P. gingivalis
W50 lysate, CTD - His-RgpB-CTD.
5.3 Formaldehyde Cross-linking of His-RgpB-CTD:
P. gingivalis Interactions
A caveat with the technique described above is that during sample washing transi-
ently interacting proteins will be washed off. Therefore, the method was altered to
5.3 Formaldehyde Cross-linking of His-RgpB-CTD: P. gingivalis Interactions 121
incorporate chemical cross-linking. By introducing chemical cross-links between the
two binding partners it is possible to capture more transient protein interactions [? ].
In addition, more stringent washing conditions can be used without losing captured
protein complexes. The washing step was increased from three 15 minutes washes to
three 30 minutes washes to remove non-specific bands in the W50 lysate only and
His-RgpB-CTD only control samples.
Formaldehyde was selected as a chemical cross-linker for this experiment as it is
a non-specific cross-linker. Therefore, any protein complex can theoretically be cap-
tured using formaldehyde cross-linking. Formaldehyde is a small electrophilic molecule
susceptible to nucleophilic attack by amino acids [227]. Formaldehyde is initially at-
tacked by a primary amine in the protein and leads to the formation of a Schiff base.
The Schiff base is then susceptible to nucleophilic attack by another nucleophile. This
could be another protein brought into proximity of the Schiff base by interaction with
the initial protein. The second nucleophilic attack causes the formation of a methyl-
ene bridge that covalently links the two proteins [228]. This bridge links nucleophilic
groups of proteins that are 2 Å apart, making it well suited to capturing interacting
proteins and reduces the number of non-specific interactions that would be captured
by use of chemical cross-linkers with longer linkage distances.
The same pull-down method was used as before, however, His-RgpB-CTD was
added directly to W50 lysate with either 0.1 or 1% formaldehyde. PBS was used
for cross-linking reactions as it is an amine-free buffering agent, unlike Tris, which
does not react with formaldehyde. The cross-linking reaction was performed at 37
°C for 30 minutes followed by the addition of glycine to a final concentration of 125
mM to quench the reaction. Following 15 minutes of quenching at room temperature
8M urea and 1% SDS was added to the cross-linked samples to denature proteins in
the sample. The suspension was loaded onto Ni-NTA resin and washed with Ni-NTA
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wash buffer supplemented with 8M urea and 1% SDS. Samples were eluted directly
into SDS-PAGE loading buffer and heated to 70 °C for 20 minutes.
Recombinantly expressed His-tagged LspD-N0 protein, from Legionella pneumo-
phila, was used as an additional control to test for non-specific binding. LspD-N0 is the
N0 domain taken from the Type 2 Secretion System secretin LspD [229]. This protein
was selected because it is of a similar size to His-RgpB-CTD and because it also pos-
sesses an N-terminal His-tag. This construct was readily available in our lab and has
no known or expected interactions with the T9SS. The W50 lysate with His-RgpB-
CTD and no formaldehyde cross-linking sample was repeated to use as a negative
control for the pull-down. W50 lysate and His-RgpB-CTD were each incubated with
formaldehyde alone to provide further negative controls for the experiment.
Figure 5.3.1: SDS-PAGE analysis of His-RgpB-CTD pull-down against P.
gingivalis lysate with formaldehyde treatment. Cross-linking of pull-down
samples was performed using 0.1% (A) and 1% (B) formaldehyde. No additional
bands can be observed in the test samples relative to the control. The higher band,
indicated by the red line, represents the cross-linking induced oligomerisation of His-
RgpB-CTD. Legend: W50 - P. gingivalis W50 lysate, CTD - His-RgpB-CTD, FA -
formaldehyde.
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Figure 5.3.1 shows the result of SDS-PAGE separation of formaldehyde cross-
linked pull-down samples. Only one higher band can be observed in the test sample
(W50+CTD+FA). However, this band is also present for His-RgpB-CTD incubated
alone with formaldehyde. The size of this band suggests it corresponds to the CTD
dimer that is formed by the addition of a chemical cross-linker, as described in chapter
4. An additional band can also be seen for LspD-N0. This band corresponds to the
dimeric form of LspD, consistent with previous observations from our lab.
5.4 Recombinant Expression of His-Tagged CTD
in P. gingivalis
5.4.1 Construct Design and Assembly
Because of the difficultly in identifying protein complexes via the addition of His-
RgpB-CTD to P. gingivalis lysate it was reasoned that the CTD may only interact
with an intact secretion system and that capturing complexes in vivo would prove
more effective in identifying interaction partners. To pursue this hypothesis, constructs
were designed for His-tagged CTD from RgpB using pTIO-AI as a vector. The pTIO-
AI vector was gifted by Dr. Mark Roberts and is derived from the vector pTIO-1
by the addition of the RgpA promoter to allow recombinant expression of protein
constructs within P. gingivalis [230, 231]. This vector possesses an AmpR cassette to
allow positive selection in E. coli and possesses and ErmF cassette to allow positive
selection in P. gingivalis.
Constructs were designed using Gibson Assembly to allow the single-step assembly
of multiple fragments by incorporating the necessary overhangs into primer sequences.
Constructs of RgpB-CTD were designed to carry a 6×His-tag on either the N- or
C-terminus. Both N- and C-terminally tagged constructs were created to mitigate
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against any potential interference in protein interactions arising from the addition of
artificial protein sequences. However, it has previously been demonstrated that the
addition of a 6×His-tag to the C-terminus of PorZ does not disrupt export of this
protein to the outer membrane [92].
Figure 5.4.1: Plasmid maps for pTIO-AI constructs containing RgpB-CTD
variants. (A) circular plasmid map of pTIO-AI prior to assembly. (B) Linear map
of pTIO-AI-SCH containing the Sec signal peptide, RgpB-CTD with a C-terminal 6X
His-tag. (C) pTIO-AI-SCH containing the Sec signal peptide, RgpB-CTD with an N-
terminal 6X His-tag. (D) Linear maps of pTIO-AI-SHC containing RgpB-CTD with
an N-terminal 6X His-tag.
The N-terminal signalling peptide of RgpB, for Sec mediated trafficking to the
periplasm, was added to the N-terminus of these constructs. An additional construct,
containing a C-terminal His-tag but no Sec signalling peptide was created to use as
a negative control. A plasmid map for the three constructs can be seen in Figure
5.4.1. The constructs were named pTIO-AI-CH, pTIO-AI-SCH and pTIO-AI-SHC
according to the arrangement of Sec signalling sequence (S), His-tag (H) and CTD
(C) fragments.
The NcoI and BamHI cut-sites in pTIO-AI, downstream of the RgpA promoter,
were used to linearise the vector for fragment insertions. Following assembly of the
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pTIO-AI constructs using the NEBuilder® HiFi DNA Assembly Cloning Kit, the
sample was transferred to E. coli NEB5α cells by heat-shock transformation. Positive
colonies identified on plates containing ampicillin were used for plasmid mini-prep and
insert sequences were confirmed by Sanger sequencing (SourceBioscience).
Following sequencing confirmation of plasmid assembly, the pTIO-AI constructs
were electroporated into P. gingivalis W50 with positive selection using erythromycin.
Using this method erythromycin-resistant strains were successfully established for each
of the CTD plasmid constructs.
5.4.2 Periplasmic Extraction of His-tagged CTD
To check that the pTIO-AI constructs were successfully expressing folded protein and
that trafficked to the periplasm, a periplasmic extraction followed by nickel affinity
chromatography was performed for each construct. 10 mL cultures of P. gingivalis in
BHI-H media were prepared and cells harvested by centrifugation. A sample of the
culture fluid was taken to check for release of His-tagged CTD. Cell pellets were treated
by osmotic shock to release periplasmic proteins. Following periplasmic extraction,
the samples were centrifuged and a sample of the pellet taken for SDS-PAGE analysis.
The cleared periplasmic fraction was then processed by Ni-NTA chromatography to
capture only His-tagged proteins. As can be seen in Figure 5.4.2, no CTD protein,
for any of the three constructs, could be purified following Ni-NTA chromatography
of periplasmic extracts. In addition, no CTD protein was present in the culture fluid
suggesting no secretion by the T9SS was occurring.
5.4.3 Whole Cell Extraction of His-tagged CTD
To determine if any expression could be detected for His-tagged CTD constructs a
purification was performed using whole-cell extracts rather than using periplasmic
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Figure 5.4.2: SDS-PAGE of Ni-NTA chromatography for periplasmic ex-
traction of pTIO-AI constructs. samples of culture fluid, insoluble cell material,
and the flow-through and elution of Ni-NTA chromatography were separated for the
three pTIO-AI constructs. The expected band for RgpB-CTD, at ~10 kDa, could not
be observed in any sample. Legend: FT - Flow-through, CF - Culture fluid.
fractions only. P. gingivalis cells carrying the correct vector were grown in 10 mL
BHI-H media. Cells were harvested by centrifugation and resuspended in 1 mL PBS.
The cell suspension was then lysed by sonication and again centrifuged to remove
unbroken material. The cleared lysate was then loaded onto Ni-NTA agarose resin for
capture of the His-tagged protein. The batch method of Ni-NTA was used with 50 µl
of resin loaded into a 1.5 mL micro-centrifuge tube. Three 15 minutes washing steps
were used, each with 5× resin bed volume of wash buffer supplemented with 5 mM
TLCK. Elution was achieved by adding SDS-PAGE loading buffer directly to the resin
followed by heating to 95 °C for 5 minutes. Samples of the Ni-NTA chromatography
flow-through, wash and elution were taken for SDS-PAGE analysis.
Figure 5.4.3 shows the flow-through, wash and elution of the Ni-NTA chromato-
graphy for the SCH, SHC and CH constructs. As can be seen sample elution fraction,
the above method was not successful in purifying any His-tagged material from P.
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Figure 5.4.3: SDS-PAGE of Ni-NTA chromatography for whole-cell ex-
traction of pTIO-AI constructs. Ni-NTA chromatography flow-through, wash
and elution samples for each construct are shown. No bands could be observed for the
RgpB-CTD at the expected molecular weight of ~10 kDa. Legend: FT - flow-through.
gingivalis lysate. To test for misfolding of the CTD constructs, the same purification
was repeated with 8 M urea and 1% SDS added to buffers during lysis and purification.
However, it was still not possible to identify any CTD protein using this technique.
5.5 Co-Immunoprecipitation
Whilst working on the pTIO-AI constructs, polyclonal rabbit immunoglobulins were
raised by Generon against recombinantly expressed and purified RgpB-CTD. Access to
this antibody provided an effective means of identifying the presence of CTD protein
in a given sample, but also allowed for a co-immunoprecipitation approach to be
pursued for the identification of protein-protein interactions. Co-immunoprecipitation
allows for the indirect capture of interaction partners that are bound to the bait
protein recognised by the antibody. These complexes can then be separated by SDS-
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PAGE and potential interaction partners identified by mass spectrometry. The main
advantage of using this system, over the traditional pull-down methods described
above, is that complexes can be captured in vivo. This means the CTD proteins
would pass through the native intact secretion system, which may be necessary for
the capture of interaction complexes.
All co-immunoprecipitation reactions were performed using the BioVision Immun-
oprecipitation Kit with either the non-denaturing or denaturing lysis buffer. The
initial screens were carried out using the P. gingivalis W50 wild-type strain lysed with
non-denaturing lysis buffer. The lysate was passed over protein A/G beads alone and
beads bound to Anti-RgpB-CTD. Protein A/G beads bound to Anti-RgpB-CTD with
no loading of P. gingivalis lysate was used as a negative control. Suspensions were
incubated at 4 °C for 1 hour with gentle mixing. The samples were then washed three
times using 1 mL of kit washing buffer with 5 minutes incubation at 4 °C with gentle
mixing for each wash step.
As can be seen in Figure 5.5.1, the Anti-RgpB-CTD antibody runs as a major band
around 46 kDa and a minor band at 25 kDa. No difference could be observed between
the lysate only sample and test sample containing anti-RgpB-CTD. This suggests that
protein binding was due to non-specific interaction of proteins with the protein A/G
beads.
To address the issue of high background binding, more stringent washing conditions
were incorporated into the method. Each washing step was increased from 5 minutes
to 15 minutes, again for a total of three washes. To ensure protein complexes would
not be lost due to the increase in washing stringency, cells were also treated with DSP
and formaldehyde cross-linkers prior to lysis. As any protein complexes would now be
trapped by chemical crosslinks it was possible to use the denaturing RIPA lysis buffer
for more effective release of protein from the cells. The addition of 2×SDS-loading
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Figure 5.5.1: Co-immunoprecipitation using P. gingivalis W50 lysed with
non-denaturing lysis buffer. W50 lysate, loaded onto Protein A/G beads without
anti-CTD shows there are many non-specifically interacting proteins are captured. No
additional bands can be observed in the test sample using W50 lysate captured using
anti-RgpB-CTD.
buffer was used for sample elution. This was supplemented with 1×NuPAGE® Sample
Reducing Agent (ThermoFisher) to ensure that the DSP cross-links would be broken
allowing for the separation of individual protein-complex constituents.
The W50 derived D7 strain (∆RgpB) was used as an alternative negative control
to beads loaded with lysate only. Because the beads are still bound to anti-RgpB-
CTD in this control sample it provides a more accurate picture of the non-specific
interactions that occur in the absence of RgpB. Figure 5.5.2 shows the result of the
co-immunoprecipitation using these conditions. It shows that no proteins were pre-
cipitated using the denaturing buffer either with or without chemical cross-linking.
As demonstrated by Glew et al., [112] only a weak signal is detected for unprocessed
RgpB in the W50 wild-type strain. This could be because the T9SS exports and
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Figure 5.5.2: Co-immunoprecipitation of cross-linked P. gingivalis W50
WT and ∆RgpB strains. Cells were treated with DSP or formaldehyde and lysed
using RIPA buffer. No bands, other than for the anti-RgpB-CTD itself can be ob-
served.
processes cargo proteins before there is a chance of protein accumulation within the
periplasm. To address this, the co-immunoprecipitation experiments were adapted to
use the W50 derived ∆PorV knock-out strain. It was hoped that this would cause
cargo proteins to become trapped within the T9SS and accumulate, allowing easier
capture with anti-RgpB-CTD.
For these co-immunoprecipitation experiments, the ∆RgpB strain was again used
as a negative control for detecting non-specific binding of protein to the anti-RgpB-
CTD antibody. In addition, a rabbit anti-mouse antibody was used as a negative
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control for non-specific protein binding to the antibody Fc region and the protein A/G
beads. Western blot analysis was used to distinguish which protein bands were being
precipitated due to interaction with anti-RgpB-CTD and which bands are being co-
precipitated due to interaction with other proteins in the sample or due to interaction
with the protein A/G beads.
The reaction was performed using non-denaturing lysis to ensure interaction part-
ners were not lost. The duration of each washing step was also optimised with 10,
15 and 20 minutes being tested. Despite changes in band intensity no changes in
banding pattern could be detected by changing the duration of sample washing. The
precipitate of samples washed with three 15 minute washes is shown here.
Figure 5.5.3: Co-immunoprecipitation for P. gingivalis ∆PorV and ∆RgpB
strains with non-denaturing lysis conditions. (A) SDS-PAGE analysis of
co-immunoprecipitation elution and (B) corresponding western blot analysis of the
samples detected with anti-RgpB-CTD or anti-mouse. Using the ∆PorV mutant it
was possible to capture the [II] and [III] forms of pro-RgpB, previously identified by
Glew et al., [82]. Anti-mouse and ∆RgpB were used as a negative control samples.
As can be seen in Figure 5.5.3 it was possible by using the ∆PorV mutant, to
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precipitate the [II] and [III] proteolytically processed pro-RgpB, previously identified
by Glew et al., [82] using ∆PorU and ∆PorV mutants. Significantly more protein
bands were found to co-precipitate following chemical cross-linking with formaldehyde
or DSP. However, comparison of these bands to the ∆RgpB and anti-mouse negative
controls reveals that the co-precipitated bands in the ∆PorV are not due to non-specific
interactions.
Figure 5.5.4: Co-immunoprecipitation of P. gingivalis ∆PorV and ∆RgpB
strains with denaturing lysis conditions. (A) SDS-PAGE analysis of co-
immunoprecipitation elution and (B) corresponding western blot analysis of the
samples detected with anti-RgpB-CTD or anti-mouse. Anti-mouse and ∆RgpB were
used as a negative control samples.
Because it was possible that the high number of non-specific bands, particularly
in the DSP cross-linked sample, were causing genuine interactions to be masked the
reaction was repeated using denaturing lysis buffer. Given that the banding pattern
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was very similar for the uncross-linked and formaldehyde cross-linked samples (Figure
5.5.3), the formaldehyde treatment was not repeated. The optimised washing condi-
tions of three 15 minute washes was used. Figure 5.5.4 shows that Pro-RgpB was still
precipitated under denaturing conditions. There was no detection of co-precipitating
bands due to interaction with the Pro-RgpB protein.
5.6 Discussion
The experimental techniques described in this chapter were performed with the aim of
identifying components of the T9SS that are able to interact with the CTD of T9SS
cargo proteins. Identification of CTD interaction partners in P. gingivalis would not
only advance understanding of the functional role of proteins comprising the T9SS, but
would also allow for such interactions to be characterised in greater detail. Following
the identification of novel interactions, structural studies for the complex were intended
to gain a better understanding of the structural motif present in the cargo CTD that
mediates transport through the system.
When this study was initiated no interaction between cargo CTDs and compon-
ents of the T9SS had been characterised. It still remains unclear what components
of the T9SS are capable of directly interacting with the CTD, if there are any peri-
plasmic chaperones and in what order the cargo is transferred between components of
the system. To identify these potential interactions a range of experimental protein
interaction screening techniques were applied. Techniques were selected that screen
for interactions in a non-specific way to allow identification of novel interaction and
isolation of unknown interaction partners not currently considered part of the T9SS
machinery. Therefore, methods that test specific interactions between two selected
proteins, such as a bacterial-2-hybrid system, were not employed here. The pull-down
and co-immunoprecipitation techniques were selected as they allow a large pool of
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potential interaction partners to be tested simultaneously with the ability to capture
transient interactions by the addition of cross-linking treatment. These techniques,
as described here, were employed unsuccessfully towards this aim. In light of more
recent publications, describing the structure and function of the T9SS, many of the
limitations in the methodology can be reasoned.
5.6.1 Limitations of Ni-NTA Pull-Down Methodology
Ni-NTA pull-down experiments were designed to use recombinant His-RgpB-CTD
mixed with P. gingivalis lysate. This method relies on solubilised protein from P.
gingivalis being exposed to binding sites on immobilised CTD protein. The lysis
method employed here involved sonication of cells suspended in PBS containing triton
X-100 to allow the solubilisation of membrane proteins. It is possible that the lysis
method used causes dissociation of large protein complexes comprising the T9SS. For
example, the purification of a 50 nm diameter protein ring, comprised of PorK and
PorN was achieved using osmotic shock, and the addition of 1% DDM for membrane
solubilisation, to ensure the complex remained intact [115]. It may be that intact
complexes are necessary to mediate interactions with the CTD. Adjustment of the
method to utilise chemical lysis may ensure protein macrostructure is maintained.
The method of protein extraction may also be ineffective at releasing membrane
protein components of the system. For example, glew et al., [112] were able to separate
complexes of PorV bound to the cargo proteins HagA, Kgp/RgpA, RgpB, PG2102 and
PG2172 in a PorU deletion mutant. The protein was extracted using BN-PAGE lysis
buffer containing 1% DDM and separated by 2D BN-PAGE. In addition, extraction
of PorV from P. gingivalis using 1% LDAO as a solubilising agent has been described
[107]. However, the protein extraction method described here utilised triton X-100 for
membrane protein solubilisation. This agent may be ineffective at solubilising PorV
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and other membrane protein components of the T9SS.
Transient interactions are often not observed in pull-down experiments due to the
chemical stress of sample washing. Given that the cargo protein may need to be trans-
ferred between multiple binding partners it is possible that transient interactions occur
during the secretion process. In an attempt to capture potential protein interactions
that are being lost during sample washing a cross-linking step was incorporated into
the pull-down experiment. An additional advantage of this technique is that denatur-
ing conditions can be following cross-linking treatment to solubilise all proteins in the
sample. However, it is possible that cross-linking treatment causes the formation of
large insoluble complexes that are lost during Ni-NTA loading and washing steps.
5.6.2 Limitations of pTIO-AI Expression System
The pTIO-I plasmid was developed as a vector suitable for general use, easy handling
and high electrotransformation efficiency to facilitate molecular biology studies in P.
gingivalis [230]. Previously available plasmids for use in P. gingivalis suffered from
low electrotransformation efficiency, vector instability and large vector size. However,
the pTIO-I plasmid was not developed for recombinant expression of proteins in P.
gingivalis. It was further developed by Dr Mark Roberts to include an RgpA promoter
to allow for recombinant expression of genes within P. gingivalis. The success of this
expression system was confirmed by the insertion of the β-galactosidase gene and
subsequent analysis of β-galactosidase activity within cells. The pTIO-AI plasmid
was gifted by Dr Mark Roberts for use in this study.
Given that this vector has been shown to remain stable within P. gingivalis, is
easy to manipulate and now carries a promoter allowing expression of a given gene
of interest, it was selected as an ideal vector for use in this study. However, despite
successful assembly and electrotransformation into P. gingivalis, no expression of the
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CTD constructs could be detected. This suggests that the constructs were either
not expressed, they were quickly degraded or that the expression level was too low
to be detected by SDS-PAGE. Detection of β-galactosidase expression was achieved
by checking cellular β-galactosidase activity which is more sensitive that SDS-PAGE
analysis. This supports the theory that expression of the CTD constructs is too
low to be detected by SDS-PAGE. By scaling-up the volume of P. gingivalis culture
loaded onto Ni-NTA resin it may be possible to enhance the concentration of His-
tagged CTD protein. More extensive testing of promoter efficiency and testing of
alternative promoters may be necessary before this expression can be used for effective
recombinant protein expression in P. gingivalis.
At this time anti-RgpB-CTD became available making co-immunoprecipitation
possible. Given that co-immunoprecipitation also facilitates in vivo capture of protein
complexes, but without the need for optimisation of protein expression, this method-
ology was not developed further. Further justification of this decision is that it the
same issues arising during the co-immunoprecipitation experiments would likely occur
as the CTD is exposed to the system in a very similar way. However, the poten-
tial issue of competitive binding between components of the secretion system and the
anti-RgpB-CTD antibody would have been circumvented. This spatial separation of
the His-tag epitope, present on the pTIO-AI expressed protein, from the CTD may
have allowed more efficient capture of protein by Ni-NTA chromatography relative to
Co-immunoprecipitation of native protein.
5.6.3 Limitations of the Co-Immunoprecipitation Methodo-
logy
Co-immunoprecipitation experiments were adapted for use in a ∆PorV strain of P.
gingivalis W50 in the hope that this would interrupt the secretion process causing
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cargo proteins to become blocked within the secretion system. Ishiguro et al., [107]
describe the accumulation of Arg-gingipains within the periplasm in a PorV deletion
mutant derived from P. gingivalis W83 suggesting that secretion is disrupted in the
absence of PorV. Therefore, co-immunoprecipitation experiments were adapted for
use in a ∆PorV strain of P. gingivalis W50 in the hope that this would interrupt the
secretion process. As shown in Figure 5.5.3 it was possible to capture pro-RgpB by
immunoprecipitation from this strain. However, no co-precipitating proteins could be
identified.
Figure 5.6.1: In the absence of PorV the SprA pore is blocked by a plug
protein. Structural model of SprA (blue) in complex with the T9SS plug protein
(orange). In the presence of the plug protein prevents the export of proteins across
the outer membrane.
More recently a cryo-EM structure for SprA, the Sov homolog in Flavobacterium
johnsoniae, has been determined [113]. The protein forms a large transmembrane β-
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barrel with a cap at the extracellular end. A lateral opening is present which creates
a cavity between the periplasm and the outer membrane. The structure is presen-
ted in two states, the first has PorV bound to the lateral opening with three loops
exposed to the periplasmic cavity. The second state contains a plug protein bound
to periplasmic opening of SprA. The evidence presented by the authors suggest that
in the absence of PorV the porin of the T9SS is maintained in a closed state as
shown in Figure 5.6.1. This would prevent the capture of any Sov-RgpB complexes
by co-immunoprecipitation in the ∆PorV mutant. This mechanism of inactivation
may also interrupt the interaction of other system components with RgpB and ex-
plain why protein complexes could not be captured. It is possible that the use of
other mutants in co-immunoprecipitation experiments, such as porU or PorZ deletion
mutants, in which cargo proteins appear to accumulate in a PorV bound state at
the outer membrane, would cause cargo proteins to be blocked within an open sys-
tem. This may have allowed protein complexes involving pro-RgpB to be captured by
co-immunoprecipitation.
5.6.4 The Role of PorV in Cargo Protein Transport
To date, there is only one study demonstrating an interaction between the T9SS system
and T9SS cargo proteins [112]. The authors were able to demonstrate using 2D BN-
PAGE followed by LC-MS, in a ∆PorU strain, that PorV interacts with cargo proteins
of the T9SS. They were able to isolate PorV in complex with HagA, Kgp/RgpA,
PG2102 and PG2172. Although they did not directly demonstrate that this interaction
was being mediated by the CTD, all proteins isolated were in their unprocessed state
possessing both pro-peptides and CTDs. That the authors required a PorU deletion
strain to isolate interaction partners is consistent with the hypothesis that processing
in wild-type cells is too fast to allow capture of complexes containing unprocessed
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protein.
The authors also isolated complexes from a strain possessing a deletion mutation
in the PorU cleavage site in the RgpB gene. It was observed in this mutant that
unprocessed RgpB would accumulate in a PorV bound state on the surface of the cell.
This again further suggests that the interaction between RgpB and PorV is being
mediated by the CTD. It also suggests that the use of a PorU deletion mutant for co-
immunoprecipitation experiments would have allowed capture of the PorV interaction.
5.6.5 Selection of CTD Interaction Partners
Although it is speculated that the interaction between PorV and RgpB is mediated by
the CTD, given that it is the only component common to all cargo proteins, it has not
been directly demonstrated. The ambition of this thesis is to directly demonstrate an
interaction between the CTD of RgpB and the T9SS. Therefore, PorV was selected as
the candidate interaction partner suitable for further analysis. To allow for a thorough
examination of this interaction no further experiments were conducted to identify other
components of the T9SS that may interact with the RgpB-CTD protein.
5.7 Summary
This chapter describes the application and optimisation of non-specific protein inter-
action screening using RgpB-CTD tested against proteins from P. gingivalis. The
aim of this was to isolate candidate proteins, one of which would be taken forward
for further characterisation and structural studies. The initial approach involved the
addition of His-tagged RgpB-CTD to P. gingivalis lysate followed by capture using
Ni-NTA chromatography. This was adapted to incorporate chemical cross-linking in
the hope of trapping transient interactions. This approach was unsuccessful in isolat-
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ing interaction partners. Therefore, an in vivo approach was developed using pTIO-AI
for expression of tagged RgpB-CTD in P. gingivalis. However, no protein could be
identified by SDS-PAGE using this system and it requires further optimisation. Co-
immunoprecipitation using anti-RgpB-CTD was then applied to capture native RgpB
passing through the T9SS. Despite using chemical cross-linking no RgpB could be cap-
tured in wild-type P. gingivalis. The technique was adapted to use ∆PorV with the
aim of reducing export efficiency and causing cargo proteins to become trapped within
the T9SS. However, Lauber et al., [113] demonstrated that when PorV is deleted a plug
protein blocks the T9SS secretin and may prevent CTD proteins interacting with the
T9SS. Given that no viable interaction partners were identified using these techniques,
PorV was selected for further characterisation based on evidence from 2D-BNPAGE





The aim of this chapter was to characterise the hypothesised interaction between
RgpB-CTD (described in Chapter 4) and PorV (selected in Chapter 5) using in vitro
methods for studying protein-protein interactions (PPI). This would be the first in
vitro characterisation of an interaction between the CTD of any T9SS cargo protein
and a component of the T9SS. This information would further our understanding
of how cargo proteins are recognised and processed by the T9SS. Furthermore, if a
structural model of the complex could be developed this may provide new possibilities
for the development of therapeutic molecules that prevent CTD recognition by the
T9SS.
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6.2 Rational Design of Recombinant PorV
To achieve the chapter aims it was necessary to develop a method for the expression
and purification of PorV protein to be used for in vitro PPI experiments. The objective
was to generate purified PorV sample that could be used in pull-down experiments
with purified RgpB-CTD to directly demonstrate the interaction between the two
proteins. Point mutations would then be generated for each protein to generate low
resolution restraints that could be used to define an interaction interface between the
two proteins. The P. gingivalis W50 PorV (PG0027) was selected as the RgpB-CTD
construct described in this thesis was also taken from P. gingivalis W50.
6.2.1 Export Prediction
Selection of the correct protein sequence is an important first step in the design of pro-
tein constructs for recombinant expression. Analysis of the protein sequence provides
insight into the most appropriate system for expression and purification. It has pre-
viously been demonstrated that PorV is localised to the outer membrane and is pre-
dicted to possess a β-barrel fold [108]. Bacterial outer membrane β-barrel proteins are
known to possess N-terminal signal peptides for transfer from the cytoplasm to the
periplasm via the Sec system [232]. Therefore, the primary sequence of P. gingivalis
W50 PorV was uploaded to the SignalP-5.0 server [159] for the prediction of signal
peptides and cleavage sites. As shown in Figure 6.2.1 PorV is predicted to contain
an N-terminal signal peptide (residues 1-27) for Sec transport with peptide cleavage
occurring between residues A27 and Q28. For expression of PorV in E. coli, residues
28-391 were taken for assembly into pASK-IBA2 or modified pET-28, carrying the
E. coli OmpA Sec signalling peptide. The OmpA signalling peptide was selected as
it provides a highly effective signal that has been used extensively for recombinant
expression of periplasmic and membrane proteins in E. coli [233].
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Figure 6.2.1: SignalP server result for porV protein sequence. This predicts
that PorV contains a Sec signal peptide spanning residues 1-27. Peptide cleavage is
predicted to occur between residues A27 and Q28.
6.2.2 Tertiary Structure Prediction
When work for this chapter began no structural model was available for the PorV
protein. Therefore, a prediction of the protein tertiary structure was calculated to
determine the location of N- and C-terminal residues. This was used to ensure the
addition of purification tags would not block the putative interaction site, expected
to be localised to the outer face of PorV. Tertiary structure modelling was performed
using the online Phyre2 server [168] which predicts protein folds via sequence alignment
to known protein structures. As shown in Figure 6.2.2, PorV is predicted to contain
14 transmembrane β-strands with an N-terminal coil passing through the centre to the
extracellular face. It was predicted that the C-terminus is located at the periplasmic
side of the outer membrane. This orientation suggests that a C-terminal purification
tag should not interfere with CTD interactions. The length of the N-terminal plug
also suggests that the addition of a purification tag to the N-terminus may also remain
distal from putative interaction sites in the inter-strand loops of PorV. Therefore,
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constructs of PorV were assembled using both N-terminal and C-terminal tags.
Figure 6.2.2: Phyre2 3D structural model prediction of P. gingivalis W50
PorV. The predicted model calculation suggests PorV is composed of 14 transmem-
brane β-strands with an N-terminus coil forming a plug passing to the extracellular
surface. The C-terminus be exposed at the periplasmic face.
6.2.3 Construct Design
PorV28-391 was cloned into pASK-IBA2C. This vector was selected as it contains
the OmpA Sec signalling peptide for transport of fusion protein across the inner-
membrane, a C-terminal Strep-tag®II purification peptide allowing for highly efficient
purification of functional protein [234] and inducible tetracycline promoter/operator
providing highly stringent control of protein expression [235].
Additional PorV constructs were made with the assistance of Sunjun Wang (Gar-
nett lab, KCL) using pET28(b) modified to contain the OmpA Sec signalling peptide;
renamed as pET28(b)-OSS. This vector was selected as it allows for purification of
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function protein using Ni-NTA chromatography and IPTG controlled expression us-
ing a T7 promoter. Via the addition of the OmpA signalling peptide this vector could
be used to produce gene products that translocate to the outer membrane. PorV28-391
was ligated into pET28(b)-OSS carrying either an N-terminal or C-terminal 6XHis-
tag. Both fusions were created to circumvent potential issues with protein folding
arising from the addition of an artificial tag to either the C- or N-terminus. A schem-
atic highlighting the orientation of gene fragments for each of the three constructs is
shown in Figure 6.2.3.
Figure 6.2.3: Design of PorV constructs for recombinant expression in E.
coli. Vectors used for expression are shown on the left. The arrangement of gene
fragments for each construct is shown on the right.
6.3 Protein Expression and Purification
6.3.1 Selection of Cell Type for Protein Expression
Proteins that localise to biological membranes are notoriously difficult to express and
purify in comparison to soluble globular proteins. As such, a range of conditions for
growth and expression were tested for the recombinant PorV constructs to improve
protein yields.
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The first variable tested was the selection of the cell type used for expression. E.
coli strains were selected as they are Gram-negative bacteria, making it appropriate
for the expression of an outer membrane protein from P. gingivalis, which is itself
Gram-negative. In addition, E. coli cells are easy to handle and economically viable
at the large-scale required to yield membrane protein in adequate quantities.
BL21(DE3) cells were tested as this strain is effective at expressing proteins carried
by pET vectors under the control of the T7 promoter and are compatible with the
tetracycline promoter/operator system [212]. The BL21(DE3) derived Lemo21(DE3)
strain was also tested as this strain allows more stringent control of the T7 promoter
[236]. This strain carries pLemo, containing the lysY gene, which encodes lysozyme
- the natural inhibitor T7 RNA polymerase. Expression of lysozyme is controlled via
the addition of L-rhamnose to the growth media allowing finer control of T7 system
expression. This is effective at reducing the formation of inclusion bodies or reductions
in cell growth due to protein toxicity; both of which are issues common to membrane
protein expression.
The final cell type that was tested is also derived from BL21(DE3). The C41(DE3)
strain contains at least one mutation that prevents cell death from the expression of
many toxic proteins [237]. Therefore, this strain was selected for the same reasons as
for the Lemo21(DE3) strain. However, unlike Lemo21(DE3), expression is not tune-
able when using C41(DE3). Despite this many publications describing the purification
of bacterial outer membrane proteins found C41(DE3) to be a successful and effect-
ive host [237]. Both the Lemo21(DE3) and C41(DE3) strains possess the same host
features and benefits of the BL21(DE3) parent strain.
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6.3.1.1 pASK-IBA2C Cell Type Screen
pASK-IBA2C was tested first as the tetracycline promoter/operator system and Strep-
tag II is a highly effective system for expression of membrane proteins. Expression was
tested using C41 and BL21 cells, but not Lemo21(DE3), as this strain is incompatible
with the tetracycline promoter system. Cultures of C41 and BL21 carrying the pASK-
PorV plasmid were grown to an OD600 of ~0.4 and protein expression induced via the
addition of 0, 1 or 2 µg ml-1 of anhydrotetracycline. This tetracycline derivative is
capable of activating the Tet promoter on the pASK-IBA2C plasmid but does not
exhibit any antibiotic activity. This allows the promoter to be activated without
slowing bacterial growth and protein expression. Following induction the cultures were
grown at 18 °C for 16 hours and a 1 ml sample taken from each culture and lysed using
BugBuster® Protein Extraction Reagent (ThermoFisher Scientific). Following lysis
half of the sample was centrifuged to clear insoluble material. Whole cell lysate and
soluble fraction lysate was separated by SDS-PAGE and immunoblotted using Strep-
Tactin®-HRP (IBA-Lifesciences) for the detection of Strep-tag®II fusion proteins. As
shown in Figure 6.3.1A only one band at the 25 kDa mark could be detected, despite
an expected molecular weight of ~46 kDa for the PorV construct, and that this band
was also present in uninduced cells. To determine if this band could correspond to
leaky expression of PorV, or a fragment of the full protein, a lysate fraction was
analysed from BL21(DE3) carrying the empty pASK-IBA2C vector (Figure 6.3.1B).
This showed that the same band is present in absence of the fusion protein confirming
that is not the PorV protein.
6.3.1.2 pET28 Cell Type Screen
For cell type screening with pET-28-OSS-PorV-His and pET-28-OSS-His-PorV was
performed using a similar method as described above. Lemo21 (DE3) were also used to
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Figure 6.3.1: pASK-PorV expression trial. (A) Comparison of cell types for
the expression of PorV-StrepII fusion protein expressed in pASK-IBA2C. 0, 1 and 2
µg ml-1 of anhydrotetracycline was used to induce protein expression. (B) Analysis
of expression background in BL21(DE3) carrying the empty pASK-IBA2C vector.
Legend: ATC - anhydrotetracycline, WC - whole cell lysate, Sol - Soluble cell lysate.
allow more stringent control of IPTG induction. For the Lemo21(DE3) cultures 0, 100,
250, 500, 750, 1000 or 2000 µM L-Rhamnose was added. Increasing concentrations
of L-Rhamnose reduces the total level of protein expression but should reduce the
tendency for inclusion body formation. For all cultures 0.4 mM IPTG was used to
induce cells at an OD600 of ~0.4. Following 16 hour incubation at 18 °C cells were
then treated using the same method as for the pASK-PorV samples. The samples
were immunoblotted using anti-His-HRP (ThermoFisher Scientific) for the detection
of His-tag fusion proteins.
For the C-terminal tagged construct no bands could be detected in the western blot
in any sample (Figure not shown). For the N-terminal tagged construct one major
band just below the 46 kDa marker could be detected (Figure 6.3.2). This band was
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most prominent in the BL21(DE3) sample and Lemo21(DE3) with 0 or 100 µM L-
Rhamnose. Given the expected molecular weight of ~44 kDa for the PorV construct
this band was taken to correspond to the PorV construct. Based on the observed
levels of expression pET-28-OSS-His-PorV and BL21(DE3) was taken forward as the
best construct and cell type, respectively, for expression of the PorV construct.
Figure 6.3.2: Comparison of cell types for expression of pET28-OSS-His-
PorV. pET28-OSS-His-PorV was expressed in BL21(DE3), C41 and Lemo21(DE3)
cells using 0.4 mM IPTG for protein induction. L-Rhamnose optimisation was also
used for optimisation of Lemo21(DE3) expression. Legend: WC - whole cell lysate,
Sol - Soluble cell lysate.
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6.3.2 Optimisation of Expression Parameters
Preliminary screening of PorV expression showed that the protein was prone to the
formation of insoluble inclusion bodies. Therefore, extensive screening of expression
conditions was performed to identify conditions conducive to the expression of correctly
folded protein.
Alterations in growth media were analysed as this can have a significant impact
on protein expression levels without large increases in preparation costs [238]. Rich
media (LB and 2XYT) was compared using a range of culture densities prior to IPTG
induction. OD600 values of 0.4, 0.8 and 1.2 were used for cells grown in LB. Given that
2XYT can support higher cell densities OD600 values of 0.8, 1.2 and 1.6 were used.
Cells grown in M9 minimal media will grow slower than cells grown in rich media.
Although this may reduce the total level of protein expression it was hoped that the
slower growth may help to prevent inclusion body formation. Following induction cells
were grown at 18 °C for 16 hours. The same method as before was used for sample
lysis and separation. Immunoblots were performed using anti-His-HRP. Only soluble
lysate fractions were analysed.
As shown in Figure 6.3.3A expression could be observed for all OD600 values using
LB and 2XYT. However, no expression could be observed when using M9 minimal
media. The 2XYT sample, induced at OD600~ 0.8, was taken to be the most effective
expression condition of those tested. This set of parameters was taken forward into
IPTG concentration screening. Cultures were grown in 2XYT to an OD600~ 0.8 and
induced with 0, 50, 100, 200, 400 or 600 µM IPTG. As shown in 6.3.3B the most
effective concentration range for IPTG is between 50-200 µM. Therefore, 50 µM was
selected as the concentration of IPTG to use for large-scale expression.
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Figure 6.3.3: Expression parameter screening for pET28-OSS-His-PorV in
BL21(DE3). (A) Screening of growth media composition and induction OD600. (B)
Screening of IPTG concentration for the best media and induction OD600 parameters
(2XYT and OD600 ~0.8).
6.3.3 Detergent Screening
For the membrane proteins to be extracted for the native biological membrane de-
tergents that mimic the lipid bilayer are typically used to disrupt the membrane and
surround the hydrophobic transmembrane portion of the protein. The exact detergent
used requires careful selection as they can also cause denaturation of the membrane
protein or fail to solubilise the protein at all. Furthermore, some detergents cause the
solubilised protein to lose its functionality.
The majority of detergents used for the solubilisation of membrane proteins are
non-ionic [239] as ionic detergents, such as SDS, are harsher to the membrane and pro-
tein. For the solubilisation of PorV the non-ionic detergents OG, LDAO, C8E4 and
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DDM were used. In addition, solubilisation using styrene–maleic acid (SMA) was also
tested as proteins solubilised via this method are retained in lipid discs which is more
similar to their native environment [169]. This has been shown to increase thermosta-
bility and protein functionality relative to detergent solubilised proteins [240–242]. A
range of different SMA co-polymers are available but SMA2000 has been shown to be
the most effective for protein solubilisation and is the most commonly used co-polymer
[169].
Extracted membranes containing the PorV were solubilised using C8E4 (1%),
LDAO (1%), DDM (2%), OG (2%) and SMA2000 (2.5%) at room temperature for
1 hour. The samples were then ultracentrifuged to clear the insoluble material. Sol-
uble and insoluble fractions from each sample were then separated via SDS-PAGE and
immunoblot analysis performed using anti-His-HRP. This was performed in triplicate
and used to calculate solubilisation efficiency of each additive (Figure 6.3.4). This
showed that LDAO is significantly more effective at solubilising PorV than any other
additive (P < 0.00001, ANOVA). Therefore, LDAO was selected for solubilisation of
PorV in large-scale purifications.
6.3.4 Large-Scale Protein Expression
The optimised expression parameters were used to prepare PorV protein from pET-
28-OSS-His-PorV grown in BL21(DE3) cells. Cells were grown to an OD600 of ~0.8
in 2XYT media at 37 °C and induced with 50 µM IPTG. The cultures were then
grown at 18 °C for 16 hours and the cells harvested by centrifugation. For the large-
scale preparation sonication was used in place of BugBuster lysis. Membranes were
collected using ultracentrifugation and solubilised using 1% LDAO. After incubation
at room temperature for 1 hour the suspension was ultracentrifuged to clear insoluble
material. The resulting supernatant was used for Ni-NTA chromatography.
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Figure 6.3.4: PorV solubilisation screening. Comparison of solubilisation ef-
ficiency for each solubilisation additive showing LDAO is the most effective solubil-
isation agent for PorV (P < 0.00001, ANOVA). Legend: S - Soluble fraction, P -
Insoluble pellet.
6.3.5 Ni-NTA Chromatography
The solubilised membrane suspension was loaded onto an equilibrated poly-prep grav-
ity flow column containing 1 ml Ni-NTA agarose resin (ThermoFisher Scientific). The
was washed using 20 column volumes of Ni-NTA wash buffer and eluted with a series
of 2 ml factions using Ni-NTA elution buffer. All Ni-NTA buffers were supplemen-
ted with 0.1% LDAO to maintain protein solubility. The fractions were separated by
SDS-PAGE and analysed via western blot using anti-His-HRP (Figure 6.3.5). This
showed that some PorV protein will dissociate from the column during washing but
the majority of the protein is eluted during the first 6 ml of elution.
6.3.6 Size Exclusion Chromatography
The first 8 ml of Ni-NTA chromatography elute (E1-4) was pooled and concentrated to
a volume of 0.5 ml. As shown in Figure 6.3.5A the protein purify was poor following
Ni-NTA chromatography alone. Therefore the sample was further purified by size
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Figure 6.3.5: Ni-NTA chromatography purification of His-PorV. (A) SDS-
PAGE analysis of purification samples and chromatography elution profile. (B) corres-
ponding western blot processed with anti-His-HRP. Legend: WC - whole cell lysate,
Sol - Soluble cell lysate fraction, TM - Total membrane fractions, CM - Cleared mem-
brane fraction, FT - Flow-through during sample loading, W1-3 - 5 ml wash fractions,
E1-5 - 2 ml elution fractions.
exclusion chromatography to remove contaminant proteins and imidazole. Due to
the molecular expected molecular weight of a His-PorV:LDAO complex (~61 kDa) a
HiLoad 16/600 Superdex 200 pg column was used as it provides good resolution for
globular proteins between 10-600 kDa. Figure 6.3.6A shows that there are four major
peaks that elute after the void volume of 45 ml. To determine which of these peaks
corresponds to His-PorV an additional purification was performed using BL21(DE3)
carrying pET28(b)-OSS with no fusion protein. Comparison of the two absorption
spectra revealed that there are unique peaks at the void volume and at ~69 ml in the
His-PorV purification sample. Separation of 2 ml elution fractions representing the
peak at 69 ml by SDS-PAGE and anti-His-HRP western blot showed the presence of
a major band just above the 43 kDa marker (Figure 6.3.6B-C). Additional smaller
bands could be observed in several fractions which may correspond to degradation of
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the full length protein. No bands were detected in any samples from the empty vector
purification suggesting the protein contaminants do not possess His-tag-like motifs.
Figure 6.3.6: Result of size exclusion chromatography for His-PorV. (A)
UV A280 absorbance chromatogram the His-PorV and pET28(b)-OSS empty vector
purification. The His-PorV peak is highlighted in grey. (B) SDS-PAGE and anti-His-
HRP western blot (C) of the His-PorV 2 ml fractions from 62 ml to 82 ml.
6.3.7 Oligomerisation analysis
Based on the observed elution volume of His-PorV using size exclusion chromato-
graphy the predicted molecular weight of this peak is ~130 kDa. A number of factors
could result in this observed disparity including potential oligomerisation of the PorV
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protein. Previous analysis of the PorU:Z:V:Q attachment complex by mass spectro-
metry showed the molar ratios of these proteins was 1:1:3:1, respectively [112]. This
is consistent with a trimeric oligomerisation state for PorV. The expected molecular
weight for a PorV trimer, in complex with a LDAO micelle, is ~130 kDa.
Therefore, the purified His-PorV protein treated using the reversible chemical cross-
linker DSP (120 µM)s with samples collected every 10 minutes for a total of 60 minutes.
The samples were separated by SDS-PAGE, under non-reducing conditions, and ana-
lysed using anti-His-HRP western blot (6.3.7). This showed that there is no propensity
for PorV to form higher oligomerisation states following the addition of DSP, suggest-
ing that PorV is monomeric in this purification.
Figure 6.3.7: Oligomerisation analysis of His-PorV using DSP cross-linking.
A concentration of 120 µM DSP was used with samples taken at 10 minute intervals.
There was no observed oligomerisation of the PorV protein.
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6.3.8 Mass Spectrometry Identification
To confirm that the purified protein sample corresponds to the His-PorV construct a
fraction of the purified sample was resolved using SDS-PAGE and sent for analysis by
high resolution Orbitrap tandem mass spectrometry coupled to liquid chromatography
at the Centre of Excellence for Mass Spectrometry (KCL).
Raw mass spectrometry data were processed into peak list files using Proteome
Discoverer V2.2 (ThermoFisher Scientific). The data was searched using the Mas-
cot search algorithm V2.6.0 (MatrixScience) and the Sequest search algorithm [243]
against the Uniprot All Taxonomy database (561,911 entries) and Uniprot E.coli
BL21(DE3) strain database (4,172 entries). The All Taxonomy database search was
performed to identify Bovine Trypsin, used for peptide digestion, and other possible
contaminants introduced in the sample processing. There was no identification of
PorV in this sample. The Uniprot E. coli BL21(DE3) database was then searched to
determine the protein contaminants arising from these cells.
Given that PorV could not be identified in either of these databases a unique
database containing only the PorV protein sequence was used. Assignment of the
peptides showed that PorV is present in the sample with 12 unique peptides and 48%
sequence coverage. Comparison to the Uniprot E. coli BL21(DE3) strain database
search shows that PorV has the highest normalised total spectrum score. In addition
to PorV a total of 47 unique proteins from E. coli BL21(DE3) were identified.
For low resolution biochemical assays this level of purity was assumed to be suf-
ficient. However, for structural analysis of PorV additional purification stages, or
alterations to the existing method, are likely to be necessary.
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6.4 In Silico Analysis of RgpB-CTD:PorV Com-
plex
Due to lab closures work on the improving the PorV purification and PorV:RgpB-CTD
pull-down experiments could not be continued. Therefore, an alternative methodology
was developed to generate the necessary structural models and restraints for a model
complex of the PorV:RgpB-CTD interaction as experimental restraints, from site-
directed mutagenesis, could not be defined. This method involved the generation of a
predicted structural model for P. gingivalis PorV and the use of molecular dynamic
(MD) simulations to sample different conformations of the protein. Representative
models from the simulation were then taken for use in docking experiments with
RgpB-CTD.
6.4.1 Prediction of P. gingivalis PorV Structural Model
During the course of the experimental work in this chapter a cryo-EM model of PorV
from F. johnsoniae (Fjoh_1555), in complex with the Sov homolog SprA (Fjoh_1653),
was published [113]. This structural model of PorV shows that it is a β-barrel protein
comprised of 14 β-strands with the C-terminus located at the inner face and the N-
terminus located at the outer face of the lipid bilayer. Given that the structural
model of PorV is derived from F. johnsoniae and the structural model of RgpB-CTD
is derived from P. gingivalis W50 it is possible that these proteins would not interact
due to differences between the two organisms. Therefore, a predicted structural model
of PorV from P. gingivalis W50 was generated for use in protein docking experiments
using the ROBETTA server using comparative modelling with the cyro-EM model of
PorV as a structural template. To avoid confusion the P. gingivalis predicted PorV
model shall be referred to as Pg-PorV and the F. johnsoniae experimental model shall
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be referred to as Fj-PorV. The quality of the predicted structure was assessed using
PROCHECK and PROSA. 99.1% of the dihedrals were located within the favoured
and allowed regions and the protein had a Z-score of -3.69. Comparison between
Fj-PorV and Pg-PorV, which have 46% sequence identity, showed that they are well
aligned with a TM score of 0.84796 and an RMSD of 2.38Å(Figure 6.4.1). Based
on the protein quality scores and alignment with the experimental PorV model the
Pg-PorV model was considered suitable for further analysis by MD simulations and
protein-protein docking.
Figure 6.4.1: Comparison of PorV structural models. The cryo-EM model of
Fj-PorV (orange) aligned to the ROBETTA model of Pg-PorV (blue). The structures
are well aligned with a a TM score of 0.84796 and an RMSD of 2.38Å.
6.4.2 Molecular Dynamics of PorV
Given that the structural model was taken from Fj-PorV in complex with SprA, mo-
lecular dynamics (MD) was used to determine how this protein would behave in an
unbound state. The second reason for running MD on this protein was to generate
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an ensemble of structural models which could be used for computational docking ex-
periments between PorV and RgpB-CTD. Both PorV models were simulated to allow
comparison between the experimental and predicted models of PorV.
Orientation of the PorV models was first determined using the online PPM server
[195] and uploaded to the CHARMM-GUI membrane builder server [197] for construc-
tion of the protein:membrane complex and the necessary input files for MD simulation.
The membrane was constructed using 80% POPC and 20% POPE with a total of 100
lipids in each leaflet. Similar lipids compositions are commonly used in the formation
of nano-discs and MD simulation of β-barrel proteins from Gram-negative bacteria
[244–246]. Given the degree of heterogoneity in P. gingivalis LPS composition, and
the unavailability of these molecules in the CHARMM-GUI membrane builder, no
LPS was included in this simulation. Furthermore, precise values for the relative ra-
tios of each LPS molecule were not available so this component was excluded to avoid
artificially biasing protein-LPS interactions in the simulation. GROMACS was used
to equilibrate the system to a constant pressure of 1 bar and a temperature of 310
K then energy minimised. Production runs were then performed for a total of 200
ns. Assistance in running and analysing the GROMACS MD simulations was kindly
provided by Dr. Chris Lorenz.
6.4.3 Structural Drift and Fluctuation
Analysis of structural drift of the protein from the initial structural model can be used
to analyse the stability and motion of the protein during the course of the simulation.
This analysis was performed by calculating the RMSD of each frame relative to the
first frame (Figure 6.4.2A). In both simulations the RMSD sharply rose for the first
5 ns then reached a steady plateau between 75-100 ns. Both models of PorV showed
similar RMSD values during the entire course of the simulation (averages in Table
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6.4.1).
Figure 6.4.2: RMSD of Fj-PorV and Pg-PorV. The protein was fitted to the
appropriate starting conformation prior to the MD simulation.
Radius of gryration (RGYR) was calculated for both proteins as a means of ap-
proximating protein compactness. The RGYR of fj-PorV decreases within the first 100
ns of the simulation to converge with the RGYR of Pg-PorV, which increases within
the first 100 ns of the simulation (Figure 6.4.2B). The two models have comparable
RGYR values (averages in Table 6.4.1) with the Fj-PorV model displaying a slightly
higher degree of flexibility.
Root mean square fluctuation (RMSF) was used to study how the conformation
of protein Cα atoms changes throughout the course of the simulation. As shown in
Figure 6.4.3 the β-barrel remains in the same conformation during the course of the
simulation but the extracellular loops of PorV show a higher degree of flexibility. The
two systems have similar RMSF profiles for the S1-2 and S3-4 loops which are the two
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Table 6.4.1: Average RMSD, RGYR and RMSF for Fj-PorV and Pg-PorV.
Measurement Fj-PorV Pg-PorV
RMSD (Å) 4.05 ± 0.61 4.25 ± 0.77
RGYR (Å) 23.05 ± 0.32 22.49 ± 0.23
RMSF (Å) 2.00 ± 1.85 1.73 ± 1.67
loops of PorV that enter the SprA pore in the cyro-EM model. Additionally, Pg-PorV
showed a higher degree of flexibility in the C-terminus and Fj-PorV displayed a higher
degree of flexibility in the S9-S10 loop (residues 263-290). This observed difference
could because the Fj-PorV sequence is 18 residues in the S9-S10 loop. The average
RMSF for all residues of each model is displayed in Table 6.4.1 and this again suggests
that the Fj-PorV model is slightly more flexible than the Pg-PorV model.
Figure 6.4.3: RMSF of Fj-PorV and Pg-PorV. Plot of RMSF values for Fj-PorV
(A) and Pg-PorV (C) Cα atoms in the protein relative to the average structure. The
structure of Fj-PorV (B) and Pg-PorV (D) coloured by the RMSF values (blue-red).
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6.4.4 Structural Clustering
In order to generate a structural ensemble for use in protein docking experiments
the python package TTClust [199] was used to cluster the structures in each frame
according to protein Cα RMSD. A linkage matrix is created and the clusters divided
according to a user defined cutoff. For Fj-PorV a total of nine clusters was selected
using an approximately unbiased (AU) p-value cutoff of 25 (Figure 6.4.4A) and a total
of ten clusters were generated for Pg-PorV using an AU cutoff of 22 (Figure 6.4.4B).
The RMSD spread of each cluster for Fj-PorV (Figure 6.4.4C) and Pg-PorV (Figure
6.4.4D) was calculated and TTClust used to output a representative model for each
cluster. The representative models are those that have the lowest average RMSD all
other models within the cluster. The clusters were all of a similar size and with a
similar RMSD spread suggesting there no clear preference for a single conformation.
Superposition of the ensemble models confirms that the majority of conformational
change in the simulation is localised to the extracellular loops (Figure 6.4.5). It can
be observed that there is no conformational changes in the β-barrel portion region of
the protein for both models. The same differences in the S9-S10 loop and protein C-
terminus flexibility, as observed by RMSF analysis, can be visualised in the ensembles.
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Figure 6.4.4: TTClust analysis of Fj-PorV and Pg-PorV. Dendrogram of Fj-
PorV (A) and Pg-PorV (B) clustering. The horizontal grey line represents the cutoff
for cluster division. 2D projection of the relative distances between Fj-PorV clusters
(C) and Pg-PorV clusters (D) using representative model RMSDs. The minimum and
maximum RMSD distances and RMSD spreads are also listed.
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Figure 6.4.5: Superposition of TTClust models. (A) Fj-PorV ensemble and
(B) Pg-PorV ensemble show the highest degree of flexibility in the extracellular loops.
relative to the Fj-PorV ensemble Pg-PorV has higher flexibility at the protein C-
terminus (red).
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6.4.5 PorV:RgpB Docking
Comparison of the MD simulations for the F. johnsoniae and P. gingivalis PorV
models showed that they behave similarly within this system. Therefore, it was deemed
that the Pg-PorV model was suitable for use in RgpB-CTD:PorV docking experiments.
The cluster ensemble of 10 representative models of P. gingivalis PorV, defined using
TTClust, was selected for the docking experiments. To reduce the computational
expense of running docking experiments a single structural model of RgpB-CTD was
taken from the ensemble of 10 water-refined models. This model was selected by
aligning all models using the online POSA server [201] and the average RMSD for
each model to all others was calculated. The structural model with the lowest average
RMSD value (1.43 Å) was taken as a representative model of the ensemble.
Molecular docking between the representative RgpB-CTD model and the Pg-
PorV ensemble was performed using the online HADDOCK 2.4 server [203]. This
algorithm uses ambiguous interaction restraints (AIRs) to define the interaction in-
terface between the two proteins and drive protein docking. The AIRs can be active,
essential for the interaction, or passive, involved but not essential. The proteins are
then randomly orientated and rigid-body docking with energy minimisation performed.
AIRs are important at this stage as they are included in the energy minimisation func-
tion. An MD based refinement is then used to introduce flexibility to interface residues
(those with < 5Å contact between proteins) to further optimise the interface. A short
MD run is then carried out for each complex solvated in water to further refine the
structure.
No experimental restraints were available for this interaction so predicted restraints
were used. To produce the necessary AIRs, the RgpB-CTD model and PorV ensemble
were uploaded to the CPORT server [202]. This server uses a combination of six
interface prediction servers to generate a consensus interaction interface prediction
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and is specifically designed for use with the HADDOCK algorithm. It generates a
list of active and passive AIRs to be used in HADDOCK docking. For RgpB-CTD
the CPORT active residue list was used as the HADDOCK active restraint list and
the passive residues were defined automatically. For the PorV ensemble the CPORT
active residue restraints that appeared in at least half of the models were used selected
and the list reduced to residues are localised beyond the outer leaflet of the membrane.
This was done because many predicted interacting residues in PorV were membrane
embedded. Figure 6.4.6 shows the RgpB-CTD model and an example PorV model
coloured by CPORT residue prediction. The predicted RgpB-CTD interface residues
are localised to the C-terminal face of the domain and contains the conserved motifs
B, D and E. The reduced list of interface residues in Pg-PorV are localised to loops
S1-2 and S3-4 which corresponds to the loops of Fj-PorV that enter the SprA pore.
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Figure 6.4.6: CPORT analysis of PorV and RgpB-CTD structural models.
(A) Representative RgpB-CTD model coloured by CPORT prediction. (B) Example
model of PorV coloured by CPORT prediction. The PorV residue list was further
refined to those occurring in at least half the ensemble models and localised beyond
the outer leaflet of the membrane. Predicted active residues are highlighted in red,
passive residues are highlighted in white and non-interacting residues are highlighted
in blue.
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Of the 200 final water refined structures generated by HADDOCK a total of 9
clusters were produced, comprised of 63 structural models (31%). These models were
first sorted according to their HADDOCK score [203]. This score is calculated for each
structural complex after docking and is used to rank the quality of the structures pro-
duced in a given run. The score is a weighted sum of the intermolecular electrostatics,
van der Waals energy, desolvation energy, AIRs energy and buried surface area.
In addition, the interface RMSD (IRMSD) was calculated for the 4 best scoring
structures within each cluster. IRMSD is calculated for the backbone atoms of all
residues within 10Åof the intermolecular contact compared to the top ranking struc-
ture. According to the membrane protein docking benchmark for HADDOCK 2.4
[247], an IRMSD of 2 − 4Å is considered acceptable, 1 − 2Å is considered medium and
< 1Å is considered high quality. Therefore, all clusters with an IRMSD > 4Å were
excluded from further analysis. This left five clusters with an IMRSD above the cutoff
limit. Of these, cluster 3 was also excluded because the RgpB-CTD was interfacing
with membrane embedded residues of PorV. According to these criteria cluster 5 is
high quality, cluster 2 is medium quality and clusters 1, 7 and 6 are acceptable. The
run statistics for the lowest scoring four structures of the refined cluster list is shown
in Table 6.4.2.
Figure 6.4.7 shows the binding poses for the best scoring model of the five clusters
with no clear convergence to a particular location. However, there is a preference for
the CTD to bind to the upper/inner face of the S3-4 loop. It is only in cluster 1 that
the CTD binds to the lower/outer face of the S3-4 loop.
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Figure 6.4.7: Binding poses for refined HADDOCK cluster list. PorV is
shown in purple an rgpB-CTD is shown in pink. The best scoring structure of each
cluster is represented.
Hydrogen bond analysis was performed for the best scoring structure from cluster
5 using the online server COCOMAPS [248]. The results of this analysis are shown in
Table 6.4.3.
Consensus inter-residue contacts were calculated using the CONSRANK server
[249] for the four best structures of cluster 1, 2, 5, 6 and 7. The rank is calculated
from the conversation of each inter-residue contact for all structures. The results of
this analysis for contacts with a conservation rate > 0.5 are listed in Table 6.4.4.
This analysis revealed that the S5-6 loop of PorV (R170-A188) is participating in the
interaction despite no AIRs being selected for residues in this loop. Furthermore, all
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Table 6.4.3: H-Bonds between best structure of cluster 5. Atom type is shown
in brackets.
PorV Residue RgpB-CTD Residue Distance (Å)
E129 (OE1) K732 (NZ) 2.67
H130 (OG1) R721 (NH2) 2.79
132D (OD1) N698 (ND2) 2.81
E133 (OE2) R701 (NH1) 2.65
L134 (O) R721 (NH1) 2.82
E136 (O) R721 (NH2) 2.74
S137(OG) K732 (NZ) 2.76
M138 (N) K732 (N) 3.03
E140 (OE2) K732 (NZ) 3.05
E140 (OE2) K736 (NZ) 2.96
D172 (OD2) K736 (NZ) 2.71
S174 (O) K736 (NZ) 2.86
S174 (OG) K736 (NZ) 3.92
H176 (NE2) I734 (O) 2.72
N177 (ND2) V678 (O) 3.06
residues with a conservation rank above 0.5 are located in loops S3-4 and S5-6 and not
in the S1-2 loop. All residues in RgpB-CTD that have a conservation score above 0.5
are located within motifs B, D and E corresponding to the residues predicted using
CPORT.
6.4.6 PorV Conservation
An NCBI BlastP [162] search using the P. gingivalis W50 PorV sequence, with an
expect threshold of 0.05, was used to identify 500 aligned sequence. These were used
to generate a multiple sequence alignment for the BlastP results using the Clustal
Omega online server [164]. The ConSurf online server [167] was used to colour the
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Table 6.4.4: Consensus inter-residue contacts for top four structures. The
refined list of clusters 1, 2, 5, 6 and 7 was used.













final trajectory model of Pg-PorV according to sequence conservation using the Clustal
Omega multiple sequence alignment (Figure 6.4.8A). The multiple sequence alignment
was uploaded to the Weblogo server to identify sequence conservation for each residue
position. The conservation for the S1-2, S3-4 and S5-6 loops is shown in Figure 6.4.8B,
numbered according the W50 RgpB-PorV sequence.
This multiple sequence alignment shows that the sequence in the S1-2 loop is well
conserved (Figure 6.4.8B). The five N-terminal residues of the S3-4 loop and P148 are
well conserved but the central region of the loop is highly variable. S1-2 and the N-
terminus of S3-4 form a surface exposed patch of well conserved residues, highlighted
in Figure 6.4.8A. The sequence alignment analysis shows that there are some highly
conserved residues in the S5-6 loop, particularly D172, whereas middle of the S5-6
sequence is the most variable. As shown in Figure 6.4.8A, it is the variable region of
the S5-6 loop that is surface-exposed and accessible for RgpB-CTD binding.
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Figure 6.4.8: ConSurf of Pg-PorV using the final the final trajectory structure as a
model for the colouring. A patch of conserved residues contained within loops S1-2
and S3-4 is highlighted.
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6.5 Discussion
6.5.1 PorV Expression and Purification
In this chapter significant progress has been made towards the expression and purifica-
tion of P. gingivalis PorV. This has not previously been recorded in the literature and
access to purified PorV protein sample will provide a useful tool for future experiments
exploring the mechanistic process of T9SS cargo protein secretion and processing. The
method described here is also a good foundation for further improvement in the ex-
pression and purification of recombinant PorV.
The OmpA signal peptide was success at targeting the fusion protein to the outer
membrane and the His-Tag allowed for successful purification of PorV protein. How-
ever, the protein yield could be further optimised and sample purity requires improve-
ment. Analysis of the protein sample UV absorbance (A280) showed that the protein
yield following size exclusion chromatography is ~0.1mg ml-1for 1 L of culture. This
yield is far below the amount required for NMR spectroscopy but could be sufficient
for small scale crystallography plate screening. However, before beginning the pro-
cess of plate screening the sample purity requires further refinement. This is because
the impurities in the sample may lead to crystallography artefacts that give poorly
diffracting crystals or the contaminant proteins may form crystals more readily than
PorV [250].
As expected the majority of contaminant proteins identified by LC-MS were of
a similar size to the PorV construct. However, the third highest scoring protein in
the LC-MS was Cytochrome ubiquinol oxidase subunit 1 (~74 kDa). This protein
is a known contaminant of LDAO purifications from E. coli, along with Cytochrome
ubiquinol oxidase subunit 2 (~35 kDa). No record in the literature was found of the two
highest scoring E. coli proteins (Elongation factor Tu and L-lactate dehydrogenase)
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occurring as contaminants in E. coli protein purifications. The two peaks seen either
side of the PorV peak in Figure 6.3.6 could correspond to contaminants identified by
LC-MS or could be different proteins entirely. An important next step in improving
the PorV purification method is to identify the proteins comprising the contamination
peaks. This knowledge can then be used to determine the best method of contaminant
removal.
The detergent screen revealed that LDAO is significantly better at solubilising
PorV compared to the other solubilising agents tested. However, the sample purity is
poor following Ni-NTA chromatography and changing the detergent using for protein
solubilisation may increase sample purity. To do this with any of the detergents tested
here would significantly decrease to protein yield. However, a more extensive screen
of different detergents could help to address this. Alternatively, transfer to a different
detergent after the initial solubilisation may assist in contaminant removal. If sample
purity could be improved still using LDAO for solubilisation and purification this
detergent may be sufficient for future crystallisation as this detergent has been used
to crystallise the homologous membrane protein FadL [251].
More extensive screening of expression systems and tags could be also performed
to improve the sample quality. The original Phyre2 model of PorV (Figure 6.2.2) was
created prior to the publication of the cryo-EM model of PorV from F. johnsoniae
[113]. Comparison of the two models shows that the initial prediction of N- and C-
termini orientation was correct. It is therefore not clear from the positioning of the
protein termini why the C-terminally tagged constructs formed inclusion bodies and
the N-terminally tagged construct successfully integrated into the outer membrane.
Use of a different N-terminal tag may improve the purification process due to different
non-specific binding patterns. It is interesting to note that cytochrome C oxidase is
also a known contaminant of Strep-tag II purifications for E. coli (MerkBioscience).
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DSP cross-linking of PorV suggests that the construct purified here is monomeric.
This may be a result of the purification method used here or it could be that PorV
is monomeric in the bacterial membrane. The cryo-EM complex of the SprA-PorV
would suggest that porV is monomeric in the membrane as only a single PorV mo-
lecule is present in this complex [113]. PorV may be forming oligomers as part of the
attachment complex only and may require the presence of PorU, Q, Z and/or cargo
protein to initiate oligomerisation.
6.5.2 PorV Molecular Dynamics
The Fj-PorV model was simulated alongside the Pg-PorV model to ensure that the
predicted model was behaving sensibly within the system and producing valid models
that could be used for protein docking. The results of this analysis show that the
behaviour of the two models is similar. The most obvious difference occurs in the flex-
ibility of the S9-S10 loop where Fj-PorV had an additional 18 residues. The density
of these residues was missing in the cryo-EM structure of Fj-PorV supporting the ob-
servation of high flexibility. Whether this structural difference conveys any functional
difference between the two organisms is unclear. Interestingly, for some of Pg-PorV
models used in the CPORT server run some residues in the S9-S10 loop were predicted
to be active protein interface residues. This loop could therefore be facilitating other
protein interactions, potentially in the formation of the attachment complex. This
could be investigated further in future studies.
In both models the extracellular loops showed increased flexibility relative to the
rest of the protein. This, along with the interface prediction from CPORT, would
suggests that it is the S1-S2, S3-S4 and S5-6 that interact with Sov to capture CTD
proteins in P. gingivalis as is the case in F. johnsoniae [113]. The increased flexibility
of these loops may play a role in facilitating their entry into the Sov channel and allow
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for conformational rearrangement as the cargo is pulled through the pore.
However, the flexibility observed here could, in part, be due to the exclusion of
any LPS component during the simulation. Cryo-EM of P. gingivalis cells and OMVs
shows that they a possess an electron-dense surface layer (EDSL) of ~20 nm [108]. This
layer is predicted to be composed of LPS molecules and attached T9SS cargo proteins
[84]. The presence of this layer would provide additional spacial constraints of the
extracellular PorV loops and specific interactions between the EDSL and PorV may
occur. This could limit the degree of flexibility observed during the MD simulation
using a lipid bilayer only.
6.5.3 PorV:RgpB-CTD Interaction
The interface residues identified by the CPORT server correspond well with the region
of PorV that enters the SprA channel in the cryo-EM model. Despite, the S5-S6 loop
entering the SprA channel, no interface residues were predicted for this loop in the
Pg-PorV model. The majority of interfacing residues predicted in RgpB-CTD by
CPORT are located in conserved motifs B, D and E and correspond to conserved
residues identified in Section 4.2.1.
In the resulting HADDOCK dock for Pg-PorV and RgpB-CTD, the involvement
of the conserved CTD motif B (I694-V703) and motif D (A713-A723) is clear (Table
6.4.4). This supports the theory that the last two strands of the CTD (motif D and
E) are essential for cargo protein recognition by the T9SS [88]. Despite the difficulty in
identifying motif E in the multiple sequence alignment shown in Section 4.2.1, residues
K732 and V735were shown to be highly conserved. Both of these residues were found to
be consensus interfacing residues in the RgpB-CTD:Pg-PorV interaction (Table 6.4.4).
Residue T728 was shown to be a consensus interface residue but is not well conserved
either in W50 CTDs or across species containing RgpB. Therefore, this residue would a
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interesting target for further experimental analysis to determine if it plays a significant
role in the interaction.
The previously published D696A mutant, for RgpB in P. gingivalis, showed secretion
of RgpB but no surface attachment. It was therefore suggested that motif B does not
play a role in cargo protein secretion but may provide a signal for cargo processing.
In the HADDOCK model presented here the moderately conserved residues M697 and
N698 are both consensus interfacing residues, suggesting motif B does appear to play
a role in the binding of PorV to the CTD. Perhaps this motif is not essential for
recognition of the cargo in Sov but helps to maintain cargo cell surface attachment
via the PorV interaction.
The docking structures suggest that the S5-S6 loop is involved in the interaction
despite no predicted residues being identified by CPORT. This interaction is consistent
with current understanding of the system as the S5-6 residues would be able to interface
with the CTD present in the Sov channel. However, sequence conservation analysis
of this loop reveals that the exposed residues are not well conserved. The interfacing
between S5-6 and RgpB-CTD could be an artefact of the docking simulation due to
the close proximity of this loop to the S1-2 and S3-4 binding site. Alternatively, the
S5-6 loop may only play an accessory role in the interaction and may not be essential
for the interaction.
Despite different binding poses being observed in the five clusters the orientation
of RgpB-CTD relative to PorV was the same in each cluster. As shown by the interac-
tion conservation scoring (Table 6.4.4) the S1-2 loop of PorV interacts primarily with
motif B, whereas motifs D and E interface primarily with the S3-4 loop with secondary
interactions to the S5-6 loop. The consensus binding residues from PorV are predom-
inantly located within the non-conserved region of the S3-4 loop. This could be due
to differences in cargo protein recognition between different species or could be due to
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incorrect docking in the HADDOCK simulations. Experimental validation (Discussed
in Section 7.2.3) of the residues involved in the interaction could help to determine if
the non-conserved residues of the S3-4 loop are essential for the Pg-PorV:RgpB-CTD
interaction .
The hydrogen bond analysis was performed to determine the involvement of elec-
trostatic in the interaction. This is a low resolution model given that a predicted
structure and interface restraints were used. However, it does suggest that electro-
static interactions play a significant role in the interface with charge complementarity
between the two proteins. As shown in Table 6.4.3 the majority of H-bond donors are
present in RgpB-CTD and the majority of acceptors are from Pg-PorV.
6.6 Summary
This chapter describes the design of a recombinant PorV construct for use in vitro in-
teraction studies. A method of expression and purification was developed and optim-
ised to yield purified and folded PorV protein. The final refinement of the purification
method and progression to in vitro interaction studies with RgpB-CTD was halted
due to lab closures. A predicted model of Pg-PorV was generated using the cryo-EM
model of F-PorV and MD simulation was ran for both proteins in a lipid bilayer sys-
tem. This was used to generate an ensemble of Pg-PorV models sampling different
conformations. Predicted interaction residues were predicted for Pg-PorV and the
NMR structural model of RgpB-CTD. The partner proteins were docked using the
HADDOCK 2.4 algorithm to produce structural models of the complex showing in-
teraction between motifs B, D and E of RgpB-CTD with loops S1-2, S3-4, S5-6 of
PorV. The docking models can now be used for the design of point mutations to give





The work in this project has sought to understand how the CTD of T9SS cargo
proteins can facilitate secretion. RgpB-CTD was selected for analysis and successfully
expressed and purified. This thesis contains the first NMR solution-state structural
model of a T9SS cargo protein CTD showing it to be a seven stranded β-sandwich
domain. The RgpB-CTD NMR structural model has been compared to the recently
published X-ray crystallography models of RgpB-, Hbp35- and PorZ-CTDs [92, 170,
225]. Analysis of the structures has confirmed that the CTD is structurally conserved
and that sequentially conserved motifs B, D and E are located at the C-terminal face of
the domain. This has provided insight into the important structural motifs of the CTD
that facilitate secretion and suggest that it is the C-terminal face that is recognised by
the system. This has been supported by the CPORT interface prediction that suggests
all interfacing residues are located at the C-terminal face.
The NMR relaxation data presented here suggest= that the domain is monomeric
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in solution. Furthermore, the X-ray crystallography structural models for RgpB-CTD
containing the preceding IgSF domain, and the structural models of Hbp35 and PorZ
are also monomeric. The size of the SprA pore in the Cryo-EM model also suggests that
cargo proteins are secreted as monomers [113]. This evidence supports the conclusion
that RgpB-CTD is a monomer in solution state and is recognised by the T9SS as a
monomeric domain.
Work was undertaken to identify P. gingivalis proteins that interact with the CTD
of RgpB. Unfortunately, the method described here was not successful in identifying
components of the T9SS that interact with RgpB-CTD. It is clear now that working
with PorV would not have yielded positive results as this would have caused the plug
protein to close the Sov channel [113]. However, it is unclear why the PorV:CTD com-
plex could not be captured from Wt P. gingivalis using the Co-immunoprecipitation
method. Given that the antibody used was polyclonal it is expected that there would
be solvent-accessible epitopes in RgpB-CTD if the current HADDOCK docking model
is correct.
Despite being unsuccessful in observing any interactions using the non-specific
screening method, evidence of an interaction between PorV and T9SS cargo proteins
was published [112] but no direct binding to the CTD was demonstrated. Therefore,
the PorV protein was selected for direct interaction studies with RgpB-CTD. Signi-
ficant progress has been made towards the recombinant expression and purification of
this protein. The current method is capable of providing purified PorV for biochemical
assays that do not require highly purified protein samples, such as protein pull-down
assays. For an experimental structural model to be developed the expression and
purification method requires alteration to improve protein yield and purity. The data
presented here, along with the SprA:PorV structure [113], would suggest that PorV
is a monomer in the outer membrane and binds to a single cargo protein. PorV may
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then form oligomers as part of the attachment complex with a necessary minimum of
two copies: one to bind PorU and one to bind the cargo.
Significant progress has been made in understanding the interaction between RgpB-
CTD and PorV. The predicted PorV structural model presented here appeared to align
well to the experimental PorV structure from F. johnsoniae. The molecular dynamics
simulation of this protein suggests that the extracellular loops are highly flexible and
capable of sampling different conformations. The docking models generated using
representative models of these conformations show that a variety of binding poses are
possible.
Figure 7.1.1 shows the two possible mechanisms of secretion according to the bind-
ing poses observed in the HADDOCK structures. According to the HADDOCK dock-
ing, the CTD can bind to either the lower or upper face of the PorV loops that enter
the Sov pore. In the context of protein recognition by the Sov:PorV complex, clusters
2, 5, 6 and 7, in which RgpB-CTD binds to the upper face of the PorV loops, allow
for the simplest model of cargo recognition. This is because the N-terminus points
into the centre of the Sov channel, towards the periplasm, in these models. In cluster
1, where the CTD is binding to the lower face of PorV, the location of the N-terminus
means that the CTD is located ’up-side-down’ in this cluster. In all the models the
CTD is held above the lipid bilayer and would allow for the cargo to be recognised by
and transferred to the attachment complex.
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Figure 7.1.1: Possible models of cargo protein recognition by PorV. (1) Sov
is either in a plug-bound state, preventing secretion, or in a PorV-bound, allowing for
cargo protein recognition. (2) The cargo protein enters the Sov channel and binds to
either the upper-face or the lower-face of the PorV loops. (3) The PorV:Cargo complex
dissociates from Sov to allow tracking to the attachment complex. It is possible that
the cargo stays in the same orientation relative to PorV or a conformational change
may occur.
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7.2 Future Perspectives
7.2.1 Structural Analysis of Cargo Protein CTDs
The chemical shift assignment for RgpB-CTD can now be used for future interaction
studies with T9SS components or for structural analysis of the CTD protein using
NMR spectroscopy. This is a valuable tool for probing cargo protein recognition and
processing by the T9SS. In the future, it would be beneficial to develop a structural
model of the T9SS sortase PorU (Section 1.9) or of the PorU-CTD. This is because the
protein is responsible for the removal of cargo protein CTDs and A-LPS attachment,
but it is itself a cargo protein of the T9SS. However, the CTD of PorU is not cleaved
off and no A-LPS modification occurs. Having a structural model for this protein
would allow comparative studies to be performed with the aim of understanding the
differences between A-LPS modified cargo proteins and the PorU sortase. By studying
the secretion and processing of PorU, and other T9SS cargo proteins, it will be pos-
sible to better understand what structural components are conserved or vary between
different CTDs.
7.2.2 Identification of CTD Interaction Partners
Despite the identification of many T9SS components that are essential for cargo protein
recognition and processing [98], functional characterisation for most of these proteins
is lacking. There is a great deal of interest in assigning a functional role of these
proteins in the context of the T9SS. One aspect of this, that this thesis has attempted
to address, is how cargo proteins are recognised, secreted and processed by the T9SS.
Although the non-specific screening approach employed here was unsuccessful, this
type of screening would be beneficial in future studies for the identification of CTD
interaction partners. Use of alternative T9SS component mutants that do not cause
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the plug protein to block the Sov pore could be identified and used in the screening
method. For example, a ∆PorM mutant may remove the T9SS motor, preventing
export of cargo proteins, but may still allow cargo proteins to bind to other system
components. Using this method may yield positive results and provide a pool of
potential interaction partners that can be experimentally examined in further detail.
7.2.3 PorV:RgpB-CTD Structural Complex
To generate experimental interaction restraints for the HADDOCK docking, work has
already started to directly demonstrate the interaction between recombinant PorV and
RgpB-CTD using protein pull-down assays. Once this method has been developed,
and if the interaction is verified, it will be possible to apply this to mutant constructs of
PorV and RgpB-CTD. The published conservation data [81], previous point mutation
studies [207, 226], the CPORT prediction and the CONSRANK interface conservation
analysis can be used in future studies for the rational design of mutations in PorV and
RgpB-CTD. Given that PorV loops S1-2, S3-4 and S5-6 all appear to be involved in
the interaction, mutations should target residues in all three loops. This would help to
clarify the role of the S5-6 loop in the interaction given lack of sequence conservation
for this loop. The same method can also be used for conserved residues identified in
RgpB-CTD. Based on the interaction profile of these mutants, new active restraints
can be defined for future HADDOCK runs.
Docking experiments may also be performed using the Hbp35-CTD models, and
any future published CTD models, to allow cross-examination in CTD recognition by
PorV. This could validate the importance of certain structural motifs in cargo protein
recognition. It appears that PorQ may directly bind to Sov to facilitate PorZ transport
as PorZ is still found in the outer membrane fraction in a PorU deletion mutant [112].
How this is mediated and regulated is still unknown and further research in this area
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is required.
By generating an experimentally verified structural complex of PorV:RgpB-CTD
we will better understand how cargo proteins bind to and are processed by the T9SS.
In the future, it would be beneficial to develop complexes for CTD proteins with com-
ponents of the T9SS at different stages of secretion. This will allow us to understand
which structural components of the CTD are essential for all stages of secretion and
what structural components guide secretion at a specific stage only.
7.2.4 Two Types of CTD
There is an increasing body of evidence that some cargo proteins are secreted, the CTD
removed and A-LPS attached to the cargo as a surface anchor. However, not all cargos
follow this process. PorU and PorZ both possess a T9SS CTD but are anchored to the
cell surface via interaction with PorV and PorQ, respectively. Furthermore, PG1035
was found to bind to PorP at the cell surface and had an intact CTD (preprint:
[89]). The CTD of PG1035 was found to be similar to the ’type B’ CTD found in F.
johnsoniae. In F. johnsoniae there are 11 type B CTD proteins with 11 corresponding
PorP-like proteins [252]. The disparity in processing between different CTD proteins is
an interesting area that requires further investigation. Questions also exist regarding
the commonality of the CTD, given that all cargo proteins appear to pass through
the Sov channel. Further study of the different CTD structures and their interaction
with the T9SS should begin to resolve these questions regarding the secretion of cargo
proteins.
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Number Shift SD Assign Name Residue
1 55.86958 0.02816 Ca 654His
2 174.42915 0 C 654His
3 29.68379 0.03785 Cb 654His
4 4.66464 0 Ha 654His
5 3.18144 0 Hba 654His
6 3.18144 0 Hbb 654His
7 8.10138 0.00302 H 655Val
8 121.58626 0.03530 N 655Val
9 62.28577 0.03112 Ca 655Val
10 32.85398 0.04235 Cb 655Val
11 175.55527 0.00730 C 655Val
12 21.00443 0 Cgb 655Val
13 20.43368 0 Cga 655Val
14 8.37434 0.00594 H 656Asp
15 122.95294 0.02801 N 656Asp
16 41.29520 0.05142 Cb 656Asp
17 54.60766 0.03602 Ca 656Asp
18 176.05622 0.03887 C 656Asp
19 8.15443 0.00211 H 657Asp
20 120.23387 0.05826 N 657Asp
21 55.00993 0 Ca 657Asp
22 41.59007 0 Cb 657Asp
23 176.26944 0 C 657Asp
24 41.03181 0.10588 Cb 658Asp
25 176.28368 0.01278 C 658Asp
217
Number Shift SD Assign Name Residue
26 54.67223 0.03679 Ca 658Asp
27 8.21067 0.00317 H 659Asp
28 120.49930 0.11444 N 659Asp
29 40.91372 0.08361 Cb 659Asp
30 54.67539 0.08397 Ca 659Asp
31 176.63999 0.00890 C 659Asp
32 4.57781 0.00651 Ha 659Asp
33 2.72897 0 Hba 659Asp
34 2.72897 0 Hbb 659Asp
35 8.11428 0.00598 H 660Lys
36 120.50508 0.03479 N 660Lys
37 56.53956 0.08878 Ca 660Lys
38 32.49050 0.04465 Cb 660Lys
39 177.06874 0.01493 C 660Lys
40 28.79369 0 Cd 660Lys
41 24.68451 0 Cg 660Lys
42 40.92490 0 Ce 660Lys
43 4.28584 0.00813 Ha 660Lys
44 3.01578 0.00805 Hea 660Lys
45 3.01984 0.01211 Heb 660Lys
46 1.88717 0.00347 Hbb 660Lys
47 1.81472 0.00363 Hba 660Lys
48 1.45712 8.34826e-04 Hgb 660Lys
49 1.42251 0.00689 Hga 660Lys
50 1.67298 2.74782e-04 Hda 660Lys
51 1.67298 2.74782e-04 Hdb 660Lys
52 8.22061 0.00495 H 661Met
53 119.64824 0.02854 N 661Met
54 55.69198 0.05325 Ca 661Met
55 176.96730 0.01092 C 661Met
56 32.40414 0.08732 Cb 661Met
57 31.92803 0.07354 Cg 661Met
58 4.47216 0.00491 Ha 661Met
59 2.62992 0.00279 Hgb 661Met
60 2.53671 0.00438 Hga 661Met
61 2.11579 0.00783 Hbb 661Met
62 2.07549 0.00541 Hba 661Met
63 8.30490 0.00708 H 662Gly
64 109.52039 0.02917 N 662Gly
65 45.62336 0.05679 Ca 662Gly
66 174.35288 0.01662 C 662Gly
67 4.00637 0.00570 Haa 662Gly
218
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68 4.05276 0.00887 Hab 662Gly
69 7.98536 0.00853 H 663Thr
70 113.14732 0.04785 N 663Thr
71 61.79305 0.06530 Ca 663Thr
72 69.80660 0.05454 Cb 663Thr
73 174.65896 0.04811 C 663Thr
74 21.50787 0.04413 Cg2 663Thr
75 1.20312 0.00638 Hg2* 663Thr
76 4.39981 0.01413 Ha 663Thr
77 4.24995 0.00838 Hb 663Thr
78 8.33806 0.00670 H 664Ser
79 118.40031 0.12178 N 664Ser
80 58.19256 0.04653 Ca 664Ser
81 63.89416 0.10650 Cb 664Ser
82 174.44497 0.04236 C 664Ser
83 3.87665 0.00113 Hba 664Ser
84 3.87665 0.00113 Hbb 664Ser
85 4.53928 0.00297 Ha 664Ser
86 8.09999 0.00762 H 665Ile
87 122.33016 0.07938 N 665Ile
88 61.24325 0.07955 Ca 665Ile
89 38.69700 0.09746 Cb 665Ile
90 175.83455 0.01232 C 665Ile
91 27.27774 0.04687 Cg1 665Ile
92 17.62296 0.05758 Cg2 665Ile
93 13.10261 0.03864 Cd1 665Ile
94 4.19425 0.00359 Ha 665Ile
95 1.88170 0.00437 Hb 665Ile
96 1.44509 0.02256 Hg1b 665Ile
97 1.18340 0.00769 Hg1a 665Ile
98 0.91263 0.01745 Hg2* 665Ile
99 0.86060 0.00780 Hd1* 665Ile
100 8.17938 0.00744 H 666Ala
101 127.11133 0.04919 N 666Ala
102 52.49050 0.10132 Ca 666Ala
103 19.49263 0.01975 Cb 666Ala
104 177.25588 0.00458 C 666Ala
105 4.38359 0.02194 Ha 666Ala
106 1.39290 0.02431 Hb* 666Ala
107 8.15461 0.00574 H 667Asp
108 119.80123 0.08065 N 667Asp
109 41.27910 0.03711 Cb 667Asp
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110 54.47759 0.06585 Ca 667Asp
111 176.30087 0.01234 C 667Asp
112 4.65004 0.01062 Ha 667Asp
113 2.61880 0.00932 Hba 667Asp
114 2.71782 0.01186 Hbb 667Asp
115 7.90634 0.00872 H 668Val
116 119.51860 0.02170 N 668Val
117 175.92552 0.00982 C 668Val
118 62.22452 0.05987 Ca 668Val
119 32.65996 0.04874 Cb 668Val
120 20.52764 0.00416 Cga 668Val
121 4.12419 0.00913 Ha 668Val
122 2.13155 0.00659 Hb 668Val
123 0.93748 0.00707 Hga* 668Val
124 0.93885 0.01017 Hgb* 668Val
125 21.05940 0 Cgb 668Val
126 8.24986 0.00656 H 669Ala
127 126.59109 0.04365 N 669Ala
128 52.58668 0.07991 Ca 669Ala
129 19.29508 0.02201 Cb 669Ala
130 177.41375 0.00242 C 669Ala
131 4.32394 0.00675 Ha 669Ala
132 1.39407 0.00662 Hb* 669Ala
133 8.19675 0.00531 H 670Asn
134 117.76598 0.02671 N 670Asn
135 174.76373 0.00242 C 670Asn
136 38.96364 0.08587 Cb 670Asn
137 53.17687 0.09347 Ca 670Asn
138 4.70058 0.00584 Ha 670Asn
139 2.72817 0.00768 Hba 670Asn
140 2.83228 0.00330 Hbb 670Asn
141 7.57286 0.00451 Hd2b 670Asn
142 112.61077 0.04558 Nd2 670Asn
143 6.80883 0.00799 Hd2a 670Asn
144 8.20401 0.00684 H 671Asp
145 120.28347 0.05187 N 671Asp
146 175.52914 5.04637e-06 C 671Asp
147 54.42832 0.08053 Ca 671Asp
148 40.99764 0.04319 Cb 671Asp
149 4.57469 0.01142 Ha 671Asp
150 2.63892 0.00673 Hba 671Asp
151 2.68397 0.02363 Hbb 671Asp
220
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152 7.93795 0.00848 H 672Lys
153 120.54407 0.04445 N 672Lys
154 32.89549 0.03932 Cb 672Lys
155 53.56980 0.03432 Ca 672Lys
156 175.28428 0 C 672Lys
157 42.03973 0.00795 Ce 672Lys
158 29.00793 0.01901 Cd 672Lys
159 0.98228 0.00499 Hba 672Lys
160 1.35758 0.00574 Hbb 672Lys
161 4.26321 0.00381 Ha 672Lys
162 24.72070 0.02308 Cg 672Lys
163 2.94086 0.00761 Hea 672Lys
164 2.94086 0.00761 Heb 672Lys
165 1.51348 0.00784 Hdb 672Lys
166 1.46637 0.01743 Hda 672Lys
167 1.13348 0.01143 Hgb 672Lys
168 1.09120 0.00651 Hga 672Lys
169 63.21311 0.03499 Ca 673Pro
170 174.25640 0.00106 C 673Pro
171 29.49247 0.06029 Cb 673Pro
172 49.84446 0.05109 Cd 673Pro
173 27.29547 0.07085 Cg 673Pro
174 4.64992 0.00542 Ha 673Pro
175 3.54160 0.00426 Hdb 673Pro
176 2.91607 0.00404 Hda 673Pro
177 2.33659 0.00438 Hbb 673Pro
178 1.97345 0.00463 Hba 673Pro
179 2.15235 0.00490 Hgb 673Pro
180 1.55733 0.00514 Hga 673Pro
181 7.11406 0.00699 H 674Tyr
182 115.51116 0.01207 N 674Tyr
183 40.63953 0.06619 Cb 674Tyr
184 55.46252 0.07901 Ca 674Tyr
185 173.25380 0.03734 C 674Tyr
186 5.30269 0.00685 Ha 674Tyr
187 2.90899 0.00474 Hbb 674Tyr
188 2.74358 0.00423 Hba 674Tyr
189 6.19310 0.01619 He* 674Tyr
190 6.21451 0.01557 Hd* 674Tyr
191 117.76262 0 Ce* 674Tyr
192 133.10071 0 Cd* 674Tyr
193 8.85859 0.00771 H 675Thr
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194 111.82832 0.02736 N 675Thr
195 61.15733 0.06654 Ca 675Thr
196 71.84521 0.05852 Cb 675Thr
197 173.18849 0.00846 C 675Thr
198 21.48586 0.06440 Cg2 675Thr
199 1.14010 0.00618 Hg2* 675Thr
200 4.03149 0.00630 Hb 675Thr
201 4.55892 0.00518 Ha 675Thr
202 8.55328 0.01004 H 676Val
203 123.85466 0.02347 N 676Val
204 34.41013 0.08954 Cb 676Val
205 61.16906 0.07664 Ca 676Val
206 173.93550 0.00925 C 676Val
207 21.60773 0 Cgb 676Val
208 4.81053 0.00877 Ha 676Val
209 2.00404 0.00341 Hb 676Val
210 0.90674 0.00420 Hgb* 676Val
211 0.80614 0.00516 Hga* 676Val
212 21.57452 0.07996 Cga 676Val
213 9.08063 0.00782 H 677Ala
214 130.45282 0.02046 N 677Ala
215 50.98016 0.04576 Ca 677Ala
216 22.42653 0.06090 Cb 677Ala
217 175.15918 0.02061 C 677Ala
218 4.79431 0.00347 Ha 677Ala
219 1.33128 0.00849 Hb* 677Ala
220 8.47949 0.00880 H 678Val
221 121.60707 0.06826 N 678Val
222 33.85632 0.05812 Cb 678Val
223 60.86556 0.07876 Ca 678Val
224 175.85541 0.00384 C 678Val
225 4.85317 0.00591 Ha 678Val
226 1.94030 0.00571 Hb 678Val
227 0.86460 0.01266 Hga* 678Val
228 0.86637 0.01285 Hgb* 678Val
229 21.78443 0 Cgb 678Val
230 21.32922 0 Cga 678Val
231 8.51686 0.00828 H 679Ser
232 123.04399 0.03027 N 679Ser
233 56.05662 0.09199 Ca 679Ser
234 63.47448 0.08779 Cb 679Ser
235 175.25351 0.00637 C 679Ser
222
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236 3.65032 0.00546 Hba 679Ser
237 3.77133 0.00623 Hbb 679Ser
238 4.69269 0.00888 Ha 679Ser
239 9.11266 0.00950 H 680Gly
240 119.04147 0.02002 N 680Gly
241 173.69744 0.00959 C 680Gly
242 47.43756 0.07301 Ca 680Gly
243 4.01640 0.00713 Hab 680Gly
244 3.66738 0.00735 Haa 680Gly
245 8.58975 0.00994 H 681Lys
246 126.05018 0.01893 N 681Lys
247 55.09503 0.05616 Ca 681Lys
248 31.73769 0.03908 Cb 681Lys
249 174.39004 0.01354 C 681Lys
250 28.58934 0.08728 Cd 681Lys
251 25.15078 0.05934 Cg 681Lys
252 42.52459 0.10685 Ce 681Lys
253 4.33939 0.00519 Ha 681Lys
254 2.93224 0.00784 Heb 681Lys
255 2.93113 0.00422 Hea 681Lys
256 1.58867 0.00738 Hba 681Lys
257 2.28413 0.00417 Hbb 681Lys
258 1.51746 0.00239 Hdb 681Lys
259 1.23995 0.00459 Hga 681Lys
260 1.36892 0.00569 Hgb 681Lys
261 1.51746 0.00261 Hda 681Lys
262 8.10571 0.00698 H 682Thr
263 115.38384 0.02616 N 682Thr
264 62.42962 0.05486 Ca 682Thr
265 69.56692 0.07309 Cb 682Thr
266 174.39710 0.06215 C 682Thr
267 22.69044 0.05105 Cg2 682Thr
268 0.97368 0.00520 Hg2* 682Thr
269 4.10477 0.00399 Hb 682Thr
270 4.64283 0.01110 Ha 682Thr
271 9.37770 0.00980 H 683Ile
272 129.64137 0.03717 N 683Ile
273 40.18077 0.05879 Cb 683Ile
274 61.01442 0.10307 Ca 683Ile
275 174.90204 0.00761 C 683Ile
276 27.00995 0.05892 Cg1 683Ile
277 16.93583 0.04533 Cg2 683Ile
223
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278 13.67812 0.03513 Cd1 683Ile
279 4.54742 0.00368 Ha 683Ile
280 1.77582 0.00473 Hb 683Ile
281 0.66493 0.01176 Hg1a 683Ile
282 0.64844 0.00814 Hg2* 683Ile
283 0.40133 0.00542 Hd1* 683Ile
284 1.60034 0.00245 Hg1b 683Ile
285 9.08959 0.00907 H 684Thr
286 123.39000 0.05619 N 684Thr
287 61.56314 0.09346 Ca 684Thr
288 70.06474 0.04711 Cb 684Thr
289 174.21129 0.03853 C 684Thr
290 20.81430 0.03305 Cg2 684Thr
291 1.11294 0.00494 Hg2* 684Thr
292 3.91526 0.00623 Hb 684Thr
293 5.32527 0.00707 Ha 684Thr
294 9.01814 0.00968 H 685Val
295 126.74109 0.04321 N 685Val
296 59.74014 0.05804 Ca 685Val
297 34.74174 0.08488 Cb 685Val
298 173.96552 0.02706 C 685Val
299 22.03941 0.01159 Cgb 685Val
300 5.09763 0.00453 Ha 685Val
301 1.81044 0.00971 Hb 685Val
302 0.82126 0.00449 Hgb* 685Val
303 0.81420 0.00257 Hga* 685Val
304 21.42157 0.00498 Cga 685Val
305 8.56339 0.00789 H 686Glu
306 124.83958 0.03950 N 686Glu
307 175.52219 0.00572 C 686Glu
308 33.41255 0.05881 Cb 686Glu
309 55.32158 0.08222 Ca 686Glu
310 36.43063 0.03185 Cg 686Glu
311 2.12197 0.02103 Hga 686Glu
312 2.20617 0.00498 Hgb 686Glu
313 1.97557 0.01092 Hbb 686Glu
314 1.93146 0.01147 Hba 686Glu
315 5.03525 0.00675 Ha 686Glu
316 8.60438 0.00756 H 687Ser
317 117.47216 0.02992 N 687Ser
318 171.64466 0 C 687Ser
319 56.44729 0.05121 Ca 687Ser
224
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320 64.37910 0.03811 Cb 687Ser
321 3.85476 0.00388 Hbb 687Ser
322 4.79784 0.00759 Ha 687Ser
323 3.50274 0.00463 Hba 687Ser
324 177.22470 0.01716 C 688Pro
325 64.92859 0.09364 Ca 688Pro
326 31.94094 0.06584 Cb 688Pro
327 50.97306 0.01910 Cd 688Pro
328 27.53251 0.07509 Cg 688Pro
329 4.27970 0.00502 Ha 688Pro
330 3.81764 0.00753 Hdb 688Pro
331 3.74946 0.00572 Hda 688Pro
332 2.13921 0.00532 Hgb 688Pro
333 1.99635 0.00918 Hga 688Pro
334 1.97637 0.00747 Hba 688Pro
335 2.31154 0.00488 Hbb 688Pro
336 8.54346 0.00888 H 689Ala
337 121.96132 0.02936 N 689Ala
338 176.03788 0.00793 C 689Ala
339 17.84220 0.08554 Cb 689Ala
340 53.13325 0.04418 Ca 689Ala
341 4.24497 0.00890 Ha 689Ala
342 1.51589 0.00970 Hb* 689Ala
343 8.16685 0.00515 H 690Ala
344 121.73424 0.01856 N 690Ala
345 177.45097 0.00341 C 690Ala
346 51.64229 0.04747 Ca 690Ala
347 22.60003 0.03554 Cb 690Ala
348 4.87615 0.00586 Ha 690Ala
349 1.27984 0.00452 Hb* 690Ala
350 8.65315 0.00624 H 691Gly
351 107.42327 0.02940 N 691Gly
352 45.49228 0.06996 Ca 691Gly
353 172.99354 0.00958 C 691Gly
354 4.42846 0.00439 Hab 691Gly
355 3.79564 0.00666 Haa 691Gly
356 8.79797 0.00711 H 692Leu
357 126.41654 0.02158 N 692Leu
358 53.27044 0.06852 Ca 692Leu
359 176.13910 0.00786 C 692Leu
360 44.59544 0.06861 Cb 692Leu
361 26.32392 0.09939 Cg 692Leu
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362 26.03448 0.05406 Cda 692Leu
363 5.35121 0.00504 Ha 692Leu
364 1.72425 0.00617 Hbb 692Leu
365 0.95594 0.00895 Hba 692Leu
366 1.55558 0.00309 Hg 692Leu
367 0.69444 0.00562 Hdb* 692Leu
368 0.52921 0.00553 Hda* 692Leu
369 25.75127 0.04506 Cdb 692Leu
370 8.66285 0.00826 H 693Thr
371 117.64714 0.02762 N 693Thr
372 72.14565 0.08432 Cb 693Thr
373 61.52367 0.08683 Ca 693Thr
374 172.07313 0.01491 C 693Thr
375 23.13174 0.04234 Cg2 693Thr
376 0.69394 0.00534 Hg2* 693Thr
377 3.67871 0.00590 Hb 693Thr
378 4.88727 0.00673 Ha 693Thr
379 8.15453 0.00562 H 694Ile
380 123.26075 0.03371 N 694Ile
381 60.02762 0.06473 Ca 694Ile
382 39.81869 0.04329 Cb 694Ile
383 173.82816 0.00894 C 694Ile
384 28.01645 0.02139 Cg1 694Ile
385 18.16016 0.03739 Cg2 694Ile
386 13.45886 0.06053 Cd1 694Ile
387 5.02119 0.00528 Ha 694Ile
388 1.01546 0.00692 Hb 694Ile
389 1.28176 0.00740 Hg1b 694Ile
390 0.77090 0.00346 Hg1a 694Ile
391 0.34861 0.00610 Hd1* 694Ile
392 0.49657 0.00873 Hg2* 694Ile
393 9.49410 0.00878 H 695Phe
394 126.51016 0.02945 N 695Phe
395 42.91501 0.03589 Cb 695Phe
396 55.63028 0.04502 Ca 695Phe
397 176.16901 0.00960 C 695Phe
398 5.64905 0.01138 Ha 695Phe
399 2.95218 0.01417 Hbb 695Phe
400 2.93836 0.01010 Hba 695Phe
401 7.19841 0.01087 He* 695Phe
402 6.98724 0.00668 Hd* 695Phe
403 131.86651 0 Cd* 695Phe
226
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404 131.06837 0 Ce* 695Phe
405 8.80330 0.00655 H 696Asp
406 120.18541 0.02724 N 696Asp
407 52.14285 0.07350 Ca 696Asp
408 41.71768 0.06672 Cb 696Asp
409 178.62854 0.01096 C 696Asp
410 4.76942 0.00692 Ha 696Asp
411 3.39505 0.01055 Hbb 696Asp
412 2.73314 0.00653 Hba 696Asp
413 8.31211 0.00685 H 697Met
414 116.49600 0.01965 N 697Met
415 57.63792 0.07556 Ca 697Met
416 176.62508 0.01733 C 697Met
417 31.78302 0.08340 Cb 697Met
418 31.85671 9.84622e-04 Cg 697Met
419 4.25394 0.00461 Ha 697Met
420 2.53965 0.00516 Hgb 697Met
421 2.53946 0.00544 Hga 697Met
422 2.14776 0.00279 Hba 697Met
423 2.14776 0.00279 Hbb 697Met
424 8.21672 0.00522 H 698Asn
425 117.76625 0.01997 N 698Asn
426 175.50540 0.01640 C 698Asn
427 52.96821 0.05628 Ca 698Asn
428 39.36413 0.05660 Cb 698Asn
429 4.90786 0.00708 Ha 698Asn
430 2.99988 0.00888 Hbb 698Asn
431 2.80587 0.00974 Hba 698Asn
432 6.93906 0.00349 Hd2a 698Asn
433 113.99694 0.05897 Nd2 698Asn
434 7.69215 0.00508 Hd2b 698Asn
435 8.26639 0.00530 H 699Gly
436 108.51929 0.01825 N 699Gly
437 174.01257 0.00214 C 699Gly
438 45.55177 0.08147 Ca 699Gly
439 4.18232 0.00809 Hab 699Gly
440 3.62057 0.00577 Haa 699Gly
441 8.45750 0.00592 H 700Arg
442 122.07652 0.06898 N 700Arg
443 176.31053 0.04752 C 700Arg
444 55.74249 0.09537 Ca 700Arg
445 30.52252 0.02846 Cb 700Arg
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446 43.39462 0.06462 Cd 700Arg
447 27.64535 0.06887 Cg 700Arg
448 4.39778 0.00527 Ha 700Arg
449 3.25177 0.00648 Hdb 700Arg
450 3.25143 0.00574 Hda 700Arg
451 1.65171 0.00497 Hgb 700Arg
452 1.52540 0.00497 Hga 700Arg
453 1.85471 0.00789 Hba 700Arg
454 1.88054 0.01580 Hbb 700Arg
455 8.77273 0.00981 H 701Arg
456 125.65842 0.02827 N 701Arg
457 56.54648 0.07843 Ca 701Arg
458 30.16337 0.03003 Cb 701Arg
459 176.46785 0.02106 C 701Arg
460 43.62962 0.06336 Cd 701Arg
461 26.96914 0.08197 Cg 701Arg
462 3.97677 0.00477 Ha 701Arg
463 3.03552 0.00729 Hdb 701Arg
464 3.03435 0.00666 Hda 701Arg
465 1.62128 0.00420 Hba 701Arg
466 1.72496 0.00428 Hbb 701Arg
467 1.12624 0.00236 Hgb 701Arg
468 1.00957 0.00360 Hga 701Arg
469 8.68655 0.00715 H 702Val
470 121.70460 0.02362 N 702Val
471 32.80365 0.04604 Cb 702Val
472 61.70564 0.06525 Ca 702Val
473 175.38832 0.01873 C 702Val
474 22.64053 0.05254 Cgb 702Val
475 20.16865 0.06032 Cga 702Val
476 4.43197 0.00694 Ha 702Val
477 2.28484 0.00639 Hb 702Val
478 0.59054 0.00525 Hga* 702Val
479 1.01748 0.00473 Hgb* 702Val
480 7.12991 0.00617 H 703Ala
481 120.33529 0.01172 N 703Ala
482 22.54005 0.03414 Cb 703Ala
483 52.79636 0.05409 Ca 703Ala
484 175.38992 0.06522 C 703Ala
485 4.47635 0.00738 Ha 703Ala
486 1.02148 0.00837 Hb* 703Ala
487 8.21037 0.00536 H 704Thr
228
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488 113.82951 0.02992 N 704Thr
489 60.30833 0.06525 Ca 704Thr
490 71.85718 0.07424 Cb 704Thr
491 172.38198 0.00143 C 704Thr
492 20.74984 0.02872 Cg2 704Thr
493 1.12145 0.00649 Hg2* 704Thr
494 3.98407 0.00723 Hb 704Thr
495 5.13329 0.00759 Ha 704Thr
496 8.96717 0.00711 H 705Ala
497 125.04904 0.03369 N 705Ala
498 175.28830 0.02387 C 705Ala
499 52.07666 0.03113 Ca 705Ala
500 23.72654 0.06934 Cb 705Ala
501 4.65333 0.00583 Ha 705Ala
502 1.54816 0.00747 Hb* 705Ala
503 8.41444 0.00902 H 706Lys
504 119.39519 0.01909 N 706Lys
505 55.34111 0.09643 Ca 706Lys
506 34.56470 0.03127 Cb 706Lys
507 178.26150 0.00611 C 706Lys
508 41.96423 0.08247 Ce 706Lys
509 29.02724 0.06677 Cd 706Lys
510 24.88718 0.04281 Cg 706Lys
511 5.08356 0.00645 Ha 706Lys
512 2.94478 0.01003 Hea 706Lys
513 2.94520 0.01141 Heb 706Lys
514 1.66208 0.00931 Hda 706Lys
515 1.73983 0.02088 Hba 706Lys
516 1.74642 0.00681 Hbb 706Lys
517 1.45422 0.00817 Hgb 706Lys
518 1.38869 0.00297 Hga 706Lys
519 1.66609 0.00802 Hdb 706Lys
520 8.90320 0.00771 H 707Asn
521 116.94023 0.02485 N 707Asn
522 58.55316 0.08741 Ca 707Asn
523 38.00781 0.04226 Cb 707Asn
524 175.04104 0.01896 C 707Asn
525 4.62861 0.00538 Ha 707Asn
526 3.51210 0.00822 Hbb 707Asn
527 2.92509 0.00303 Hba 707Asn
528 113.59247 0.05335 Nd2 707Asn
529 7.59046 0.00349 Hd2b 707Asn
229
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530 6.88157 0.00353 Hd2a 707Asn
531 9.27432 0.00863 H 708Arg
532 124.45264 0.03226 N 708Arg
533 32.84200 0.05644 Cb 708Arg
534 55.61096 0.08659 Ca 708Arg
535 173.38366 0.00679 C 708Arg
536 43.25407 0.09377 Cd 708Arg
537 27.73047 0.03819 Cg 708Arg
538 5.02953 0.00742 Ha 708Arg
539 3.15278 0.00713 Hda 708Arg
540 3.15316 0.00637 Hdb 708Arg
541 1.49798 0.00586 Hgb 708Arg
542 1.41803 0.00365 Hga 708Arg
543 1.75654 0.01742 Hba 708Arg
544 1.77474 0.01812 Hbb 708Arg
545 8.94616 0.00774 H 709Met
546 123.41306 0.01204 N 709Met
547 54.43430 0.08829 Ca 709Met
548 37.96128 0.04012 Cb 709Met
549 172.73536 0.00526 C 709Met
550 30.37447 0.06792 Cg 709Met
551 4.63077 0.00534 Ha 709Met
552 1.76235 0.01628 Hba 709Met
553 2.22142 0.00456 Hgb 709Met
554 2.02708 0.00457 Hga 709Met
555 1.81191 0.01172 Hbb 709Met
556 8.28712 0.00786 H 710Val
557 125.50878 0.03978 N 710Val
558 33.40827 0.06098 Cb 710Val
559 61.82893 0.08900 Ca 710Val
560 175.04587 0.00286 C 710Val
561 4.73632 0.00753 Ha 710Val
562 1.90493 0.00728 Hb 710Val
563 21.13487 0.07576 Cga 710Val
564 20.60193 0.05646 Cgb 710Val
565 0.90391 0.01065 Hgb* 710Val
566 0.76581 0.00356 Hga* 710Val
567 9.34520 0.00931 H 711Phe
568 129.26617 0.10846 N 711Phe
569 172.58649 0.00747 C 711Phe
570 56.15282 0.05503 Ca 711Phe
571 42.97462 0.06285 Cb 711Phe
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572 4.84185 0.00785 Ha 711Phe
573 2.73228 0.00618 Hbb 711Phe
574 2.50128 0.00327 Hba 711Phe
575 6.87682 0.00807 Hd* 711Phe
576 6.92728 0.00182 He* 711Phe
577 131.18264 0 Ce* 711Phe
578 131.17227 0 Cd* 711Phe
579 7.26497 0 Hz 711Phe
580 7.91128 0.00872 H 712Glu
581 129.22518 0.03111 N 712Glu
582 173.16255 0.00499 C 712Glu
583 55.72020 0.09806 Ca 712Glu
584 28.66367 0.05276 Cb 712Glu
585 35.50736 0.04975 Cg 712Glu
586 4.26639 0.00467 Ha 712Glu
587 1.71229 0.00598 Hbb 712Glu
588 1.60542 0.00331 Hba 712Glu
589 1.99384 0.00292 Hga 712Glu
590 1.99384 0.00292 Hgb 712Glu
591 8.46126 0.00872 H 713Ala
592 130.37577 0.02797 N 713Ala
593 22.21586 0.02686 Cb 713Ala
594 50.97904 0.05121 Ca 713Ala
595 176.16221 0.00750 C 713Ala
596 4.05704 0.00406 Ha 713Ala
597 1.20658 0.00374 Hb* 713Ala
598 7.52783 0.00673 H 714Gln
599 115.26354 0.03336 N 714Gln
600 30.79684 0.04810 Cb 714Gln
601 54.14264 0.06578 Ca 714Gln
602 175.50559 0.00409 C 714Gln
603 33.76967 0.06998 Cg 714Gln
604 4.48091 0.00410 Ha 714Gln
605 1.94325 0.00338 Hba 714Gln
606 2.25119 0.00412 Hbb 714Gln
607 2.45719 0.00289 Hga 714Gln
608 2.45741 0.00289 Hgb 714Gln
609 8.32814 0.00643 H 715Asn
610 117.84555 0.06451 N 715Asn
611 175.81601 0.00388 C 715Asn
612 38.13380 0.05908 Cb 715Asn
613 54.65494 0.08375 Ca 715Asn
231
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614 2.73165 0.01169 Hbb 715Asn
615 2.72253 0.00804 Hba 715Asn
616 4.42321 0.00568 Ha 715Asn
617 110.58652 0.02409 Nd2 715Asn
618 6.71165 0.00484 Hd2a 715Asn
619 7.48536 0.00408 Hd2b 715Asn
620 8.95097 0.00874 H 716Gly
621 111.10024 0.02000 N 716Gly
622 170.56229 0.01096 C 716Gly
623 44.78995 0.10055 Ca 716Gly
624 4.30883 0.00765 Hab 716Gly
625 3.91274 0.00568 Haa 716Gly
626 7.44187 0.00765 H 717Val
627 119.25553 0.01722 N 717Val
628 33.32585 0.03552 Cb 717Val
629 61.54045 0.10047 Ca 717Val
630 174.89695 0.00994 C 717Val
631 21.21844 0.09458 Cga 717Val
632 4.80449 0.00330 Ha 717Val
633 1.84244 0.00306 Hb 717Val
634 0.89804 0.00847 Hga* 717Val
635 0.96422 0.01137 Hgb* 717Val
636 21.44924 0.08622 Cgb 717Val
637 9.11396 0.00988 H 718Tyr
638 124.48682 0.10374 N 718Tyr
639 56.80569 0.03805 Ca 718Tyr
640 41.87417 0.03143 Cb 718Tyr
641 174.38296 0.00919 C 718Tyr
642 4.93319 0.00792 Ha 718Tyr
643 2.81255 0.00576 Hbb 718Tyr
644 2.45865 0.00578 Hba 718Tyr
645 6.91201 0.00792 Hd* 718Tyr
646 7.02175 0.00733 He* 718Tyr
647 133.76566 0 Cd* 718Tyr
648 117.72826 0 Ce* 718Tyr
649 8.92340 0.00850 H 719Ala
650 123.59545 0.03152 N 719Ala
651 175.69447 0.00287 C 719Ala
652 50.43756 0.07016 Ca 719Ala
653 20.82090 0.05310 Cb 719Ala
654 5.17829 0.00672 Ha 719Ala
655 1.29829 0.00552 Hb* 719Ala
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656 9.20919 0.00768 H 720Val
657 122.98456 0.03200 N 720Val
658 60.59649 0.06413 Ca 720Val
659 174.05461 0.01052 C 720Val
660 4.70756 0.00895 Ha 720Val
661 1.93511 0.00328 Hb 720Val
662 33.26912 0.04362 Cb 720Val
663 0.70875 0.00247 Hga* 720Val
664 21.58135 0.04118 Cga 720Val
665 20.80102 0.05866 Cgb 720Val
666 0.77819 0.00539 Hgb* 720Val
667 9.42886 0.00949 H 721Arg
668 127.91363 0.02610 N 721Arg
669 54.67555 0.08677 Ca 721Arg
670 175.01951 0.00305 C 721Arg
671 33.16420 0.04740 Cb 721Arg
672 43.79750 0.07211 Cd 721Arg
673 27.51193 0.06468 Cg 721Arg
674 5.30580 0.00571 Ha 721Arg
675 3.16708 0.00603 Hdb 721Arg
676 3.16469 0.00455 Hda 721Arg
677 1.87294 0.00405 Hbb 721Arg
678 1.79556 0.01120 Hba 721Arg
679 1.58754 0.00523 Hgb 721Arg
680 1.48766 0.00506 Hga 721Arg
681 9.20153 0.00906 H 722Ile
682 128.52152 0.02628 N 722Ile
683 40.17126 0.05860 Cb 722Ile
684 61.16824 0.05535 Ca 722Ile
685 173.99450 0.01784 C 722Ile
686 28.75165 0.06815 Cg1 722Ile
687 20.03606 0.05859 Cg2 722Ile
688 14.96618 0.03868 Cd1 722Ile
689 4.47789 0.00384 Ha 722Ile
690 1.56442 0.00536 Hb 722Ile
691 0.90549 0.00538 Hg1b 722Ile
692 0.34759 0.00555 Hg1a 722Ile
693 0.59347 0.00441 Hg2* 722Ile
694 -0.16047 0.00725 Hd1* 722Ile
695 9.43607 0.01042 H 723Ala
696 130.95010 0.02417 N 723Ala
697 176.94903 0.01131 C 723Ala
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698 51.26885 0.05962 Ca 723Ala
699 19.60115 0.06771 Cb 723Ala
700 5.19097 0.00615 Ha 723Ala
701 1.38127 0.00544 Hb* 723Ala
702 8.28765 0.00559 H 724Thr
703 116.92389 0.03206 N 724Thr
704 173.86177 0.00604 C 724Thr
705 70.32979 0.04582 Cb 724Thr
706 60.12222 0.08918 Ca 724Thr
707 21.40415 0.05495 Cg2 724Thr
708 1.38112 0.00510 Hg2* 724Thr
709 4.56815 0.00436 Hb 724Thr
710 4.93769 0.00777 Ha 724Thr
711 8.88349 0.00944 H 725Glu
712 121.72214 0.01797 N 725Glu
713 28.65289 0.06692 Cb 725Glu
714 58.46822 0.06788 Ca 725Glu
715 176.93753 0.00869 C 725Glu
716 36.16607 0.06145 Cg 725Glu
717 4.08217 0.00569 Ha 725Glu
718 2.37546 0.00476 Hgb 725Glu
719 2.31608 0.01298 Hga 725Glu
720 2.12327 0.01218 Hba 725Glu
721 2.12937 0.01150 Hbb 725Glu
722 8.40897 0.00812 H 726Gly
723 108.02226 0.02333 N 726Gly
724 173.87573 0.00718 C 726Gly
725 45.51506 0.06669 Ca 726Gly
726 3.98456 0.01711 Hab 726Gly
727 3.97405 0.00674 Haa 726Gly
728 7.61497 0.00445 H 727Lys
729 120.51717 0.03703 N 727Lys
730 175.08002 0.01833 C 727Lys
731 55.99346 0.08347 Ca 727Lys
732 35.46609 0.07140 Cb 727Lys
733 24.75020 0.03016 Cg 727Lys
734 4.43470 0.00504 Ha 727Lys
735 2.87564 0.00774 Hea 727Lys
736 1.67638 0.00852 Hbb 727Lys
737 1.36656 0.00648 Hba 727Lys
738 28.77083 0.09669 Cd 727Lys
739 0.98645 0.00613 Hga 727Lys
234
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740 1.12396 0.00567 Hgb 727Lys
741 1.59573 0.00541 Hdb 727Lys
742 42.03510 0.03771 Ce 727Lys
743 1.59391 0.00704 Hda 727Lys
744 2.87593 0.00582 Heb 727Lys
745 8.34036 0.00920 H 728Thr
746 119.80928 0.03450 N 728Thr
747 61.40821 0.04774 Ca 728Thr
748 70.13314 0.05542 Cb 728Thr
749 173.03534 0.00841 C 728Thr
750 21.84853 0.03024 Cg2 728Thr
751 1.03989 0.00541 Hg2* 728Thr
752 5.26167 0.00724 Ha 728Thr
753 3.84826 0.00390 Hb 728Thr
754 9.23645 0.00848 H 729Tyr
755 127.20205 0.02256 N 729Tyr
756 56.44687 0.09072 Ca 729Tyr
757 41.59646 0.05059 Cb 729Tyr
758 175.06743 0.00487 C 729Tyr
759 4.83400 0.00524 Ha 729Tyr
760 3.17325 0.00577 Hbb 729Tyr
761 2.62043 0.00445 Hba 729Tyr
762 6.85247 0.00626 He* 729Tyr
763 7.27247 0.00889 Hd* 729Tyr
764 134.67803 0 Cd* 729Tyr
765 118.14031 0 Ce* 729Tyr
766 8.62222 0.00971 H 730Thr
767 116.26265 0.01340 N 730Thr
768 61.30505 0.03163 Ca 730Thr
769 71.06038 0.07727 Cb 730Thr
770 173.82426 0.00588 C 730Thr
771 21.03381 0.03542 Cg2 730Thr
772 1.04607 0.00476 Hg2* 730Thr
773 5.44375 0.00796 Ha 730Thr
774 3.91637 0.00167 Hb 730Thr
775 9.04489 0.00913 H 731Glu
776 125.59238 0.01757 N 731Glu
777 54.48766 0.08963 Ca 731Glu
778 33.19122 0.06085 Cb 731Glu
779 174.75107 0.00211 C 731Glu
780 34.90968 0.04837 Cg 731Glu
781 4.71397 0.00417 Ha 731Glu
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782 1.56034 0.00265 Hba 731Glu
783 2.22629 0.00978 Hgb 731Glu
784 2.13973 0.00777 Hga 731Glu
785 2.02868 0.00586 Hbb 731Glu
786 8.70719 0.00870 H 732Lys
787 124.57960 0.01194 N 732Lys
788 55.50923 0.08485 Ca 732Lys
789 33.55290 0.04978 Cb 732Lys
790 176.19420 0.02156 C 732Lys
791 25.05923 0.09467 Cg 732Lys
792 41.69436 0.08010 Ce 732Lys
793 29.01491 0.05907 Cd 732Lys
794 5.17700 0.00625 Ha 732Lys
795 2.89006 0.00632 Hea 732Lys
796 1.68482 0.00981 Hba 732Lys
797 1.76439 0.00979 Hbb 732Lys
798 1.47659 0.00591 Hgb 732Lys
799 1.24616 0.00786 Hga 732Lys
800 1.65572 0.00955 Hda 732Lys
801 1.68471 0 Hdb 732Lys
802 2.89198 0.00316 Heb 732Lys
803 9.11982 0.01919 H 733Val
804 123.42393 0.08238 N 733Val
805 35.32762 0.05537 Cb 733Val
806 173.54989 0.01199 C 733Val
807 60.55927 0.04261 Ca 733Val
808 1.91190 0.00561 Hb 733Val
809 4.53072 0.00663 Ha 733Val
810 21.95437 0.07373 Cgb 733Val
811 0.78048 0.00268 Hga* 733Val
812 0.80643 6.56863e-04 Hgb* 733Val
813 20.98310 0.03916 Cga 733Val
814 8.46059 0.00894 H 734Ile
815 125.31105 0.03348 N 734Ile
816 60.79610 0.04234 Ca 734Ile
817 39.87838 0.10726 Cb 734Ile
818 174.92111 0.01834 C 734Ile
819 28.42270 0.07331 Cg1 734Ile
820 17.60563 0.01756 Cg2 734Ile
821 13.74112 0.02861 Cd1 734Ile
822 4.67375 0.00307 Ha 734Ile
823 1.78038 0.00495 Hb 734Ile
236
Number Shift SD Assign Name Residue
824 1.60228 0.00469 Hg1b 734Ile
825 1.12255 0.00310 Hg1a 734Ile
826 0.83753 0.00171 Hg2* 734Ile
827 0.91814 0.00454 Hd1* 734Ile
828 9.08129 0.00946 H 735Val
829 129.17787 0.02293 N 735Val
830 32.73268 0.02348 Cb 735Val
831 62.43732 0.09061 Ca 735Val
832 174.87364 0.02687 C 735Val
833 4.16852 0.00607 Ha 735Val
834 2.44900 0.00622 Hb 735Val
835 0.85100 0.00700 Hga* 735Val
836 0.91221 0.00391 Hgb* 735Val
837 21.87564 0.02733 Cgb 735Val
838 21.44569 0.00596 Cga 735Val
839 8.03985 0.00836 H 736Lys
840 132.67456 0.02120 N 736Lys
841 34.41198 0.04863 Cb 736Lys
842 57.25529 0.07769 Ca 736Lys
843 170.43650 0 C 736Lys
844 4.27379 0.00556 Ha 736Lys
845 41.94342 0.06415 Ce 736Lys
846 24.50601 0.09587 Cg 736Lys
847 29.12689 0.07635 Cd 736Lys
848 1.74425 0.00441 Hbb 736Lys
849 2.98613 0.00639 Heb 736Lys
850 1.65391 0.00912 Hdb 736Lys
851 1.36823 0.01307 Hgb 736Lys
852 1.33904 0.00688 Hga 736Lys
853 1.74271 0.00508 Hba 736Lys
854 1.65383 0.01068 Hda 736Lys
855 2.98603 0.01035 Hea 736Lys
